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Preface 
Over the last ten years hyperthermia has been introduced as an experimental 
therapy that is available to the clinician in the treatment of malignant 
disease. Intensive experimental and clinical research is continuing into 
various aspects of treatment. 
Since the importance of enviromental factors in hyperthemic cellular 
destruction was realised, a large 
studies aimed at ellucidating the 
number of investigators have undertaken 
role of hyperthermia on cells under the 
influence of such factors as nutrition, oxygenation and hydrogen ion 
concentration. Investigations are continuing into temperature/time 
relationships for killing of both normal and malignant tissues, while other 
studies are focusing attention on heat dose fractionation and thenna 1 induced 
thennal resistance. 
Efforts have been made to achieve greater understanding of the structure 
and functioional limitations of tumor microcirculation, of disturbances 
brought about in it during hyperthermia, and the resultant changes occurring in 
oxygenation and acid base balance at the 1 ocal 1 evel. 
Additional studies are in progress with the aim of investigating the role of 
hyperthermia in potentiating damage to normal and malignant tissues brought 
about by radiotherapy and the sequential effects of the two modalities. The 
effects of combined chemotherapy and thermotherapy are also under intensive 
investigation. 
In a clinical setting hyperthermic treatment may be given in two ways -
locally or systemically. In the case of local hyperthermia attempts are made to 
maximise the temperature rise in the malignant tissues while minimising the 
effects on norma1 tissues - in some cases by employing active cooling. During 
whole body hyperthermia treatment (WBHT) the entire patient is heated and a 
body temperature of 41.8° -42°( is reached. It is usually necessary to carry out 
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this treatment either under general anaesthesia or under a generalised sedation 
technique. 
Since 1978 hyperthennia treatment, both local and 'IBHT has been undertaken 
in the Rotterdam Radiotherapeutic Institute. This work has been carried out by 
the department of Experimental Radiotherapy and the deparunent of Anaesthesia 
of the Erasmus University, Rotterdam. 
This thesis will first discuss some relevant aspects of the theoretical and 
experimental background to the treatment. Then certain aspects of WBHT wi 11 be 
discussed, including heating techniques and anaesthesia for this type of 
therapy. Finally the results wi 11 be presented of some experiments that were 
carried out to determine the causes of some post treatment complications. 
It should be noted that this thesis restricts itself to early patho-
physiological changes induced by hyperthennia treatment and no attempt will be 
made to describe or interpret the effects of hyperthermia on experimental 
tumors or clinical malignancy. The clinical trials of Whole Body Hyperthennia 
inevitably involved a large group of specialists from a large range of 
scientific disciplines. It is intended that the results of Whole Body Hyper-
thermia Treatment should be dealt with in separate publications that are in 
preparation 
here will 
task of 
by colleagues in t.oe field. It is hoped that the U1esis presented 
provide helpful guidelines for any anaesthetist presented with the 
anaesthetising patients for Whole Body Hyperthennia Treatment. It is 
also probable that general conclusions from these studies will be applicable to 
future work in deep local body heating. With these aims in mind only the most 
important aspects of thennobiology have been presented and the reader should 
not expect to find a full review of all the work that has been perfonned on 
this subject. 
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CHAPTER I 
THERMAL SENSITIVITY OF NORMAL TISSUES AND THE INTACT ANIMAL 
Bligh (1979), has stated that constituent metabolizing cells of virtually 
all anililals and plants are destroyed by temperatures outside the approximate 
range of DoC to 45°C. 
It waul d seem, however, that the intact animal is 1 ess able to withstand 
high temperatures than its constituent tissues. Reed et al. (1964) working in 
dogs have shown that it is possible to heat the perfused liver, via portal vein 
infusion, to a temperature of 46°C for short periods of time, provided that 
hepatic r>ypoxia is avoided. Raised enzyme levels indicating possible liver 
damage gradually reduced to normal within 21 days. Lung tissue of the dog has 
been shown to tolerate temperatures up to 43°C for periods as long as 60 
minutes without significant permanent disturbance of structure or function-
Reed ( 1965). 
In the intact animal, Frankel et al. (1963) have presented evidence of 
developing generalised tissue hypoxia in dogs at body temperatures between 42° 
and 43°C, and Magazanik et al. (1980) have confirmed the occurrance of 
increasingly severe metabolic acidosis in dogs at rectal temperatures above 
42°(, It should not, however, be forgotten that temperatures of different 
tissues may vary \v'i dely in the same animal when that animal is subjected to 
hyperthermia; Dickson et al. ( 1979), working with adult pigs have demonstrated 
that, at a rectal temperature of 42°C, the temperatures of the internal organs 
may vary considerably. The temperature measured in the 1iver, for instance, is 
constently 0.1-D.4oC higher than that in the rectum. Fletcher et al (1980), 
working with anaesthetised rats, have reported that liver temperatures may be 
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as much as 2oC higher than rectal temperatures. 
Shibolet et al. (1976), have stated that levels of temperature incompatible 
1r1ith life appear to begin, in man, around 42°C, though this cannot be taken as 
an absolute limit, in view of the report of Ferris et al. (1938) of recovery of 
t\'10 out of four t1eat stroke patients admitted to hospital with rectal 
temperatures in excess of 44°C. 
The concept of critical thermal maximum (CHit) was introduced by Cowles and 
Bogart in 1944 and Hutchinson (1961) has defined it as the minimum raised body 
temperature that is lethal for the animal in question. Wright (1976), working 
with mice has established a CTM of approximately 44°C. This was the 
temperature at which heat induced convulsions and loss of the righting reflex 
was seen and usually occurred after about 90 minutes in a 40,8°C, 50 percent 
relative humidity, environment. They noted that the CTfvl was higher in animals 
preacclimatized at 30oC than those acclimatized at !5°C. They noted no change 
in CT.'I caused 
42oC or after 
by prior hyperthermic exposure to either a core temperature of 
survival from CHI exposure. Hubbard et al. ( 1977), in a study 
using rats, related mortality to the product of the rise in oc above 40.8°C and 
the minutes of exposure and found a positive correlation between the two. They 
also made the observation that long tenn survivors (in the non-exercising and 
heated group of animals) had a faster cooling rate than those animals that died 
following the experiment. Bynum et al (1977), by raising the body temperature 
by ].SoC per hour followed by passive cooling, established a CHI of 43.4°C for 
anaesthetized dogs. Above this threshold all dogs died. This confimed the 
work of Shapiro et al. (1973) who found a value between 43oC and 44oC in awake 
non-exercising dogs. 
Bynum et al. (1978), commenting on the reports of Pettigrew et al. (1974a) 
on the maintenance of patients under general anaesthesia at rectal temperatures 
of 42cC for up to eight hours without persistent side effects, considered there 
to be a need for raising the CH1 of humans to above 42oC or that the whole 
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concept of CTM should be modified. They went on to suggest that "the concept of 
CTM be expanded to include a combination of exposure time and body temperature 
which results in both CTMs and CTMc injuries". CTMs they defined as the 
thennal maximum necessary to achieve specific subclinical biotherrnal injuries 
and CTMc as that necessary to achieve the clinical syndrome of heat stroke and 
shock. To aid in the application of these concepts they used the term 
Tequivalent 42 (Teq 42). This is the thermal dose administered expressed as if 
it were in minutes at a temperature of 42.,C. They further demonstrated 
correlation both between Teq 42 and mortality in heat stressed dogs and between 
Teq 42 and mortality in mammalian cell cultures. 
Temperature Time Relationships for tissue damage 
One of the first studies of the re1ationship between the temperature and 
time of maintainance of that temperature and the succeeding tissue damage was 
and Henriques (1947) who studied the thermal reaction of performed 
the skin 
by 
of 
established, 
Moritz 
pigs - this varied from erythema to transepidermal necrosis. They 
that between 44oC and 51 °C, for every one degree rise of 
temperature the tissue required only half the exposure time to sustain the same 
degree of damage. They also established that there was a critical temperature 
for damage above which only a very small rise of temperature was necessary for 
a rapid increase in the rate of damage. Tests were also carried out on human 
volunteers and it was found that there was little or no difference in thermal 
sensitivity or reaction as between porcine or human skin. 
Similar temperature/time relationships were obtained by Cri1e (1963) and 
Suit (1977) using mice feet. The latter found a two thirds reduction in heating 
time required to produce the same effect fo11 owing clamping of the arterial 
supply at 43°C. This would indicate the importance of an intact circulation, 
and hence the ability to transport heat away from overheated areas, in the 
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mai ntai nance of them1a1 homeostasis. 
Morris et al ( 1977) used tails of baby rats as an assay system and found 
similar results in that doubling the heating time or a rise in temperature of 
1 oC had a similar effect on necrosis or stunting of tail growth between 41oC 
and 46°C. Clamping of the tails, and hence occlusion of the blood supply, gave 
a reduction in heating time by a factor of 3- equivalent to a tenperature rise 
of 1.5°C. They also established that at a critical point an increase of only 
20% in heating time or 1 ess than 1/2oC was all that was required to increase 
necrosis from 0% to 100% indicating the presence of a very steep dose 
response relationship at around the critical temperature. 
Similar temperature/time rel ati onshi ps have been demonstrated by Okumura 
and Reinhold (1978), who employed an assay method using thermal damage to the 
skin of rats. They confirmed that when the skin tenperature was lowered by )°C 
twice the heating duration was necessary to produce the same degree of thermal 
damage. 
The above 
very accurate 
Bleehan 1979). 
results would indicate the vital necessity of uniform wanning and 
temperature monitoring during clinical hyperthennia (Field and 
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CHAPTER II 
CELLULAR THERMOB!OLOGY 
ARE ~IAL!GNANT CELLS ~lORE SENSITIVE TO HEAT THAN NORMAL CELLS? 
As pointed out by Field and Bleehan (1979) in a recent review, the most 
important question to be answered is whether hyperthenni a is more damaging to 
tumors than to normal tissue. A great deal of work has been done in both 
tissue cultures and in intact animal experiments. 
In 1941 Vollmar attempted to quantitate survival of malignant cells 
following hyperthermia (Jensen sarcoma and Ehrlich ascites carcinoma from 
rodents) in comparison with normal splenic fibroblasts; she based her 
measurements on subjective assessment of growth rate of tumorss following 
exposure to various temperatures for 3 hours. It was concluded that whereas 
normal cells were resistant to thermotherapy at temperatures up to 43°C, 
malignant cells were killed at between 40'C and 42'C. Auersperg (1966), on the 
other hand, in a study based on the use of vital dye exclusion as an end point 
for cell surviva1, concluded that malignant epithelial cells derived from 
Carcinoma line C4 and C27 were less sensitive to heat than nol'Tilal human 
fibroblasts obtained by skin biopsy. 
Bender and Schramm {1966) using microscopic evidence of increase of cell 
numbers after incubation at 37°C as the criterium of cell survival after 
treat~ent, studied a number of cultures of human and animal tissues; organ and 
embryonic cultures were used as controls. They demonstrated that malignant 
cel1s were l-2°C more thermosensitive than normal cells. 
In a much quoted study ,Chen and Heidel berger ( 1969), using plating 
efficiency as an i ndicatior of survival~ detennined that C3H mouse ventral 
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postate cells, that had been malignantly transfonned by methylcholanthrene were 
more themosensitive than normal controls. Pretreatment at 42.5oC for four 
hours did not effect the rate of malignant transformation, which, the authors 
stated, demonstrated true acquisition of thermal sensitivity and not that only 
the most heat sensitive cells had been transformed. 
It may be that the method of malignant transformation has an influence on 
the acquisition of thermal sensitivity, as Ossovski and Sachs (1967) found that 
cells transfonned by a strain of polyoma virus were more stable to heat than 
untransformed cells. Similarly thermosensitivity may vary between different 
cell lines. 
Kim et al. (1974) found 1 ess colony formation abi 1 i ty, and thus greater 
thermal sensitivity in malignant HeLa cells than in nonnal mouse fibroblasts 
following hyperthermia at 42°C. 
Harisiadis et al. (1975) used colony counting following post-treatment 
incubation at 37°C as an index of survival for short exposure (less than 30 
minutes) to temperatures of 45°C. They were unable to demonstrate increased 
thermo-sensitivity of malignant cell lines (V79 and CHO derived from the 
chinese hamster and a cloned hepatoma cell line in the Morris 5123 tumor), 
when compared with nonnal cells derived from rat liver. 
G i ovanell a et al. ( 1976) state that is necessary to define malignancy and to 
decide what constitutes a neoplastic cell when considering the question of 
thermo-sensitivity. They have defined human cells as being neoplastic only 
when the cells have been cultured from human neoplasms, are aneuploid and 
capable of producing malignant tumors when injected into thymus deficient nude 
mice. On this basis, working entirely with material of human origin, they 
demonstrated higher 
comparing them with 
foetal material. In 
thermo-sensitivity in four malignant cell lines when 
normal, presumably euploid, cell lines derived from human 
these experiments the number of surviving cells following 
treatment were counted and expressed as a percentage of control (untreated) 
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numbers. Statistical significance was apparant after two hours at 43°C in the 
case of colon carcinoma cells {compared with foetal intestinal cells), and 
after 4 hours in the case of melanoma cells under the same conditions 
{comparing with foetal melanocytes). It also required 4 hours treatment- this 
time at 42.5oC- to differentiate between survival of terato-carcinoo1a cells in 
comparision w·ith foetal neuroepithelial cells, In the case of adult 
fibrosacoma cells, which were compated with adult fibroblasts~ an exposure time 
of eight hours at 43'C resulted in significant differences. It should be noted 
that the percentages of normal cells destroyed by the treatment were not 
negligible; for instance, after eight hours of treatment, though about 95 per 
cent of melanoma cells had been destroyed, at the same time about 70 per cent 
of normal melanocytes had been destroyed, Nonetheless, this study does suggest 
that; using tf1e abovementioned definitions of neoplastic cells, nonnal cells 
might be more thel1Tlo-resistant than their non-malignant counterparts. 
Dewey et al. ( !977), in a short review of cellular processes under hyper-
thermia~ considered that, in general t there are no consistant differences 
between nonna1 cells and malignant tumor cells in the·ir thermosensitivity and 
tl1ei r react·lons to t1yperthermic temperatures. They admit however 1 that studies 
of morphologiccd changes and inhibition of metabol·ic reactions such as 
resf:dration and macromolecular synthesis do tend to indicate that normal ce11s 
are more resistant to thermal stress than undifferentiated malignant cells. 
Cava"liere et al (!967) for instance, have shown that Novikoff hepotoma and 
Ehrlich Ascites carcinoma cells had a lower oxygen consumption at 42'C than at 
38'C; normal and regenerating liver cells showed similar consumptions at the 
two temperatures. Similar results were obtained by Muckle and Dickson (197!) 
who observed reduction in oxygen uptake by rabbit VX2 carcinoma cells at 42'C 
in comparison to 37.5'C, while anerobic glycolysis was not increased in either 
malignant or nonnal cells at hyperthermic temperatures, 
Some recent work by Symonds (1982) deserves mention. When comparing heat 
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sensitivity of normal mouse llaemopoietic stem cells from bone marrow (CFU-S 
cells) and Ll210 c1onogenic mouse leukemia cells taken fr"n bone marrow, it was 
shown that there was a markedly greater heat sensitivity in the leukemic cells. 
However, when Ll210 cells were grown as an ascites tumor they were not 
significantly more sensitive to hyperthermia than CFU-S cells. The effect of 
the presence of normal healthy marrow cells on the mortality of the malignant 
cells, was investigated by heating a mixture of L1210 asities cells with 
healthy marrow cells. Thermo-senstivity of the Ll210 cells was increased by 
this mixing and it was postulated that this was caused by release of lysosomal 
enzymes from heat damaged haemopoietic stem cells capable of penetrating the 
membranes of adjacent malignant cells, rendered unusually permeable by heat. 
As Field and Bleehen (1979) have pointed out, there are as yet no clear 
reasons why tumor cells would be more heat sensitive per se than other cells. 
Probably most authorities would agree that there is negligable difference 
between normal and neoplastic cells in this respect. 
FACTORS EFFECTING SENSITIVITY OF CELLS TO HYPERTHERMIA 
Cell Cycle 
Cells synthesizing mJA are relatively resistant to x-rays and hence their 
sensitivity to radiation depends on the stage in the cell cycle. This has been 
demonstrated by a number of workers including Sinclair and Morton (1965) who 
used synchronized V79 chinese hamster cells and demonstrated most x-ray 
resistance in the later part of S-phase with equal sensitivity before (G1) and 
after (G2) this period. Dewey et al. (1970) have shown that Gl cells are two or 
three times as sensitive to radiation as S-phase cells. 
When considering heat damage the teverse of the above is observed- i.e. 
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cells are more sensitive in S-phase than in Gl phase. This has been demon-
strated by Westra and De~<ey (1971) and Dewey et al. (1971). The latter authors 
considered the possibility that heat inactivation of mammalian cells resulted 
from denaturation of proteins. 
Palzer and Heidelberger (1973),working with Hela cells, found late Sand 
early G2 phases to be the most therraosensitive parts of the cycle. Cells in 
other phases, following similar heat dosages, exhibited survival that was seven 
times that of those in the late S and early G2 phases. 
Effect of Hypoxia and pH 
As will be discussed in a later pan: of this thesis, cells of malignant 
tumors are frequently in a hypoxic milieu and at a 1ow pH. It is therefore of 
considerable importance to know if these conditions will decrease or increase 
the theiTilal sensitivity of these ce11s. 
The fact that hypoxia and 1ow pH are interrelated to a certain extent makes 
consideration of the separate contribution of the two variables rather 
di ffi cult - especially in intact tissues. Separation is only feasabl e using 
cell cultures. 
Gerwecl( et al. (1974), showed that hypoxic asynchronous CHO cells were at 
least as sensitive as their oxygenated controls to hyperthermia at 45.5oC 
whereas the hypoxic cells were more resistant to radiation. Hahn (1974) also 
demonstrated that hypoxia was of little importance when considering the effects 
of hyperthemlia on HAl cells at 43°C. Tnese results were confinned for chinese 
hamster V79 cells and mouse EMT6 cells by Power and Harris (1977). 
In contrast, Harisiadis et al. (1975) found that hypoxic V79 Hamster cells 
were 'dramatically more susceptible to killing by heat than areated cells'. 
They also found, as others have done, that the reverse was true in the case of 
radiation. This vvork might be criticised on the grounds that the investigators 
12 
made no attempt to standardise the pH of the different cell groups. Recent work 
by Leith et al. ( 1982), working with human col on cells in media buffered to a 
constant pH of 7.4, have demonstrated no difference between oxic and hypoxic 
cell suspensions in terms of hyperthermic inactivation. 
It is thus probable that the process of cell killing by hyperthermia is, in 
contrast to that of radiation, largely independant of the degree of cell 
oxygenation. 
Effect of pH 
Gerweck and Rettinger (1976) demonstrated a ten-fold decrease in survival 
of CHO cells at pH 7.0 at 42oC compared to pH 7.4. At pH 6.7 decrease of sur-
vival was 500-fold. Overgaard and Sichel (1977) maintained both oxic and 
hypoxic cells (JB-!E tumor cells) at 42.5oC at a pH of 6.4 or 7.2. At pH 7.2 
the decreased survival, assesed using c1onogenic assay methods, was slightly 
enhanced by hypoxia. This increased mortality they attributed to a accumulation 
of lactic acid in the hypoxic cells caused by anerobic glycolysis, which is 
apparently unimpaired under 
Dickson (1971), Cavaliere et 
hyperthermia as earlier shown by Muckle and 
al. (1967), Mondovi et al. (1969), and Dickson 
and Shah (1972). Overgaard and Sichel (1977) went on to demonstrate a very 
much greater depression of survival after treatment at 42.5oC in cells main-
tained at a pH of 6.4 and under these conditions there were no differences 
between oxygenated and hypoxic cells. The same authors, (Sichel and Overgaard, 
1977) demonstrated that at pH 7.2 plateau cells were more sensitive to heat 
than exponentially growing cells. They were even more sensitive at pH 6.4, but 
the relative sensitivity of the exponentially growing cells had increased. 
This observation of the greater thennal sensitivity of plateau phase cells, as 
confirmed by Hahn ( 1974), is of importance due to the fact that many cells in 
solid tumors in animals are nonpoliferating and hence are relatively radio-
resistant. A similar situation may well exist in human tumors and hence these 
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observations have important therapeutic consequences. 
Freeman et al. (1980), 
the increased sensitivity 
pre- or post-hyperthennic 
of their findings with 
working 
of cells 
with CHO cells, confirmed earlier work on 
at low pH and investigated the effect of 
incubation at various pH values. The most important 
regard to the present discussion was the finding that 
past- treatment 
damage. This 
cells. 
incubation in an acid medium caused augmentation of the thennal 
effect was not however seen by Gerweck (1977), who also used CHO 
In a short review of the role of tissue envi rorrnental factors, Overgaard 
and Nielsen (1980) have postulated that the enhanced response to hyperthennia 
under acidic conditions may be effected in three different ways. There may be 
a direct increase in sensitivity to heat as shown by a decreased Do (heating 
times to reduce survival to 1/e in the exponential part of the survival curve) 
as shown in the study of Sichel and Overgaard (1977). in the second case there 
may be a reduced ability to repair sublethal damage - this is demonstrated by a 
reduced shoulder on the survival curve and can be seen in the study by Nielsen 
and Overgaard (1979). Lastly, they suggest that there may be a mechanism 
whereby reduced survival is due to lowering of the level at which thermal 
resistance occurs during prolonged heating. 
The mechanisms whereby increased thermal sensitivity is bought about by 
exposure to low pH conditions are uncertain. Overgaard (1977) initially 
suggested that lysosomal destruction of malignant cells was being accelerated 
ac a low pH and Overgaard and Poulsen (1977) have demonstrated increased 
proteolytic 
when PNJ 
activity following 
ascites tumor cells 
hyperthern1ic treatment under acidic conditions 
were incubated with cytochrome C. This was 
interpreted as meaning that lysosomal activity may account for the greater 
thennal sensitivity of malignant cells in vivo than similar cells treated in 
vitro (Overgaard 1977). 
It is not clear if extracellular pH per se is the most important factor or 
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if it is just causing a modification of intracellular pH. Haveman {1979) has 
claimed that the change of i ntracell ul ar pH is of importance in heat 
sensitivity, whereas Dickson and Oswald {1976) stated that there was no 
relationship between intracellular pH and hyperthennic cell destruction. 
Nutritional state of the cells 
A number of studies have been carried out on the nutritional state of cells 
in vitro in which the heat sensitivity has been assessed. Conflicting results 
have been obtained. Kase and Hahn {1975) demonstrated increased hyperthermic 
survival of unfed 
cells; but Hahn 
heat. The study 
plateau phase cells compared wich exponentially growing 
{1974) has shown that unfed cells become more sensitive to 
by Sichel and Overgaard {1977), already alluded to, would 
indicate that pH is the dominant factor determining heat sensitivity and 
Overgaard and Nielson (1980) considered that increased heat sensitivity of 
unfed plateau phase cells, {Hahn 1974) might be due to increased envirormental 
acidity. 
Thermal Resistance 
Gerweck {1977) has demonstrated that the shape of cell survival curves in 
response to temperature may be biphasic at marginally lethal temperatures. CHO 
cells at pH 7,4 were used and they demonstrated that at 41 oc the initial 
decrease of survival leveled off after 2,5 hours and that further treatment at 
41.5°C caused no further cell killing. A similar levelling occurred after 
three hours at 42°C, whereas at 43°C cell killing proceeded exponentially after 
2 hours of heating. Relative survival of cells heated for 4 hours at 42oC was 
decreased by low pH and it was demonstrated that at 42oC the resistant tail of 
the survival curve developed after 3.5 hOurs at a pH of 7.0 {instead of the 3 
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hrs at pH 7,4). At pH 6.7 the shoulder of sub-lethal heat damage that was seen 
in the previous curves, practically disappeared and the survival decreased 
exponentially. Similar results have been obtained by Bauer and Henle (1979) 
who went on to demonstrate that the temperature compatible with bi phasic 
survival curves could be increased by acute heat conditioning for ten minutes 
at 45oC; this causes acute thermotolerance. This phenomenom wi11 be discussed 
below. 
Thennotol era nee 
Thennotolerance is a tenn given to a certain degree of thermal resistance 
that is acquired as a result of a previous (sub-lethal) hyperthermic dose. 
Pal zer and Heidel berger ( 1973) working with HeL a cells demonstrated 
increased survival fallowing thennotol era nee development during facti onated 
dosage of 42oC hyperthermia. This thermotolerance developed after 2 treatments 
of one hour each separated by an interval of 3 hours and declined by the time 
the separation interval had reached 8-10 hours. They concluded that their cells 
were recovering from sub-1 ethal hyperthermic damage. 
Gerner et ai (1976) also working with Hela cells demonstrated that the 
degree of thermotolerance acquired following a first thermal dose depended on 
the magnitude (temperature/time product) of that dose. They demonstrated that 
cell metabolism was necessary by showing that tolerance did not develop when 
the cells were incubated at OoC in the period between the two hyperthermic 
exposures. This has been confirmed by Stickney et al (1980), who have 
presented results that suggest tl1at manipulation of polyamine biosynthesis can 
be effective in regulating the development of thermotolerance and have shown 
that if polyamine decarboxylation is inhibited thermotolerance does not 
develop. 
Nielson and Overgaard (1979) investigated the effect of extracellular pH on 
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thermotolerance and recovery of hyperthermic damage in vitro. The L!A2 cells 
that they studied developed maximum tal erance 10 hours after the first thermal 
dose. The degree of tolerance in cells grown in a pH adjusted modified Krebs-
Ringer phosphate buffer was lower in conditions of increased acidity. The 
pattern 
s trated 
of development with 
that a low pH in 
time, however, did not change. They also demon-
the interval between hyperthermia treatments was 
the observed i nhi bi ti on of thennotol era nee particularly responsible for 
development. Nielson 
found that, though 
similar, the degree 
(1981) studied unfed L1A2 cells in plateau phase and 
the overall pattern of thermotolerance development was 
of tolerance was less than that found in exponentially 
growing cells. It was also noted that this was not due to the increased environ-
mental acidity in the plate au phase cells. 
Gerweck and Bascomb (1982) investigated the effect 
development of thermotolerance. They concluded that, 
of hypoxia 
using CHO 
on the 
cells, 
'reduction in oxygen concentration during and between heat treatments effected 
neither the magnitude nor the kinetics of thermo tolerance development'. There-
fore it may be concluded that hypoxia alone is not an important factor in 
causing change in thermotolerance but that pH is the most important environ-
mental factor determining this phenomenon. 
L i et al ( 1982) in experiments using plateau phase chinese hamster HAl 
cells came to the conclusion that the duration of the first (sensitising) dose 
had very little to do with the rate of development or the decay of thermo-
tolerance. They also found that a low sensitising temperature 41oC or 42oC 
caused maximum thermotolerance to develop earlier than when a high sensitising 
temperature (43°C) was used. They hypothesized that thermotolerance is an non-
specific defence mechanism of cells and that sublethal damage caused by the 
first thermal dose triggers a mechanism that can only act successfully when the 
cells are maintained at a temperature below 43°C- hence the apparent inconsis-
tency of their findings. 
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Step Down Heating 
This is a term used to describe an interesting phenomemon in temperature 
time heating relationships. A marginally lethal or non-lethal temperature may 
become toxic when preceeded by acute heat treatment of higher temperatures such 
as 45°(, Henle and Leeper (1976), while studying the combined modalities of 
hyperthennia and radiation on CHO ce11s, demonstrated reduced survival 
following incubation at 40oC given after a pretreatment at 45°(. 
Henle et al. (1978) presented similar results, again using CHO cells. They 
showed that increased cell killing was dependent on the temperature of the post 
treatment incubation. They 
hyperthermia temperature of 
also produced evidence that preincubation at a low 
40°( reduced cell killing at 45°(. This they 
attributed to enhanced cellular capacity to accumulate sub-lethal damage, 
though it might also be considered as being due to induced thermotolerance. 
~1odi fyi ng Treatments 
Search is continuing for chemical substances that will modify the effects 
of hypertherm·ia. Not only will these modifications indicate possible causes of 
hyperthermic damage but may point the way to more effective clinical treatment. 
Henle and Leeper (1982) have recently reported studies of hyperthermia on 
CHO cells in which inhibitors of macromolecular synthesis were used. Exposure 
of the cells to cyclohexamide for 2 hours before a 2 hour treatment at 45oC 
increased survival by a factor 1,8. When the drug was administered during a 7 
hour 37oC incubation following a 10 minute 45oC heat treatment a 50% decrease 
in subsequent therrnotolerance development resulted. Lucanthine, a reversible 
inhibitor of RN.A synthesis, and hydroxyurea, an inhibitor of DNA synthesis had 
no effect on the development of thermotolerance. This would indicate that 
thennotolerance may require synthesis of new proteins. 
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Yatvin {1977) has studied membrane effects and cell killing by hyper-
thermia. Using a B coli mutant, K1060, in whict1 the unsaturated fatty acid 
{UFA) content of the cell membranes could be altered, he concluded that the 
higher the UFA content, and hence the lower the viscosity, the lower was the 
hyperthennic killing rate. By increasing membrane fluidity with Procaine he 
was able to increase cell killing. Yau (1979) has confinned this increase in 
hyperthennic mortality caused by Procaine and has found it to be dose 
dependent. These findings .suggest, at least in part, that thennal killing may 
be attributed to changes in ce1lu1ar membranes caused by hyperthermic exposure. 
Azzam et al (1982) incubated chinese hamster V79 cells at various hyper-
thermic temperatures in 87% Oeuterated Water (020) (which has been shown to 
cause stabilization of macromolecular structures). Below 43oC the thermo-
resistant tai 1 of the survival curves occurring in untreated controls was 
e1 imi nated in the cells incubated in 020, but above 43oC themwprotecti on was 
provided. This may indicate stabilisation of either cellular membranes or DNA 
and enzyme structures in the cell. 
Glycerol has been shown to significantly increase the temperature at which 
50% protein denaturation occurs (Back et al. 1979) and Henle and Waters (1982) 
have recently demonstrated that it can protect CHO and Hela cells against 
thermal killing. This protection was concentration dependent. They also demon-
strated that glycerol could protect cells at low extracellular pH and could 
increase thermal resistance of cells undergoing step down heating. An 
interesting observation was that, during long tenn nutrient deprivation {8.5 
hours), glycerol increased cell killing at 41.5°C. Therefore protection by 
glycerol must be dependent on the presence of, or a metabolic by-product of, 
some unknown deficient nutrient. 
Discussion of the interactions of hyperthermia and chemotherapeutic agents 
will be discussed a later section. 
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CO~iBINED CELLULAR EFFECTS OF HYPERTHERt1IA AND RADIATION 
There is a 1 arge amount of work that indicates that hypertl1enni a 
potentiates radiation damage in cells (Ben-Hur et al. 1974; Kim et al. 1974; 
Power and Harris 1977; Ross-Riveros and Leith 1979) • 
Hyperthermia has been shown to cause a steeper slope of the survival curve 
fo1lowing radiation and, in most cases, causes a reduction in the 1 Shoulder 1 of 
the curve. As already r.1entioned hyperthennia sensitivity and radiobiological 
sensitivity occur at different stages in the cell cycle. Kim et al. (1976) 
using synchronized cultures of Hela cells has shown that combined treatment of 
hyperthemi a and radiation resulted in various i ntensi ties of enhanced ce11 
killing throughout the cell cycle. The greatest synergism occured in cells in 
the late S phase. 
Ben-Hur et al. ( 1974) used split dose experiments with CHO cells to 
demonstrate that hyperthennia was inhibiting repair of sub-lethal damage. This 
view of the action of the combined modalities was supported by Dewey et a1. 
{1977), and Suit and Gerwick (1979). 
Suit and Gerwi ck ( 1979) have sumrnari sed experimental evi de nee and have 
concluded that there is no evidence that sensitisation to radiation by 
hyperthennia is greater in malignant than in cells of nonnal tissue origin. 
Effects of Hypoxia 
Hypoxic cells are less sensitive to radiation than are well oxygenated 
cells and the oxygen enhancement ratio (OER} for radiation is in the order of 
2.5 to 3 (Suit and Gerwick 1979) - in other words cell killing is increased 
when the cells are oxygenated. In the case of hyperthermia the OER is 
approximately unity i.e. there is in general no greater thenTiosensitivity in 
oxygenated as opposed to hypoxic cells. 
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A number of studies have been carried out into the influence of hyperthermia on 
radiation OER in the mammalian cells. Robinson et a 1. I 1974) and Kim et al. 
(1975) used mouse bone marrow and Hela cells respectively. They demonstrated 
reduced OER's at hyperthermic temperatures. Power and Harris (1977), however, 
in studies with E~1T6 mouse tumor cells and V79 chinese hamster cells showed no 
change in OER at 43'C. 
These studies would indicate that differences exist between different types 
of malignant cells in th.eir sensitivity to combined heat and radiation and 
would point to the necessity, in some cases, of sequential applicat·ion of the 
two modalities. 
Effect of pH 
The effect of 1 ow pH on the cell ki 11 i ng of the combined modalities of 
radiation and hyperthenni a is of no small importance. This is especially so 
when it is realised that both normal and malignant cells are probably equally 
sensitive to the combined treaunents (Suit and Gerwick 1979) and that there are 
areas of low pH in tumors (Bicher et al. 1980). 
Rottinger and Mendonca (1982) have demonstrated that both human glial cells 
and chinese hamster ovary cells showed improved post radiation survival if 
maintained at a low pH following treabment. 
Lunec and Parker (1980) working with Hela-S3 cells established that these 
were more sensitive to hyperthennia at pH 6.7 than at 7.4. They went on to 
demonstrate a slight increased tlyperthennic potentiation of radiation damage at 
the lower pH value. 
Freeman et al. ( 198la) 
when radiation was carried 
demonstrated slight radioprotection of CHO cells 
out at an acid pH - thus confirming the work of 
Haveman (1980) who obtained similar results working with murine carcinoma 
cells. Freeman et al. (1981a) went on to show that both heat treabment alone 
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and combined heat and radiation in acid medium produced more cell killing than 
treatments in alkaline medium. Subsequent recovery from heat damage was less 
in an acid pH. FreBnan et al. (198lb) have produced similar results working 
with Madcap-37 cells and in addition, showed that an acid environment prolonged 
the duration of hyperthermic radiosensitisation when heat preceeded radiation. 
Timing of Heat and Radiation 
Sapareto et al. {1978), in an extensive investigation into the combined 
effects of X-irradiation and hyperthemia on CHO cells, studied not only the 
timing of radiation 
the two modalities 
concluded that when 
in relation to heat, but also investigated the effects of 
on cells in different stages of the cell cycle. They 
relatively sublethal heat doses were given, (as would be 
the case in whole body hyperthermia treatment), maximum decrease in survival of 
asynchronous cells occurred when heat was given during, or following radiation. 
They noted the fact that a five minute difference in timing could well make a 
6 fold difference in the resulting cell survival. They also found that the 
regime of heat application immediately before, or immediately after, sensitized 
S phase cells to radiation. These cells are nonnally radioresistant but, under 
these conditions, there were no differences in survival between S phase and Gl 
phase cells. 
Dewey and FreBTian ( 1980) have postulated that, though the maximum effect on 
cells occurs fol1 owing simultaneous admi ni strati on of hyperthenni a and 
radiation, it may be possible to obtain a therapeutic gain by administering 
heat after radi.ation damage in tumours is repaired. This would be due to the 
enhanced thermal killing observed at low pH occurring in malignant tissues, the 
characteristics of which will be discussed in another chapter. 
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COMBINED CELLULAR EFFECTS OF HYPERTHERMIA AND CYTOTOXIC AGENTS 
Several anticancer agents have been shown to have increased activity at 
hyperthermic temperatures and to acquire increased cytotoxicity at tempertures 
that are obtainable during WBH or local hyperthermia treatment. Indeed some 
substances, not usually considered as cytotoxic at normal body temperatures, 
may acquire such activity under hyperthermic conditions. Field and Bl eehen 
(1979) have reproduced a classification of types of drugs and their actions at 
elevated temperatures. As they have pointed out, this is a somewhat arbitory 
classification, but it may be a useful one and is used below. 
Drugs Which Show no Threshold Effect 
These drugs are cytotoxic at normal temperatures and are more so at in-
creased temperatures. Johnson and Pavelec (1973), while studying the increased 
cytotoxicity of thio-TEPA under hyperthermia on chinese hamster fibroblasts, 
demonstrated a 
they 
by 
considered 
doubling of cell killing at 40'C in comparison to 37'C which 
to be a purely chemical effect consistent with that predicted 
reaction kinetics i.e. the cellular inactivation rate was linear with the 
rise in temperature. 
Other agents falling into this group are the nitroso-ureas and 
Cis-platinum; Hahn (1979) using chinese hamster HAl cells has demonstrated the 
increased efficiency of cell killing produced by these drugs at increased 
temperatures. 
Drugs exhibiting a threshold temperature effect 
a) cytotoxic drugs 
These drugs, though they may be cytotoxic at 37'C, appear to have a change 
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in action at a critical temperature of 43°C. Above this level their cell 
killing effect is considerably increased. 
Braun and Hahn (1975) have demonstrated this effect with bleomycin and 
attributed it to tne fact that the 43°C hyperthermia was preventing recovery of 
potential lethal damage caused by the chemotherapeutic agent. Hahn and Strande 
{1976), working with chinese hamster cells, demonstrated this effect using 
adriamycin. This lethal effect was short lived but prolonged heating (30 
minutes or more) caused a decrease in the cell killing. This effect was also 
seen if heating was applied before the administration of the drug. These 
effects they attributed to a biphasic permeability of the cell membranes to 
adriamycin, which was first increased by heat and later decreased. 
Donaldson et al. (1978) have also demonstrated this type of hyperthermic 
protection against cytotoxicity occurring in the case of actinomycin D. They 
showed in addition that heat, administered both before and after the drug may 
cause decreased ce1l killing and were able to demonstrate that this was not 
caused by 
have many 
altered membrane 
others, the 
permeability. They have rightly pointed out, as 
need for careful timing of admi ni strati on of 
chemotherapeutic agents when given as part of a hyperthermic regime. 
b) non-cytotoxic agents 
A further sub-group may be described as containing drugs not normally 
having cytotoxic properties at 37oC but which induce increase cell kill at 43°C 
or above. The polyeme antibiotic amphoteracin B is not cytotoxic at 37oC or 
4!°C, as shown by Hahn et al. (1977), but these investigators demonstrated that 
it produces a high degree of cell killing at 43°C. 
L i et al. (1977) have demonstrated that some organic solvents, used to 
dissolve water insoluble chemotherapeutic agents, may themselves become highly 
cytotoxic at raised temperatures. 
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Effects of Hypoxia 
The effect of hypoxia on chenotherapeuti c agents may well be important as 
pointed out by Field and Bleehen (1979). 
Roi zi n- Towle and Hall ( 1978) have demonstrated that hypoxic V79 chinese 
hffinster cells are more sensitive to bleomycin under both hypothermia (17.5°C) 
and hyperthermia (42.5° C) than are oxygenated cells. At 37.5°C, on the other 
hand~ oxygenated cells were more sensitive to the drug than hypoxic ones. 
A certain amount of work has been done on combination of electronaffinic 
nitroimi dazol e radi osensitizers and hyperthermia. Stratford and Adams ( 1977) 
have demonstrated that though l~isonidazole showed no toxicity (at the tested 
concentrations) against aerated V79 cells at 37oC and 41°C, an effect was seen 
at 37oC against hypoxic cells and this was very much increased by exposure to 
41°Co 
It would appear that cell killing potentiation by Misonidazole is not 
1 imited to hypoxic cells. Roi zi n- Towle and Hall ( 1978) have demonstrated that 
aerated V79 cells exhibit decreased survival following combined treatment with 
Bleomycin and fviisonidazole as compared with Bleanycin alone. The cytotoxic 
effect of heat in combination with mi soni dazol e has been confi nned by Stone 
(1978) using oxygenated cells from mouse 3HC mammary tumors. 
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CHAPTER I II 
THERMOBIOLOGY OF TUMORS 
Tumors and 
teristic of 
these blood 
normal tissues are not only composed of cellular material charac-
that tissue but also contain blood vessels. The blood contained in 
vessels assist in the transport of oxygen and other necessary 
organic and inorganic substances to the tissue, and removal of carbon dioxide 
and other products of cellular metabolism. 
Tumors 
tumor may 
metabolic 
often contain areas of inadequate circulation and hence part of the 
be hypoxic. Due to the inability of the circulation to remove acid 
products of the hypoxic metabolism, the tumor may also be at a lower 
pH than the surrounding normal tissues. 
Heat is also transported about the body by the circulation. For instance, 
cool blood f1 owing through a heated tissue tends to cool it down and if the 
circulation to one part of the tissue is less than to another part, the first 
will be cooled less than the second. Hence, during whole body hyperthermia 
differential heating and cooling of tumors and their overlying normal tissue 
may occur. Though this exp 1 anati on is the one usually offered to exp 1 ai n this 
phenomenon (LeVeen et al. 1976), Gullino et al. (1978), using 'tissue isolated' 
tumors~ were unable to produce a change in the difference between the tempera-
ture of the tumor and the surrounding tissue brought about by changes that 
they induced in tumor blood flow. 
Another aspect of hyperthermic 
effect of hyperthermia on the 
therapy< that must 
circulation to the 
be considered is the 
tumor and the resultant 
changes brought about in the internal milieu of that tumor. The following 
section ltJi11 attempt to deal with the characteristerics of tumor circulation 
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circulation and consequent tumor environmental effects that are the result. 
TU~tOR CIRCULATION 
Tumors may be regarded as having a macrocircu1ation and a microcirculation. 
The macrocirculation is provided by blood vessels derived from neighbouring 
structures and adjacent tissues. The amount of this circulation will vary, 
depending on tne total blood flow to the area of the body in which the tumor is 
situated. It will also vary according to the amount of blood that is admitted 
to the microcirculation of the tumor. At certain levels of hyperthermia the 
m i croci rcul ati on in tumors may be increased. 
Eddy {1980) working with a squamous cell carcinoma in a hamster cheek pouch 
preparation has demonstrated vasodilatation in tumor vasculature at 43°C. Song 
et al. {1980) 
flank of rats 
using the Walker 256 carcinoma implanted subcutaneously in the 
has shown increases in blood flow in small tumors {0.3-0.7 gms) 
at 43oC whereas larger tumors (2-5 gms) showed a decrease in blood flow at the 
same temperature. These changes will alter the amount of blood admitted to the 
microcirculation. 
Whole body hyperthermia may cause different changes in blood flow in 
different parts of the body, and it has been shown that splancnic blood flow 
may be significantly decreased under these conditions {Faithful] 1982). Though 
total f1 ow through the mi croci rcul ati on of a 1 ocally heated tumor may be 
increased if situated in, for instance, the skin, the same tumor in, for 
example, the liver may show dramatic deo·eases in its microcirculation at the 
same temperature if the organism is subjected to whole body hyperthermia. 
Measurement of Tumor Blood Flow 
Measurements of total blood flow to tumors are reported by a number of 
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authors using a variety of techniques. These techniques can be divided into 
two distinct categories (Applegren 1978) - volume flow measurements and the use 
of radioactive tracers. 
a) Vo 1 ume flow measurements 
Volume flow measurements consist of direct or indirect measurement of flow 
into or out of the tumor. If the circulation of a tumor can be isolated to a 
certain extent within the body, total venous outflow can be measured. 
Pioneering work in this respect was performed by Gullino and Grantham (1961). 
Similar methods have been used by Grantham et al. (1973) and Vaupel (1975). 
The arterial inflow into a tumor can be measured indirectly by venous occ1 usi on 
plehtysmography provided the tumor is in a suitable position- for example 
subcutaneously implanted in the foot or tail of small animals (Kjartansson et 
al. 1976). 
b) Use of Radioactive Tracers 
The second method of measuring blood flow consists in the use of radio-
active tracers whose concentration in the tissues are measured and give a 
reflection of the blood flowing through that tissue. Radioactive microspheres 
have been used by Blachard et al. (1965) and Rankin and Phernetton (1976). 
Takacs et al. (1975) have measured total tumor flow using a radioactive isotope 
of rubidium, Rb86. The method of measurement was devised by Sapirstein (1958) 
and can be used with 1131 antipyrine and C14 antipyrine uptake (Allen et al. 
1975). 
Measurement of mi croci rcul a tory flow 
The microcirculation or local tumor blood flow may be estimated by a 
variety of clearance techniques and Xe131 has been extensively used for this 
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Authors using this method include O'Brien and Veall (1974) and Robert purpose. 
et al. (1967). Na24 clearance has also been used to measure flow in malignant 
tissues by Peterson et al. (1969). Additional methods of measuring local tumor 
blood flow included distribution of dyes such as lissamine green as used by 
Owen (1960) and the use of Evans blue by von Ardenne and Reitnauer (1980b). 
Reinhold (1971) has used serial microangiogrillns. Heat clearance techniques have 
been used by ~roll er-Kl i eser et al. ( 1982). 
Peterson (1979) has summarised the results of var~ious studies in tumor 
blood flow and concludes that blood flow per unit of tissue volume decreases as 
tumor increases in size and this is reflected in the incidence of central tumor 
necrosis. Blood flow through tumor tissues is, in general, lower than the 
normal tissue of origin and is essentially inhomogeneous. 
Direct observations of BA1112 sarcomas, implanted in rats, have been made 
by Endri ch et 
able to confirm 
al. (1979) using modified Algire chamber techniques. They were 
both temporal and functi anal blood flow i nhomogeni ety in 
growing tumors. They demonstrated greater mean blood flows in peripheral 
actively growing areas of the tumor (in comparison with the surrounding normal 
tissues), but they measured decreasing flows towards the central (necrotic) 
areas of the preparations. 
EFFECTS OF HYPERTHERMIA ON TUMOR CI RCULAT!ON 
Direct microscopic observation of the microcirculation under conditions of 
hyperthermia is difficult. It has, however, been accomplished. 
Reinhold (1971} using a modification of the Algire Chamber System (Algire 
1943} has developed a method of growing 'sandwich tumors' - sheets of a tumor 
of approximately 50 microns in thickness complete with their microvasculatures. 
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These sheets are grown in situ on the host animal and the preparation is 
sufficiently translucent to allow light microscopy and study of growth and 
reaction of the microcirculation under various conditions. Reinhold and van 
den Berg-Bl ok 
of 42oC and 
demonstrated 
(1981) using a similar 'sandwich' preparation studied the effect 
42.5oC hyperthermia on a Rhabdomyosarcoma BA1112 in rats. They 
a latent period of about one hour at 42.5oC before vascular 
changes occurred. These were first manifested as a slowing of the micro-
circulation and after three hours microcirculatory damage was evident. On the 
following day the tumors demonstrated extensive central necrosis. 
At 42oC essentially the same damage occurred but to a much lesser extent. 
Additional treatments with misonidazdole, glucose or 5-thio-0- glucose at 42oC 
caused similar degrees of damage to those obtained at 42.5oC thus indicating a 
degree of 1 thermosensiti zati on 1 produced by these substances. 
In a further paper (Reinhold and van den Berg-Blok in press), the same 
authors studied 1 Step-down 1 heating. They pointed out that using the 1 t~ per 
oC' rule (whereby a rise of treatment temperature of 1oC requires half the time 
exposure to produce the same damage) the 50% circulation stoppage time was 
essentially the same for similar thermal doses, but that with step down heating 
the microci rcul ati on in the surrounding tumor bed was more impaired than was 
to be expected from simi 1 ar temperature/time related treatments at lower 
temperatures. This would indicate a possible increased tumor destruction 
following step down heating. 
Eddy ( 1980) has used a transparent cheek pouch chamber in the Syrian 
hamster. Temperature of the in vivo preparation was controlled by allowing 
water to flow through the compartmentalised chamber. Following an initial 
decrease of vascula1· diameter at all temperatures, at 43° and 45° vasodila-
tation occurred, followed at 43° by occurence of petechiae and signs of 
endothelial degeneration in the presence of persistent hyperaemia. At 45° 
haemorrage and thrombosis was accompanied by a canplete shutdown of circulation 
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and was followed by coagulation necrosis. 
Indirect studies of tumor vasculature have been carried out by Song (1978) 
who studied subcutaneously implanted Walker 256 carcinoma preparations in rats. 
locally heated in a water bath for 60 minutes at a temperature of 43°[, 
Vascular volume studies using Cr51 labelled red cells revealed significant 
increases in skin and muscle blood flow but not in the tumors. Similar changes 
were found in vascular permeability studies (using !125 labelled albumin) -
again no changes in the tumor tissue. This lack of vascular changes in tumors 
under hyperthermia would account for the differential heating of tumors and 
normal tissues that has been claimed during hyperthermia by LeVeen et al. 
(1976) and Kim et al. (1977). 
Song et al. (1980) went on to correlate the effects of hyperthermia on 
vascular function, pH, and cell survival. They demonstrated no change in blood 
flow in Walker 256 carcinomas subcutaneously implanted in rats and heated for 
one hour at 43°C, while at the same time skin and muscle blood flow increased 
to 3 
blood 
or 4 times the value at nonnothennia. Only in smaller tumors did the 
flow increase during one hour heating at 45°[, Blood flow in the larger 
tumors was significantly decreased at three hours after a heat treatment of one 
hour at 45°C. 
In the case of SCK 
implanted subcutaneously 
flow at temperatures as 
reasonable to postulate 
tumors {i.e. a mammary adenocarcinoma} which were 
in mice, they demonstrated marked slowing of blood 
low as 41oC ceasing completely at 45°C. Hence, it is 
that different tumors (or different species) may be 
more or less sensitive to hyperthermia depending on the vulnerability of their 
vascular system or of the malignant cells in the tumor system. 
The pH changes demonstrated by Song et al. (1980) correlated fairly well 
with the vascular sensitivity at various temperatures. At effective 
temperatures a fall in pH was observed. This would show partial return to 
prehyperthermia values during a recovery period. Further falls were seen when 
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heating was reapplied. 
MILIEU INTERNE OF TU~IORS 
In view of the importance of the acid/base and oxygenation state of cells 
exposed to hyperthermia, a number of studies have been carried out into the pH 
and p02 status of tumors both under nOl1llothennic and hyperthermic conditions. 
Bicher et al. (1980), working microelectrode systems with subcutaneously im-
p1 anted C3H mouse tumors, confirmed that, in general, tumor p02 is very i nhomo-
genous, being extremely low in some areas that are at the same time~ at a very 
low pH. They showed that though there was an initial rise of p02 with 
temperature in tumor, muscle and brain tissue, the 1 break point' (i.e. the 
temperature above which the p02 fell precipitously) was much lower in tumor 
than in the other two tissues. They also demonstrated, using hydrogen 
clearance methods, a fall in blood flow occurring at or near the breakpoint. 
The same authors demonstrated that the average interstitia1 pH of tumors was 
6.8 and this value was decreased to a mean value of 6.2 fo11owing one hour of 
43°C hyperthermia. 
Vaupel (1979) reporting results of other investigations (Vaupel et al. 
1974; Vaupel 1976; and Vaupel 1977), has demonstrated that oxygen consumption, 
per gram of tumor, decreases when a tumor becomes larger. This is accompanied 
by an exponential decrease in total blood flow per unit weight (Vaupel 1974). 
Under conditions of slightly increased temperature, Vaupel et al. (1977) 
demonstrated tr1at total 
carcinomas implanted in 
IHS raised from 37oC 
tumor blood flow and oxygen consumption (in OS 
rat kidneys) rose significantly when the temperature 
to 39.5°C. When the temperature was further raised to 
42°C, the values of both these parameters fell to below those occurring at 
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3rc. 
Vaupel (1979) using polarographic methods and oxygen microelectrodes of 2-5 
microns tip diameter has demonstrated that (in all but most superficial areas 
of 0-180 microns depth) marked differences of p02 exist only in the region of 
blood vessels. For the most part a monotonous pattern of very low p02 
predominates. Respiratory hyperoxia, as expected, had little effect on the 
oxygen tensions in tumor tissue, and haemoglobin oxygen saturations were only 
slightly increased from the very low values obtained at normoxia (Vaupel et al. 
1978; Vaupel et al . 1980). 
Vaupel (1980) during a study using one micron tip diameter pH micro-
electrodes has essentially confirmed the work of Bicher et al. (1980) by 
demonstrating that exposure to 43oC for one hour could reduce the pH value in 
experimental tumors by a mean of 0.54 units as compared with preheating values. 
He also noted that the pH of large tumors (mean 7.21) was distinctly higher 
than small tumors (mean of 6.75). Von Ardenne and Reitnauer (1980) have 
published similar evidence for a decrease in pH following hyperthermia. 
Reports on pH in human tumors are scarce. llaeslund and Swenson (1953) 
reported 5 pH measurements in gynaecological tumors; the mean value was 6.94. 
Pampus (1963) reported a mean value of 6.84 in miscellaneous brain tumors, 
whereas Meyer et al. (19•8) working on specimens after surgical removal 
obtained very low values of 5.54- 6.75. A recent study by van den Berget al. 
(1982) have reported mean pH values of 7.29 in mammary tumors in humans. 
Although these values were higher than those reported in other publications 
they were, never-the-less significantly less than subcutaneous values (mean 
value of 7.63). The same authors using the same electrode systems reported a 
mean pH of 7.15 in 24 measurements of rat Rhabdomyosarcomas and a mean of 7,59 
in rat muscle. 
Faithfull et al. (1980) have reported the results of pH monitoring under 
Whole Body Hyperthermia at 41.8°C. In the few cases that they reported they 
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observed no significant overall change in the pH as a result of hyperthermia 
though temporary changes caul d sometimes be induced by variations in arterial 
blood pressure, cardiac output and pC02. Bicher and Mitagavaria {1981) have 
reported pH and p02 changes in malignant tissues of mice under local hyper-
found a decrease of pH of 0.5- 1 unit following one hour treat-thenni a. They 
ment at 43'C. P02 dec rea sed to very low levels at 46'C. A sharp decrease in 
blood flow occurred at around the 'breakpoint' for oxygen {43'C). This would 
indicate that circulatory failure might well be the cause of the hypoxia that 
they observed. 
Glucose uptake in malignant tumors has been measured by a number of 
authors, but always in 'tissue isolated' tumors. Vaupel et al. {1980) using DS 
carcinoma in rats have found that glucose uptake is significantly increased at 
39'C and returns to the initial nonnothermi a 1 evel after further heating and 
temperature stabilization at 42°C. Arterio-venous differences and glucose 
extraction did not change under constant hyperthermia for 30 minutes. The same 
is true for 1 actate release. The changes were similar in both 1 arge and small 
tumors. However, Vaupel et al. {1976) have shown that the uptake of glucose per 
gram of tissue is less in large tumors than in small ones. On the other hand, 
Gulli no et al. {1978) have failed to demonstrate any consistent change in glu-
cose uptake under hyperthermia of 42'C for one hour. These authors used Walker 
256 and fv1TW9A tumors in rats. This would once more indicate differences in 
hyperthenni c metabolism in different tumor systems. 
The phenomenon that decrease of interstitial tumor pH occurs following 
massive intraperitoneal administration of glucose has been known for many years 
{Eden et al. 1955). This is attributed to build-up in the tumor of lactic acid 
produced by anaerobic glycol isis due to an inadequate circulation to the malig-
nant tissues. This phenomenon has recently been demonstrated in Rotterdam {van 
den Berg, personal communication) and the drop in pH following the administra-
tion of glucose was as much as 0.6 pH units. This phenomenon is not observed 
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with other sugars such as glactose or fructose (Eden et al. 1955, Voeghtlin et 
al. 1935). 
This hyperacidification of tumors occurring in the presence of increased 
anaerobic glycolysis is part of the central concept of the 'cancer multi- step 
therapy' (van Ardenne and Reitnauer 1980a; von Ardenne and KrUger 1980). The 
build-up of lactic acidosis is said to occur predrnninately at the venous end of 
the capillaries and, due to the stiffening of erythrocytes under the influence 
of 1 ow pH ( Smi d-Schonbei n et al . 1973), vascular occlusion occurs. Vaupel et 
al. (1980) have confirmed that this mechanism can be operative in areas of low 
pH ( 6 .4) under conditions of 42" C hyperthermia. Sluggish flow in the capi 11 ary 
beds would then tend to increase relative viscosity of the blood and under 
conditions of low sheer (low blood velocity) stasis would occur. This would 
lead to further acidification under the influence of anerobic glycolysis and so 
retrograde stiffening of the erythrocytes will occur. This is said to produce 
virtually complete destructon of the tumor circulation (von Ardenne and 
Reitnauer 1980). 
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CHAPTER IV 
HEATING TECHNIQUES 
Basically, heating techniques for whole body hyperthermia (WBHT} in use 
over the last few years divide into two types. In the first technique the skin 
is used as the major heat exchange organ. Blood is warmed by flowing through 
the heated and vasodilated skin and the heat is thus distributed to the rest of 
the body. The lungs may also be used as a secondary heat exchanger. A second 
metf1od is warming by use of an extracorporeal circulation circuit and heat 
acquisition by passage through an extracorporeal heat exchanger. Different 
heating techniques will be briefly described while the technique using the 
Siemens cabin in use in Rotterdam will be described in more detail. 
Having considered the section on thennobiology in this thesis, it may 
reasonably be asked why a treatment temperature of 41.8oC is used for Whole 
Body Hyperthermia Treatment when considerable evidence has been presented that 
maximum benefit in tenns of cellular destruction takes place at considerably 
higher temperatures. The reason for choosing this temperature is partially 
explained in Chapter I where it was pointed out that the intact animal is more 
sensitive to high temperatures than its constituent tissues. It was pointed 
out by Shibolet et al. (1976} that 42°C should be taken as the point above 
which survival in man may be jeopardized. In dogs this level is probably 
between 43°C and 44oC (Bynum et al. 1977; Shapiro 1973}. Evidence will be 
presented in a later chapter indicating that 41.8° - 42oC is the point above 
which in man unacceptable organ toxcity- in particular liver hepatic toxity, 
begins to appear. 
The question arises as to if in fact 41.8°C is a temperature at which 
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therapeutic gain can be expected. As pointed out in the preface, this thesis 
is restricted to a discussion of the short term effects of WBHT but, suffice it 
to say that numerous studies of WBHT revealed that clinical benefit may be 
gained from treatment in the 41.8° 42°C range of treatment temperatures 
(Pettigrew et al. 1974b; Larkin et al. 1977; Moricca et al. 1979; Bull et al. 
1979; Parks et al. 1979; Hennan et al. 1982, and many others). 
Hot Wax 
This technique was devised by Henderson and Pettigrew (1971) in Edinburgh, 
who introduced the revival of interest in WBHT in recent years. A mixture of 
paraffin wax B.P. (melting point 43°C) is heated to a temperature of 45°C. The 
anaesthetised patient is placed in a bath-like container and the molten wax is 
poured over him. The wax, as it comes into contact with the cooler skin 
surface, begins to solidify and, in so doing, the latent heat of fusion is 
released, producing yet more heat to warm the blood flowing through the skin 
without increasing the temperature. 
The patient may produce sweat under the influence of the rising body 
temperature, but this sweat is prevented from evaporating by the wax which 
forms a seal against the surface of the body. A further advantage of wax is 
that the body of the patient tends to float in it and hence pressure points are 
reduced to a minimum. Pressure necrosis and burns in certain points, for 
instance the wrists, elbows, heels etc may easily occur following Whole Body 
Hyperthermia treatment and are caused by occlusion or reduction of blood supply 
due to pressure on skin that, due to its raised temperature, probably has a 
greater oxygen consumption than normal and hence a greater susceptability to 
damage. 
Using this method it is possible to raise the temperature to 42oC in one 
hour (Pettigrew and Ludgate 1977). The plateau temperature is maintained by 
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allowing the body to come into thennal equilibrium by removing or peeling back 
portions of the solidified wax and allowing a greater or lesser degree of 
evaporation of sweat from the skin surfaces so exposed. The hot \vax method has 
been applied by MacKenzie et al. (1975); Pettigrew et al. (1974); and Pettigrew 
and Ludgate, ( 1977). 
A slightly less 
first placing the 
messy modification 
patient in a large 
of the original technique consists of 
plastic bag - a not inconsiderable 
undertaking when the patient is anaesthetised! This modification has been 
practised by Blair and Levin, (1977) and Greenlaw et al. (1980). A disadvantage 
of the modification is that access to the patient is somewhat more limited than 
in the original wax-only technique. 
Hot Water 
a} Immersion 
A logical progression in the total emersion theme is to use water in place 
of the wax in the 1 Pettigrew technique 1 (as this has become known}. Water 
emersion has been used by Versteegh et al. (1980) and Losheck et al. (1981). 
The latter placed the patient in a plastic bag to prevent maceration of the 
skin following prolonged contact with water. 
Water has a number of advantages over wax. It is cheap, and freely 
available and its temperature can be rapidly changed by use of a thermostatic 
mixer tap. It is essential to ensure good mixing of the water circulating 
through the bath to avoid 'hot spots'. A further advantage of water, shared 
with the Pettigrew technique, is the buoyancy of the patient in water and 
prevention of possible pressure points. A disadvantage, or rather a slight 
complexity of the water technique {and presumablly also the wax technique) is 
that pressure transducers used in vascular pressure monitoring must be 
caliberated with reference to the depth of water or wax above the patient 
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(Versteegh et al. 1g81). When draining the water at the end of treatment care 
should be taken to ensure that the decrease of external pressure from the 
surrounding water does not result in the production of a situation in which the 
veins of the patient dilate and 'hypovolemic shock' is produced (Pomp, personal 
communication). Using this technique the body temperature can be raised to 
41.8oC in approximately 50 minutes depending on the build (and hence surface/ 
volume ratio) of the patient (Losheck et al. 1981). 
b) Heating blankets and heating suits 
The use of heated water circulating blankets to produce W8HT has been 
employed by Larkin et al. (1977), Barlogie et al. (1979), Moricca et al. 
(1979), Larkin (1982), and Herman et al. (1982). The techniques employed are 
all roughly the same in that the anatheti sed patient is wrapped in water 
circulating blankets, the temperature of which is adjusted to a temperature 
warm enough to ensure rise in core temperature but cool enough to prevent the 
occurrence of skin burns. Using this technique heating times vary from 1~-2 
hours (Larkin et al. 1977), to a maximum of 2.6 hours (Barlogie et al. 1979). 
Water temperatures vary from 42oC (Barlogie et al. 1979) to 50oC (Morrica et al. 
1979). 
Heated water circulating suits, in which the patient is entirely enclosed 
in the suit apart from the head, hands and feet, have been employed by Bull et 
al. (1979); Ostow et al. (1982); and Lees et al. (1980). The latter authors 
also used an insulating blanket over the patient during treatment and achieved 
a warming rate of 3°C per hour, which is about the same as reported by other 
groups of investigators. 
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Hot Air 
a) Using the lungs as a heat exchanger 
In an early report, Henderson and Pettigrew (1971) reported a technique of 
warming the respiratory gases by utilization of large amounts of heat produced 
by the absorption of carbon dioxide by r soda 1 ime 1 (calcium hydroxide and 
sodium hydroxide) in a closed anaesthetic circuit. The same soda lime is used 
for absorption of the carbon dioxide expired by the patient as for the carbon 
dioxide that is added from outside the circuit. 
Using this technique, in combination with the wax method, the authors were 
able to raise the body temperature by 5-6'C in 20 to 40 minutes. 
b) Using the skin as a heat exchanger 
Transfer of heat to the surrounding air is one of the principles of the 
Pomp-Siemens Hyperthermia Cabin which will be described in greater detail in a 
later section. Basically, this is a semi-sealed chamber in which the patient 
lies exposed to hot air produced by two 1.2 Kw heaters. The air temperature is 
cantrall ed by a thenuostat and is recirculated by axi a1 venti 1 ati on in the 
cabin. 
This method, with or without the additional use of a 400 watt, 27 MHZ 
generater, has been used by a number of investigators including Pomp (1975); 
Neumann et al. (1974); Wust et al. (1975), Reinhold et al. (1982); van der Zee 
et al. (1979) and Faithfull et al. (1982). 
Heating times vary depending on the air temperature of the cabin (this is 
usually kept at 50-60°C) ~ the temperature to be reached and the use of the RF 
generator. Neuman et al. (1979) using RF heating reached 40.5'C in about 10 
minutes. Others using the standard heating coils report that a mean time of 
about 165 mins is required to reach 41.8oC (van Rhoon, personal communication). 
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Radiation Heating 
Heating using infra red radiation has been used by Heckel (1975). The 
apparatus enployed was able to raise the body tenperature to only 40'C in about 
2~ hours. This method is generally believed to be unsuitable. 
Pyrogen Therapy 
One of the pioneers of cancer therapy by hyperthermia was W.B. Coley who 
introduced a method of producing Hyperthermia by i nj ecti on of a pyrogenic 
vaccine containing a mixture of bacterial products (Coley 1893). The results 
were very unpredictable, though some good results were obtained in securing 
remissions of the disease process. 
Fever therapy has been intermittently applied since then in the treatment 
of malignancy. Warren (1935) used a combination of pyrogenic fever and 
external heating I produced by radiation heat from carbon filament 1 amps) to 
achieve a treatment temperature of 41.5'C. Shoulders and Turner (1942) combined 
fever therapy and deep x-ray therapy. In some clinics this method of produc-
tion of hyperthermia was recently still in use I tJ auts 1975). 
Extracorporea1 Circulation 
Initial reports of the use of extracorporeal circulation through a heat 
exchanger to induce hyperthermia appeared in 1979 (Parks et al. 1979). Other 
investigators subsequently using the method include; Sutherland (personal 
communication), Hermann et al. (1982), Bullet al. (1982),Eis'leretal. 
(1982). The technique is usually accomplished by establishment of a surgically 
prepared arteriovenous shunt in the ingunal region. Blood is then allowed to 
flow through the heat exchanger. Oesophageal temperature can be raised to 41.5' 
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in as little as 22 minutes (Parks et al. 1979) though Herman et al. (1982) 
report a mean warming time to 42oC of 1.3 hours. 
This technique 
Body Hyperthermia 
THE ROTTERDAM TECHNIQUE 
was developed over the course of 45 treatments under Whole 
at 41.8oC and is based on the use of the Pomp-Siemens Cabin 
- a diagram of which is presented in Figure 1. 
Description of the Pomp-Siemens Hyperthermia Cabin 
The patient lies on a mattress filled with granules (1-2 mm in diameter) of 
expanded polystyrene which is situated in the centre of the cabin (Pomp 1965). 
The granules ensure reduction of pressure points. On each side and at the foot 
end is a space about 10 em wide extending down and below the level of the 
patient. This is closed by a perforated plywood board which covers the space 
in which the 1,2 KW heaters are located. These heaters are elongated and are 
situated one on each side of the patient. At the foot end near the top of the 
cabin (the 'roof' and sides are made of thick perspex), is a temperature sensor 
for the thermostat. Air is circulated through grills in the plywood cover at 
the foot end by an axial ventilator. In this way hot air, which rises through 
the perforated board at the sides of the cabin, is circulated slowly around the 
cabin (velocity less than 0.5 m/sec). 
The patient's heads extends outside the cabin and the semicircular opening 
in front of the neck of the patient is closed with towels- a semicircular 
clamp is present for this purpose. Full access to the head of the patient is 
thus ensured. Further access to the patient is provided through circular 
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openings about 15 em in diameter that are provided along the sides of the cabin 
- these are closed by small sliding doors when not in use. 
The Siemens cabin, as delivered. also contains a radiofrequency system of 
heating. A coil about 40 by 50 em is incorporated into a small mattress which 
is positioned under the trunk of the patient. This 27 HHZ coil can be connected 
to a 400 watt radiofrequency generater and can thus provide additional heating. 
Also supplied is a 433 MHZ microwave applicator which can be positioned above 
the top of the cabin (the top of which consists in part of a sort of roller 
blind which can be opened). After connection to a 250 watt generator 
addi ti anal 1 ocal heating can be administered. The above mentioned heating 
systems were not employed due to the unacceptable degree of interference caused 
to all monitoring equipment. 
Patient Treatment Regimes 
In the first treatments, the only form of heating which was used was supplied 
by the two 1.2 Kw heating elements already described. The air temperature was 
maintained at 50-60'C. Using this form of heating alone patients were heated to 
41.8'C in a mean time of 165 minutes or at a rate of 1.75'C per hour. 
In an attempt to reduce cooling of the patients by evaporation of the large 
quantities of sweat produced during the procedure, the patients' exposed skin 
was covered in later treatments with sheets of thin plastic film. A regime of 
heating and humidifying of the respiratory gases to 42-43'C and warming of all 
infused fluids to 42"C was also instituted in an attempt to reduce wanning time 
as it may well be advisable, from the point of view of tumor thennotolerance 
development, to warm the patient 
combination with plastic film and 
fluids, the mean speed of warming 
as quickly as possible. Using hot air in 
heating respiratory gases and infusion 
was increased to 1.9'C per hour. A small 
decrease in warming time resulted (mean of 165 minutes to mean of 150 minutes). 
A further and more marked improvement of warming speed was produced by the 
'--, 
Fig. 1. The Pomp Siemens Hyperthemia Cabin. Size of the main body 
(without head holder) 187 em in length and 92 em in width. 
A = Sensor for thermostat. 
B = Air heating elements. 
C = Axial ventilator (not shown in front-view diagram). 
D =Adjustable holder for microwave applicators (applicators not 
shown). 
E =Ports for handling§ infusionsr etc. (sliding doors not shown). 
F = Adjustable plastic roller top. 
G =Position for radiofrequency coil under patient (not shown). 
H = Holder for sealing cloth. 
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use of a water circulating mattress placed under the patient. Warm water at a 
maximum temperature of 46°C was circulated through the mattress using a 
Churchi 11 Thet111oci rcul a tor LTS~·i thermostatically cantrall ed heater circulator. 
addition of this heating method the mean heating rate was increased Using the 
to 2.6°C per hour and the mean warming time was reduced to 108 minutes. A 
advantage of the addition of plastic film, heating of inspiratory 
heating of infusion fluids and the incorporation of the wamli ng blanket 
further 
gases, 
is evident, as van Rhoon and van der Zee (1981) have demonstrated that, using 
this regime the uniformity of temperature distribution is much better during 
the plateau of 41.8°[. 
During the plateau phase of treatment the temperature of the patient is 
easily regulated by lowering the temperature of both the water in the circu-
lating mattress and the hot air inside the cabin. Excessive rise in tempera-
ture can be easily adjusted by opening of the access windows or the roller 
blind at the top of the cabin. In the case of falling temperature the tempera-
ture of the circulating water can be quickly adjusted. 
Cooling of the patient at the end of plateau phase occurs rapidly once the 
cabin is opened and the plastic film is removed. If necessary, further cooling 
by suitably placed fans can be undertaken. Excessive cooling of the skin, for 
instance by swabbing with alcohol solutions, should be avoided as this may 
actually slow cooling of the body due to vasoconstriction of the skin blood 
vessels resulting in decreased heat dissipation. 
It is, as mentioned above, probably desirable to heat the patient under 
WBHT as fast as possible and it may be that future W8H treatments should be 
carried out using one of the faster methods of heating such as water immersion 
or extracorporeal circulation. To what extent the physiological changes that 
occur as a result of heating are dependent on the heating method employed 
remains to be elucidated. 
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CHAPTER Y 
ANAESTHESIA 
It is very difficult to describe in any detail a 1 typica1 1 anaesthetic 
administered to a group of patients. Every administration of an anaesthetic is 
inevitably tailored to the requirements and reactions of the i ndi vi dual patient 
in question. An anesthetist is constantly trying, by pharmacological means, to 
steer the physiological state of the patient in the direction in which it 
should be progressing - or at least in the direction in which the anesthetist 
in question considers that it should be progressing. 
A final physiological measurement that may be produced in, for instance, 
analysis of the cardiovascular state of the patient at one particular point in 
the hyperthenni a treatment, may very we11 represent the outcome of opposing 
forces. The thennophysiological reflexes of the patient may be forcing some 
parameters in a direction completely opposite to that in which the anaesthetist 
considers to be desirable. 
For instance, consider the mean systemic arterial pressure during the 
cooling phase of the treatment. As will be seen later, there are very signi-
ficant falls in pressure at a point 15 minutes after the initiation of cooling. 
This is a physiological reaction of the patient. The anaesthetist, who is 
constantly monitoring these changes) may consider that the pressure has fallen 
(or is about to fa1l) to unacceptably low levels and may attempt to counteract 
this fall by rapid intravenous infusion of crystalloid or colloid solutions. 
The end result that occurs in the data of 'the' patient (actually the mean 
etc of all patients) is tr1us a momentary glimpse, at one spot in time, during 
the continuously changing physiological state of the patient, under the very 
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unphysiological conditions of anaesthesia and hyperthermia treatment. 
Preoperative Preparation 
The patients were all seen by the anaesthetist on the evening before 
treatment. A final assessment of their general fitness, and in particular 
their fitness to undergo the proposed treatment, was carried out. Over the 
previous weeks all patients had undergone a vigorous 1 WorkUp 1 with particular 
regard to their cardiorespiratory systems. 
Where possible, all patients had undergone extensive pulmonary function 
tests and, with few exceptions, all had very reasonable lung function as 
assessed by pulmonary mechanics and blood gas data. It is of importance at 
this point to note that, in general, the worse the pulmonary function the 
greater the likelihood that the patient would require post-treatment pulmonary 
support and artificial ventilation. It should be stressed that it is 
absolutely imperative that a well equipped intensive care unit be available, 
staffed by personnel capable of, and regularly employed in, the treatment of 
patients with cardiorespiratory disorders. 
The cardiovascular system was assessed by the usual means and most patients 
underwent bicycle ergonometry. They were required to perform at 120 watts. 
This high requirement, (or aimed for performance- in the later stages of the 
trial patients were not required to perform as well), was initially set because 
of the high degree of stress that the cardiovascular system was expected to 
undergo. This stress has been commented on in the literature (Euler-Rolle et 
al. 1977; Bull, 1982) mostly however, without production of figures for cardiac 
work etc. As will be seen later, our patients did not appear to be greatly 
stressed from a cardiovascular standpoint. However, in view of the expected 
stress, no patients were accepted with a history of myocardial infarction or 
angina pectoris. Patients with hypertension were not initially accepted, 
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though mild controlled hypertensive patients were admitted to the trial at the 
end of the series. 
All patients underwent isotopic cerebral scanning to exclude secondary 
malignant deposits in the brain. This requirement was to be dramatically 
vindicated in one patient whose pretreatment workup was perfonned in anotl1er 
clinic. The physician in charge, though requested to carry out this investi-
gation, did not consider it necessary and, moreover, neglected to infonn the 
hyperthermia group that it had not been carried out. The day after treatment, 
the patient developed hemiplegia and a subsequent isotopic brain scan revealed 
an intracerebral secondary deposit. The hemiplegia subsided after a few days 
and was hence probably due to adem a and not to hemorrhage into the tumor as 
first feared. 
Anaesthesia and Monitoring 
The patients received premedication consisting of papaveretum 0.3-0.4 mg/kg 
body weight and scopolamine 0.004-006 mg/kg body weight. This was administered 
i ntramuscul ariy one hour before the patient was bought to the hyperthermia 
room. 
In cases where a catheter was passed into one of the hepatic veins, the 
patients were first brought to the x-ray department, where a 7 French 80cm long 
Cordis femora-renal A2 catheter was advanced through an 8 French Cordis 501-608 
catheter introducer system inserted, under local infiltration anaesthesia, into 
the left femoral vein in the groin. It was advanced under fluoroscopy until 
its tip lay in one of the hepatic veins. Through this catheter samples were 
taken, during the hyperthermic treatment, of hepatic venous blood and central 
venous pressure was measured with a Hewlett Packard 1280C pressure transducer 
and displayed on a Hewlett Packard compact monitor 78341A. Many patients were 
given intravenous diazep~~ (0,1 to 0,2 mg per kg) during insertion of this, and 
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other intravascular monitoring lines, which were, when possible, inserted 
before induction of anaesthesia. 
An intravenous infusion was set up, usually in a vein in the dorsum of the 
left hand, and an intra-arterial catheter was inserted into the radial artery 
in the left wrist and advanced into the brachial artery. Arterial pressure was 
measured with a Gould Statham P231D pressure transducer connected to a Siemens 
E2150 pressure module, displayed on a digital display module E2160 mounted on a 
Sirecust 323 unit. 
A 7 french gauge K~~ thermodilution Swan-Ganz catheter was inserted through 
another 8 french Cordis 501-608 catheter introducer system inserted into the 
left subclavian vein and the catheter was advanced under pressure monitoring 
into the pulmonary artery. The pulmonary arterial pressure was measured with a 
Hewlett Packard 1280C pressure transducer and displayed on the Hewlett Packard 
compact monitor. This gave digital readout of pulmonary artery pressures and, 
after inflating the occlusion balloon, the pulmonary capillary wedge pressures. 
Cardiac output was measured by thermodilution using a KMA thermodilution 
cardiac output computer, model 3500. The i nj ectate, which was injected 
randomly in the respiratory cycle, consisted of 10 ml of 5 percent dextrose 
solution at room temperature. 
Anaesthesia was induced with an intravenous injection of a 1 percent 
solution of methohexitone (1 mg per kg bodyweight). After muscular relaxation 
had been achieved using a nondepolarising relaxant, (in most cases d-tubo-
curarine was employed using an intravenous dosage of 0,5 mg per kg) the patient 
was intubated with a cuffed endotracheal tube. Intermittent positive pressure 
ventilation was carried out using a Siemens Elema servo- ventilator 900A with a 
mixture of 33% oxygen and 66% nitrous oxide. The frequency of ventilation was 
kept at ten inspirations per minute and the tidal volume was adjusted to obtain 
an initial end tidal expired carbon dioxide concentration of between 3 and 4 
percent. 
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Every 10-15 minutes the following measurements were taken:- heart rate, 
systolic, diastolic and mean arterial pressures~ cardiac output, systolic, 
diastolic and mean pulmonary artery pressures, pulmonary capillary wedge 
pressures and central venous pressure. Measuranents were also taken of expired 
carbon dioxide percentage, and carbon dioxide minute production using a Siemens 
Elema carbon dioxide analyser 930. The electrocardiogram was continuously 
monitored. 
At the end of the hyperthermia treatment, the non-depolarising muscle 
relaxants, which were administered when necessary throughout the treatment in 
small intravenous increments of 0,1 to 0,2 mg per kg bodyweight, were reversed 
using neostigmine 0,3 mg per kg preceeded by atropine 0,16 mg per kg. The 
patients were then removed from the cabin and transferred to the intensive care 
unit. 
~·lodification of Standard Anaesthetic Technique 
As mentioned above, most patients were maintained under nitrous oxide and 
oxygen with administration of intennittant doses of the muscle relaxant d-tubo-
curarine as required. In some patients pancuronium bromide was used as the 
relaxant. This made very little difference to the pattern of changes in the 
physi ol ogi cal state of the patient induced by the hyperthermia treatment. This 
is what one would expect when it is realised the enormously greater degree of 
vasodilatation of the cardiovascular system bought about by the hyperthermia in 
comparison to that bought about by d-tubocurarine (in comparison to 
pancuronium). 
Sa-ne patients received low concentrations of halothane (0.25-1%} or 
enflurane (0.5-1.5%} during treatment. Again these concentrations had little 
effect on the overall cardiovascular status of the patients. It was only when 
the patients were maintained solely on nitrous oxide-oxygen and halogenated 
50 
volatile anaesthetic agents using no nondepolarising muscle relaxants that the 
effects of these agents were noticable. In these cases - one patient had 
enflurane and one had halothane- we observed lower than normal mean values for 
arterial pressure and cardiac output during treatment. 
One patient received large quantities of fentanyl in an attempt by an 
other anaesthetist, 
hypotension 
be argued 
requiring 
that this 
than the author, to control tachycardia. This resulted in 
treatment with dopamine infusion. It could, of course 3 
was coincidental and that the patient had an inherant 
tendency to become hypotensive. However, the same patient received hyperthemic 
treatment one week later under a 'standard' (non fentanyl containing) 
anaesthetic and had no hypotensive problems. 
It is the conclusion of the author that patients react best when a minimal 
number of medicaments are administered. 
No cases of awareness under anaesthesia occurred in the present series. 
Wilson and Turner (1969) have advocated the use of opiate premedication in the 
prevention 
effective 
of awareness, though it has been pointed out that this is not always 
(Faithful] 1969). Most patients had amnesia for at least the first 4 
or 5 hours of the post-treatment period, and sometimes for 12 hours or more. 
The relatively heavy premedication was given in order to provide: a) sedation, 
b) analgesia during the introduction of monitoring lines, and c) amnesia for 
the rather strange and dramatic experience of being placed in, (what must seem 
to most patients), an apparatus resembling a glass coffin. 
It is interesting to note that the requirements for relaxant drugs appear 
to be very much increased during the hyperthermic period and the early cooling 
phase of treatment. The same remark applies to the volatile agents and the two 
patients, already alluded to the above, required progressively higher concentra-
tions of fluothane and enflurane to allow them to tolerate intermittent 
positive pressure ventilation. 
Increased requirement for anaesthetic agents has been commented on by 
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Pettigrew and Ludgate (1977). At first sight it would appear reasonable to 
suggest that there might be increased excretion or breakdown of drugs under 
hyperthermic conditions. However, urinary excretion was certainly not increased 
in these patients as the majority were anuric at this point in treatment. It 
is doubtful if hepatic destruction of drugs is increased in view of the 
probable decrease in hepatic metabo1 ism occurring under hyperthermia and the 
fact that hepatic blood flow and oxygen consumption are significantly reduced 
under these conditions IF ai thfull 1982). The hepatic effects of hyperthenni a 
are considered later. 
Fluid balance 
Fluid balance under anaesthesia for hyperthermic treatment has so far not 
been discussed. The maximum sweating rate in man is very high and may amount 
to a litre or more per hour (Scott 1966) and it would seem reasonable to 
suggest that patients undergoing treatment would lose vast quantities of fluid. 
It was, however, very rapidly recognised that if an attempt was made to rep 1 ace 
fluid with crystalloid solutions (on the basis of calculation of losses) the 
patients became oedema taus. This overload with water was commented on by 
Mackenzie et al. (1975) who tried (unsuccessfully) to use the Central Venous 
Pressure as a guide to fluid replacement. 
Oedema occurring under hyperthermia is usually first noticable in the 
conjunctiva. The fingers may become swollen (a further good reason for insis-
tence on removal of rings etc) and in extreme cases the face becomes very 
swollen and oedematous. The first case anaesthetised by the present author 
developed massive pharyngeal oedema. This was due to attempts to maintain 
systemic arterial pressure and replace al1 calculated losses with crystalloid 
solutions. Pulmonary oedema was never observed in our patients. Herman et al. 
( 1982), also commented on the 1 capillary 1 eak 1 syndrome and found increases in 
alveolar-arterial oxygen differences at the end of treatment which they 
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attributed to pulmonary oedema. Our alveolar arterial p02 gradients showed no 
changes as can be inferred from Table III, chapter VII. Arm and leg oedema has 
been commented on by Ostrow et al. (1981) as occurring in all patients and 
resolving within 48 hours of the therapy. 
It is of course possible to attempt to counteract the development of oedema 
by increasing urine output by the use of diuretics such as frusemi de. This 
however, only brings on the necessity of administering yet more fluid~ if the 
dogma of fluid replacement is followed. 
Urine output usually falls rapidly as plateau temperatures are reached and 
at the end of the hyperthermic phase of treatment at 41.8oC (the 'plateau 
temperature'), most patients were anuric if no attempts were made to stimulate 
urine production. There is always a diuresis, beginning at the end of the 
cooling phase and continuing into the post treatment period. The reason for 
this may be that receptors in the great veins are stimulated in response to the 
rising central venous pressure that is seen during cooling. This is discussed 
1 ater. 
Logawnay-Malik et al. (1979) have studied the effects of hyperthermia on 
renal function in dogs and have shown progressive decreases in renal plasma 
flow and glomerular filtration rates with progressive hyperthermia (maximum 
rectal temperature of 42oC) and reversal of these changes as the animals were 
cooled. These changes they could not wholly explain by the systemic 
hypotension produced by the hyperthermia and they attributed them partly to 
antidiuretic hormone release (Hellman and Weiner 1953). 
Early in the trial it was noticed that some patients developed burning and 
blistering on their toes. It was argued that this might be caused by inadequate 
cooling of the tissues as a result of sluggish circulation in the capillary 
beds in the extreme periphery of an extremely vasodilated and possibly 
relatively underfilled circulation. As a result it was decided to administer 
500 ml of a Dextran solution (molecular weight 40,000) as warming was commenced 
53 
with the aim of: a) 'desludging' the periphery and b) causing an 'osmotic 
filling' of the circulation. This treatment combined with insulation of the 
feet under a single layer of flannel decreased the incidence of blistering. 
At the beginning of the trial it was noticed that many patients, though 
apparently awake after the reversal of nondepol arising relax ants were in a very 
confused state during which no real contact was possible with the patient. 
They were frequently very restless and in some cases intravenous monitoring 
lines were accidently pulled out during this phase. Administration of tran-
quillizers such as diazapam did little to ease the situation. Disorientation 
following hyperthermia has been reported by Smith et al. (1980) and would 
appear to be quite widespread (Birch 1980; Sutherland, 1980; personal communi-
cations). 
An interesting phenomenon was often seen at this stage. The patients would 
lie in bed quite quietly and would not react until stimulated. They would then 
appear to have a form of Morrow 'startle' reflex. This may be self-perpetuating 
in the fonn of a short jactitating reaction of a almost epileptifonn character. 
We considered that these behavioural changes might be caused by small 
degrees of cerebral oedema though no obvious oedema was ever present on inspec-
tion of the optic fundi. Cerebral oedema was also not seen in a series of dogs 
treated at 4ls8oC (van Rhoon, personal communication). However, cerebral oedema 
and congestion is generally present in heat stroke (Shibolet et al. 1976) and 
hence the policy was adopted of administering 200 ml of 20% manitol solution at 
the start of cooling. At this stage 500 cc of plasma was infused in an attempt 
to counteract any excessive falls in systemic arterial pressure that were 
frequently seen at this stage of treatment. Since this regime was introduced, 
the instance of restlessness has been much reduced. 
The fluid administration that is now given during the 5 to 6 hours of 
treatment is approximately: 500 ml Dextran, 500 ml plasma, 200 ml 20% manitol 
and 3-4 litres of Ringers lactate solution. 
54 
55 
CHAPTER VI 
CARDIOVASCULAR SYSTE~I 
FIXED POINT MARKER ANALYSIS DURING TREATMENT 
In view of the unavoidable differences in rates of warming in different 
patients it was not feasable to analyse the data on a time base and therefore a 
fixed point marker analysis system was used. For each patient fixed points in 
the treatment were marked and measurements were thus analysed for each patient 
at the same stage of treatment. During cooling, which was usually very rapid, 
analysis was at fixed time intervals. The markers were chosen as follows: 
Marker 1 immediately before induction of anaesthesia; Marker 2- at the 
commencement of warming following insertion of thermocouples and covering with 
plastic sheeting; Marker 3- on reaching plateau temperatures of 4!.8'C; ~larker 
4 after one hour at plateau; Marker 5 - at the end of plateau; ~larker 6 - 15 
minutes after the start of cooling; l•larker 7 - 30 minutes after the start of 
cooling; Marker 8 - 45 minutes after the start of cooling. 
~leans + 1 SEM were calculated 
significance of difference between 
using Student's t-test (two-sided). 
for every single marker point. Statistical 
values at two marker points were tested 
To exclude patient variance a paired 
t-test was used. A 1 2p 1 value of less than 0.05 was chosen as the lowest level 
of significance. 
TABLE I Cardiovascular parameters during Whole Body Hyperthermia 
i·1arker 1 Marker 2 Marker 3 Marker 4 ~1arker 5 Marker 6 ~1arker 7 rllarker 8 
---
Before Beginning 0 n Reaching After one hr At End of After 15 mins After 30 mi ns After 45 mi ns 
Induction of of Plateau of at Plateau of of of 
Anaesthesia Warming 41.8'C 41.8'C cooling cooling cooling 
Body Temperature 37,10 37,11 41,74*** 41,82*** 41,82 40,52*** 39,45*** 38,89*** 
1 ·c 1 + 0,12 + 0,10 + 0,03 + 0,03 + 0,03 + 0.11 + 0,12 + 0,13 
-(10) -(17) -(30) -(30) -(30) -(19) -(15) - (17) 
Heart Rate 92,6 84,2 125,6*** 143 ,3*** 145,6 140,6* 136,4*** 134,0** 
{beats min-1) + 4,2 + 3,0 + 3,9 + 4,3 + 4,1 + 4,1 + 3,5 + 4,3 
-(11) -(19) -(30) -(30) -(30) -(17) -(15) -(15) 
Systolic 117,8 106,4** 109,3 95,4*** 95,7 90,7* 94,6 99,9 
Systemic Arterial + 4, 7 + 4,3 + 4,6 + 3,9 + 3,6 + 3,9 + 3,3 + 4,6 
Pressure {mm Hg) -(13) -(30) -(30) -(19) -(30) -(19) -(18) -(17) 
Diastolic Systemic 69,6 65,3 56,5** 50,0*** 50,0 46,3* 48,8 51,8 
Arterial + 2,4 + 2,6 + 2,3 + 2,1 + 2,1 + 2,2 + 1,7 + 2,7 
Pressure -(13) -(30) -(30) -(19) -(30) -(19) -(18) -(17) 
Mean Systemic 87,8 81,5 75,4 66,1*** 65,5 61,4** 65,6* 68,2 
Arterial + 3,7 + 3,4 + 3,1 + 2,5 + 2,4 + 2,6 + 2,0 + 2.9 
Pressure {mm Hg) -(13) -(30) -(30) -(18) -(30) -(19) -(18) -(17) 
Cardiac Index 4,19 3,33** 7 ,50*** 7,02 7,34 6,82 6,62 6,32* 
{L min-1m-2) + 0,37 + 0,33 + 0,41 + 0,36 + 0,32 + 0,45 + 0,30 + 0,41 
-(10) -(11) -(11) -(11) -(11) -(11) -(11) -(13) 
'-- -- --·--------- ---------··· 
Stroke volume 45,3 36 ,5** 59,2*** 49,4*** 49,8 47,9 48,4 47,7 
Index {ml) + 3,2 + 3,3 + 3,0 + 3,0 + 2,6 + 2,7 + 2,3 + 2,1 
-(19) -(11) -(11) -(11) -(11) -(19) -(19) -(11) 
--
Pulmonary 5,9 8,1** 8,7 8,5 8,5 9,7** 11 ,0** 10,0 
Capillary Wedge + 0,9 + 0,7 + 0,6 + 0, 7 + 0,5 + 0,6 + 0,7 + 0,7 
Pressure {mm Hg) - (10) - (16) - (16) -(24) -(12) -(26) -(22) -(13) 
""!~4C-"lfCC~;,.:.=,oc-=•m,•~~~~=·-=··· ~---~~·~· =~·~-~~~·o=c-=•"~''~'~"M'~"-o" •'•'•~•~==·"~"'-'~"'"'"·~·~--·~-- ~-·-•·"c·~•~- '"'~==•- -"~''" ""'"''"~-·~•••---~-~=··---•" ,,,._-,_~.,,-~~-=-,m~= ""~~ 
Lpf't_ Ventricular 4 ,B 3 11>'--!--, , 7 ,t! f.-A-* 5, J-!cA* 5,9 5,3 4 ,9 5,3 
l'lork Index + 0,5 + 0,3 r D,G + 0,4 + 0,4 + 0.6 + 0,3 + 0,4 
( Kgw m nri n--1) - 1201 - (121 -- (22) -111 I -(201 -1201 -(201 -Ill I 
--
--~-~-~-~----=·-~~-=--~----~---~-··-~~-·~--·=--·· -----------~=~~-·=----------
Central Venous 3 ,U 5 ,7** 6,8 7 '5 7 '7 8,4* 11 ,9* jj ,8 
Pressure (mm Hg) + 1 ,09 + l ,2 + 1 ,3 + 1,5 + 1,4 + 1,5 + 1 '7 + 1 ,4 
- (8 I -Ill I --Ill I -Ill I -(101 -(101 ''131 -(41 
-
Systemic Vascular 2126 2639 880*** 791* 783 031 772 783 
Res·fstance Index + 276 + 215 + 55 t 63 t 91 t 91 + 78 + 141 
(dynes sec cm-5) - 181 -Ill I -(101 -(101 -(101 -191 -(81 - 141 
Systemic 23,1 20 ,2** 24 ,7*"'-'* 24,4 22 ,6 24,6 26,4 24,9 
Pulmonary Arterial + 2,0 + 1,4 + 1, 7 + 1,5 + 1 ,6 + 4,2 + 1 '2 + 2,7 
Pressure (mm Hg) -1181 -(231 -1231 -121 I -(171 -1151 -(131 -171 
Diastolic 8,6 9,8 10,5 10,6 10,4 11,9 12,5** 13,1 
Pulmonary Arterial + l ,0 + 0,5 + 1 ,0 -1- 1,2 -1- 0,9 + 1,3 + 0,8 + 1 '1 
Pressure -1181 -(23 I -(23 I -121 I -(171 -(151 -(131 -(71 
~-1ean Pulmonary 14,1 13,7 16,4* 15,8 15,8 17,3 18,3 17,4 
Artery Pressure + 1 ,1 + 0,8 -1- 0,9 + 1 ,2 + 1 ,0 + 1 ,3 + 1 ,3 + 1 ,5 
(mm Hg) T20I -(251 -1251 -1231 -(191 -1191 -(161 - (91 
Right Ventricular 0,56 0,31** 1,11 *** 0,88 0,84 0,83 0,79 0,77 
Work Index + 0,10 + 0,06 + 0.15 + 0,12 + 0,08 + 0,18 + 0,12 + 0,12 
(Kgm m min-1) - 181 -~ 11 I -(101 -(11 I -1101 - (81 - (81 - 141 
Pulmonary 178 151* 90*** 89 91 93 92 107 
Vascular t 25 + 19 + 9 + 14 t 12 + 16 + 16 + 24 
Resistance Index T20I 122 I T22 I -121 I -1171 -1171 -1151 - 171 (Dynes sec cm-5) 
'---- --·---------- --·---
Means+ 1 SEM. Number of patients between brackets. Significance on paired t-test in comparison with previous marker point. 
* ~ p < .05 ** "- p (.01 *** "' p < .001 
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Results 
A number of the measured cardiovascular parameters are presented in Table 
I. Graphical presentation of the changes in the systemic circulation is shown 
in Fig. 2 and those of the pulmonary ci rcul ati on in Fig. 3. 
It should be noted that the expression 'cardiac index' (cardiac output per 
m2 of body surface area) has been used throughout this thesis. This was used 
in an attempt to make comparison possible between individual patients whose 
surface area lay between 1,52 and 2,12 square metres (Dubois and Dubois 1916). 
The expression of cardiac output as the cardiac index is quite common practice 
though this has been criticised by Burch and Giles (1971) who have suggested 
that it might be more accurate to express cardiac output in tenns of a more 
readily measurable variable such as body weight. 
The beginning of the warming period (marker 2) is usually between 45 and 60 
minutes after the induction of anaesthesia. When comparing cardiovascular 
values at this time, with those occurring just before induction of anaesthesia 
(marker 1), it can be seen that a number of changes have taken place. There has 
been a reduction in the cardiac index, and, because there has been no signifi-
cant fall in heart rate, a fall in stroke index must have taken place. The fall 
in mean arterial pressure is negligable though the systolic pressure has fallen 
significantly. There has been a fall in -left ventricular work index. Though 
there have been no marked changes in mean pulmonary artery pressure, the 
pulmonary vascular resistance has fall en and right ventricu1 ar work index is 
also very significantly decreased. Both pulmonary capillary wedge pressure and 
central venous pressure have increased in comparison to the preinduction 
period. 
By the time that plate au temperature of 41.8oC has been reached (marker 3), 
a number of very pronounced changes have occurred. There has been a 1 arge and 
highly significant increase in both cardiac index and heart rate. Because the 
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cardiac index has increased proportionally r.~ore than heart rate, a large in-
crease in stroke index has taken place. There have been no significant changes 
in either the pulmonary capillary wedge pressure or the central venous pressure 
and, as would be expected, there were marked decreases in both the systemic and 
puimonary vascular resistances. l•Jhereas the systemic resistance has decreased 
to 34% of its va1ue at marker 2 the pulmonary resistance has decreased to only 
54%. Hence, though the mean systemic pressures (especially the diastolic 
pressures) have decreased, there has been a significant rise in mean pulmonary 
artery pressures~ Both left and right ventricular work indices have increased 
enormously but whereas the left ventricle has increased its work by 118% the 
right ventricular work has increased by 275%. 
During the first half of the plateau period (between marker 3 and marker 4) 
many of tr1e cardiovascular changes occurring during warming continue. There is 
a further fail in the systemic vascular resistance causing very marked con-
comitant falls in the systolic, diastolic and mean arterial pressures. No 
changes occur in the pulmonary vascular resistance and there are no marked 
decreases in pulmonary artery pressures. The cardiac index does not decrease 
and thus, whereas the left ventricular work decreases to a very si gni fi cant 
extent; there is no decrease in right ventri cu1 ar work. The heart rate 
continues to rise and this results in a fall in stroke index. 
It should be noted that at this moment (marker 4), the 1 eft ventricular 
work is not significant1y more than it ~tJas before the induction of anaesthesia. 
The right ventricular work, on the other hand, is very significantly raised 
above the preinduction values and remains so throughout the plateau phase. 
During the second half of plateau (marker 4 to marker 5) there are no 
significant changes in cardiovascular haemodynamics, but once the cooling 
period commences~ the most obvious and constant change seen is a very 
significant fail of mean arteria1 pressure at 15 minutes of cooling {marker 6), 
followed by a significant rise at 30 minutes (marker 7). Over the same period 
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the mean pulmonary artery pressure is steadily rising, as are the pulmonary 
capillary wedge pressures and central venous pressures. The cardiac index does 
not decrease to any marked extent. There are no changes in either the pulmonary 
or systemic vascular resistances and whereas the left ventricular work 
significantly decreases, the right ventricular work remains constant. 
During the next 15 minutes of cooling, (marker 7 to marker 8), there has 
been a fall in cardiac index, but there are no relevant changes in systemic and 
pulmonary vascular resistances or left and right ventricular work. Every 15 
minutes of cooling, a progressive fall in heart rate takes place which. after 
45 minutes (marker 8), is not significantly faster than at the beginning of 
plateau. 
Changes 
Table I. 
No changes in the stroke index were observed during cooling. 
in systemic and pulmonary pulse pressures are also presented in 
In the case of the systemic system a fall in pulse pressure after 
induction is followed by a marked rise as plateau is reached. Similar changes 
occur in the pulmonary circulation but~ whereas by the time midplateau is 
reached (marker 4), there has been a very significant decrease in the systemic 
arterial pulse pressure, the pulmonary pulse pressure does not change. Systemic 
arterial pulse pressures are not then significantly different from those 
occurring before treatment (marker 1). 
Discussion 
When the conscious individual is subjected to them~al stress sufficient to 
raise the body temperature, considerable anxiety may be caused. Though Rowell 
et al. (1969) have trained experienced subjects to relax and not to hyper-
ventilate under these conditions this is not usually feasible under whole body 
hyperthermia treatment. Barlogie et al. (1979), Blair & Levin (1977), Larkin 
et al. (1977), Parks et al. (1979), Pettigrew & Ludgate (1977) have employed 
general anaesthesia and Bull et al. (1979), Bynum et al. (1979) and Ostrow et 
al. (1981) have used a generalised sedation technique. The different techniques 
63 
employed may affect the cardiovascular changes taking place, but t~acKenzie et 
al. (1975) have commented that they obtained similar changes in cardiovascular 
parameters when using different anaesthetic tecnhiques. During one technique, 
the patients were artifical1y ventilated while in the other, spontaneous 
respiration was permitted. 
fvlost authors, commenting on cardiovascul9-r effects of whole body hyper-
therrilia, report changes taking place in heart rate. Though absolute figures 
given for heart rates found at plateau temperatures vary, fairly good 
carrel ati on between different reports is obtai ned when the changes are 
expressed as change in the number of beats per minute per 1 °C rise of body 
temperature (beats min-! 'C-1). It is questionable if this is justifiable as 
there may not be a 1inear change in pulse rate betwen 37o and 42°C. The heart 
rates reported by varfous authors have been calculated on this basis and are 
presented in Table II (assuming basal temperature at the beginning of warming 
to be 37'C if this is not stated). As pointed out by Pettigrew et al. (1974b), 
the heart rate continues to rise after reaching plateau temperature and, where 
both maximum heart rates and those obtaining at the beginning of 
are presented. Both Pettigrew et al. (1974) and ~JacKenzie et al. 
possible, 
plateau 
( 1975) have pointed out that stable narcosis is necessary for a constant heart 
rate, 
Falls in systemic arterial pressure during whole body hyperthermia treat-
ment have been observed by Dubois et al. (1980), Larkin et al. (1977), Barlogie 
et al. (1979), Lees et al. (1980) Kim et al. (1979) and Hermann et al. (1982). 
Rises have been seen by Pettigrew et al. (1974b) and Euler-Rolle et al. (1977). 
Moricca et al. (1979), Ostrow et al. (1981) and Bynum et al. (1978), on the 
other hand, found little charge in the mean arterial pressures. 
Many authors have described a rise in pulse pressure during wanni ng -
presumably this is caused by the gross vasodilation that is occurring. The 
resulting arterial pressures are then due to the overall balance between the 
" 
"' 
TABLE II Reported values of heart rate changes during Whole BodY Hyperthermia Treatment. 
~Jean heart rate Plateau Mean heart rate change Mean of the maximum heart 
Authors at temperature at beginning of ~lateau rate change during plateau 
start of warming in beats min-1 C-1 in beats min-1 oC-1 
Barl ogi e et al 
(1979) 
91 42oC 8,1 
Mori cca et al not stated 41 .8 °[ 10,0 
(1977) 
Ostrow et al 105 41.8 °[ 11,5 
( 1981) 
Kim et al 87,6 41.5°C 11,9 
(1979) 
Larkin et al 90 42oC 14,4 
( 1977) 
Petti grew et al 
(1974 b) 
not stated 42oC 8,5 11,0 
Bynum et al (1976) 
96 41.8 °[ 12,0 14,0 
Present study 92.6 41.8oC 9.2 12.8 
-
-~-~-----~~-
-·-·-
The changes are expressed in change of number of beats per minute per degree centigrade rise in body temperature 
(beats min-1 oC-1 ). 
. 
' 
i 
I 
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increased cadiac output and the decreased peripheral resistance that occurs. 
Surprisingly, the literature on whole body hyperthernria treatment contains 
very little comment on changes in cardiac output. Herman et al. (1982) reported 
that, in 4 patients at plateau temperature, cardiac index values were 
apparently twice base-line. Parks et al. (1979) only mention that cardiac 
output lf>~as always increased averaging 10.8 litres per minute in the 14 
detenninations made. In patients 'having marginal cardiac function' they 
measured pulmonary capillary wedge pressures and comment that they were 'little 
affected 1 • As no details of systemic pressures were given it is impossible to 
calculate the systemic resistance or left ventricular work from these figures. 
l<im et al. (!979) give figures indicating cardiac indices increasing by an 
average of 72% 
up to 4!.8oC, 
during wanning to 4l,5°C; our own figures indicate a 140% rise 
remaining the same during the plateau temperature. The lower 
figures from Kims 1 group may well be attributable to the depressant effect of 
the continuous infusion of thiopentone and fentanyl that they used. In another 
publication from the same group of investigators (Bull et al. 1979), in which 
the patients received either a 1 low dose 1 infusion of ketamine or a similar 
thiopentone/fentany1 mixture, the cardiac index rose by 118%. 
It should be noted at this point that when percentage changes are referred 
to in results from the present study, these indicate mean paired percentages. 
Hence the values given may vary slightly from those that the reader may 
calculate using the figures given in table I. 
From the figures of Lees et al. (1980) it may be calculated that, in their 
patientss left ventricular work increased and systemic vascular resistance de-
creased by 25% and 51% respectively; their report also showed that a small dose 
{1.25 mg} of Dehydrobenzperido1 could~ at 4l.5°C, cause an average decrease of 
19% in cardiac work and a 16% decrease in systemic resistance. Unfortunately 
there is no mention of the phase of pi ate au during which this effect was seen. 
They noted a return of mean arterial pressure (which had decreased 50%) to 
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pre-droperidol levels within 5 minutes. 
There appear to be very few available publications on the haemodynamic 
changes taking place in the pulmonary circulation under whole body hyperthermia 
treatment. The filling pressure of the right ventricle (the central venous 
pressure) has been fairly widely reported but published results are very 
variable. Pettigrew et al. (1974b) comment that a rise of 5-10 mm Hg in 
central venous pressure occurs on wanni ng - values then return to prewarmi ng 
levels once hyperthermia is established. Lees et al. (1980) noted an average 
decrease of central venous pressure of 2.6 mm Hg, whereas Moricca et al. (1979) 
and Herman et al. (1982) noticed no significant changes. In our own patients 
the only significant changes that took place in the central venous pressure 
values occurred during cooling. Both Pettigrew & Ludgate (1g77) and Mackenzie 
et al. (1g77) comment that central venous pressure is not a good index of the 
need for fluid replacement. This accords with our own experiences that adminis-
tration of call oi dal solutions in an attempt to maintain central venous 
pressure at a certain level only leads to interstitial oedema without 
significant alteration of cardiovascular parameters. 
There 
changes 
little 
are few available publications in which pulmonary artery pressure 
were mentioned. Parks et al. (1979) noted that the pressures were 
affected, but Lees et al. ( 1979) reported an average rise in mean 
pulmonary arterial pressure of 1.3% It is assumed that this was not 
The latter publication is the only one available 
of right ventricular work and pulmonary vascular 
can be made. From the available figures it may be concluded that 
significant. 
calculations 
statistically 
from which 
resistance 
their 
and a 
patients experienced 
fall in pulmonary 
an average rise in right ventricular work of 110% 
vascular resistance of 7%. These results may be 
compared with the results of calculations using figures obtained in the present 
investigation (table I), in which the right ventricular work rose by 215'/, and 
the pulmonary vascular resistance fell by 50%. 
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Very few authors have commented on changes occuri ng during the cooling 
period following whole body hyperthennia. Bynum et al. (1978) show figures 
demonstrating no c11anges in mean arterial pressure half an hour after cooling 
had started. The cooling rate of their subjects was 2.7°C (rectal) over the 
first half hour) which corresponds quite well with our rate of 2.4°C (pulmonary 
artery) over the same period. P,t this moment the mean arterial pressures of 
our patients were also not significantly changed though, as we have mentioned 
above, there was a si gni fi cant fal1 after 15 minutes of cooling. Hennan et al. 
(1982) noted precipitous decreases in blood pressure during cooling. 
The above mentioned 1 dip 1 effect was also noticed by Rowell et al. (1969) 
1-\'hO cooled conscious volunteers (average blood temperature 38.84°C) by rapidly 
lowering the sl(in temperature. They also noted~ as was seen in the patients in 
the present study, increases in the central venous pressure associated with, in 
their subjects. and increase in central blood volume. The increase in stroke 
volL.~Tle tr1at they observed was not seen in the present study. In their subjects 
the experiments were terminated when 'the subjective sensations of thermal 
stress became intolerable'. It is thus possible that the pulse rates of their 
subjects werel at that stage. 'artifciallye elevated by psychological stress 
(the average rate 10as 149 beats/min) and that they fell rapidly with the psycho-
logical relief of cooling- hence the rising stroke volume even in the presence 
of a falling cardiac output. Our patients were unconscious and were, it was to 
be expected~ free from anxiety - their heart rates fell only 6% {from means of 
145.6 to 136.4 beats per minute) ir, tr<e first half hour of cooling. 
In conclusion~ attention should be drawn once again to the different 
relative amounts or work performed by the 1eft and right ventricles during 
hyperthermia and to reiterate that) though the left ventricular work was no~ 
significantly v··aised above pretreatment levEls during the rnidplateau phase the 
right. ventricular work was very significantly raised at this stage. These 
important results. which are graphically illustrated in Fig. 4, may have 
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considerable clinical relevance when assessing the fitness of patients to 
undergo whole body hypertherMia treatment. 
The question naturally arises as to why the decrease in systemic vascular 
resistance shou1d have 
resistance. The former 
been so much more than that of the pulmonary vascular 
decreased by mid plateau to 31.6% of its value at the 
beginning of warming wl1ereas the latter decreased to 49.8% of its pre-wanning 
value These differences can account for the rise in mean pulmonary artery 
pressure and the proportionately greater increase of right ventricular work. 
Resistance to flow through a vascu1ar bed depends on two factors. Firstly, 
there is the resistance to steady flow~ and secondly~ the resistance to 
pulsatile floltJ (impedence). Pulmonary vascular resistance defined (as in the 
calculated resu1ts earlier presented) as the ratio of the average pressure 
decrease across the pulmonary vascular bed to the average flow is very limited 
in that it fails to take into account the pulsatile nature of the flow (Foex 
1980). 
The concept of vascular impedance was introduced by Randal and Stacy (1956) 
and was applied by Care and McDonald (1981) to the pulmonary circulation. 
Milnor et al. (1966) in a study in dogs have demonstrated the effect of heart 
rate and pulmonary bl cod flow on the oscillatory component of hydraulic input 
power. At a fixed pulse rate oscillatory power varies with the square of the 
flow. They demonstrated, however~ that fiow could be increased with less imput 
pm11er increase if the pulse rate increased while the stroke val ume remained 
constant. Hence, high pulse rates may prevent excessive rises of right 
ventricular work in the patients undergoing WBHT and one should be wary of 
trying to decrease heart rate by means of beta blockers (Euler-Rolle et al. 
1977; Moricca et a1. 1979). From the above brief discussion it is clear tha.t 
the pu1satile nature of pulmonary vascular flow will tend to cause the increase 
in right ventricular work to be proporti onate1y more than is the case in the 
systemic circulation. In the latter the pulsatile component of work is much 
1 ess and hence steady work output predominates. 
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FIXED POINT MARKER ANALYSIS DURING RECOVERY FROM HYPERTHERMIA 
The last marker in the fixed point analysis of the cardiovascular variables 
during treatment was marker 8. This was 45 minutes after the beginning of 
active cooling. The majority of measured variables were still at a level 
signifiantly different from those obtained before the induction of anaesthesia. 
A further fixed point marker analysis was perfonned beginning in the 
Intensive Care Unit after the patient had been removed from the hyperthermia 
cabin and the non-depolarising muscle relaxants had been reversed by 
neostigmine. The 
beginning of 
first point for 
significantly 
cooling 
higher than 
and at 
before 
this new analysis was 2 hours after the 
this time the following parameters were 
induction of anaesthesia: body temperature, 
heart rate, cardiac index, mean pulmonary artery pressure and right ventricular 
work index. The variables that were still significantly reduced were: mean 
systemic arterial pressure~ systemic vascular resistance index and pulmonary 
vascular resistance index. Pulmonary capi 11 ary wedge pressure and central 
venous pressure had raised values at the end of treatment (marker 8), but were 
not significantly different from the beginning of treatment at this first 
marker point in the Intensive Care Unit. Stroke index had increased from the 
end of treatment and was significantly increased once more, though the mean 
value was not as high as the maximum value obtained on' attainment of the 
plateau temperature. Subsequently all the variables mentioned above were 
analysed every hour and compared with marker 1 (at the begi nn·i ng of the 
treatment). 
Results 
Figure 5 shows the time at which the above mentioned parameters became not 
s i gni fi cantly different from the beginning of treatment. It should be noted 
, ~~~~~~~-erb.;gi;;-,;ing-- ;--;· _4-Fl.6J~;~~I~111 I 12-r~3 114 r·:,-~-~16 117 fsl~-- -
Body temperature high r 
1-- ---· ]_ 
Heart rate high 
1-:-:----~------- .. -----·---····· 
Mean systemic 
arterial pressure low 
---·-·--~rdiac index I ~;~~--
Stroke index h~~ 
Pulmonary capillary 
wedge pressure 
Left ventricular 
work index 
Systemic vascula~low 
resistanc~ index --------
Mean pulmonary hi h 
artery pressure 9 
Central venous 
pressure 
Right ventricular h' h J 
work index 19 
Pulmonary vascular h' h 
resistance index 19 
still low 
Fig. 5. Time course for the return of various cardiovascular parameters to normal following WBHT. Outside the 
histogram bars the values are no longer statistically different (on a paired Student 1s T-test) from the 
pre-treatment values. Indication is given at the beginning of the chart of the direction of abnormality. ~ ~ 
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that body temperature assessed as pulmonary artery temperature, measured by the 
thermistor tip of the Swan Ganz catheter, returned to normal 5 hours after 
opening of the lwperthenni a cabin and hence 5 hours from the beginning of 
cooling. This point coincides with normalisation of the cardiac index and is 
fall owed by stroke index at 6 hours and pulmonary vascular resistance index at 
7 hours. 
Heart rate 
temperature was 
values until 10 
remained 
normal. 
hours 
significantly elevated for 3 hours after body 
Pulmonary 
after the 
artery pressure does not return to normal 
beginning of cooling and though left 
ventricular work was not significantly raised at any stage during the patients 
st~v in the intensive care unit, the right ventricular work did not return to 
normal until 11 hours of cooling had elapsed. Thirteen hours after the cabin 
was opened the systemic vascular resistance returned to normal values. The 
only remaining 
pressure. This 
'abnonnal 1 parameter was then the mean systemic arterial 
remained significantly 1ower than it was before treatment was 
commenced and even 18 hours after the end of plateau (the end of this analysis) 
it was still significantly reduced- that is not to say that the pressure at 
this stage was at a level that caused any anxiety. At 18 hours of cooling the 
mean pressure was 71.6 mm Hg as opposed to 87.7 mm Hg at the beginning of 
treatment. 
It should be noted that the numbers of patients making up the statistical 
group were in general sma11er the longer the observation time continued. This 
was due to a number of factors. As was mentioned in the section on anaesthesia 
a number of patients at the beginning of the study were in a very confused 
state and, in some cases, intravascular monitoring lines were pulled out or 
became otherwise inoperational. Without a fully patent and suitably functioning 
Swan Ganz catheter it is. of course, impossible to measure pulmonary artery 
pressure, pulmonary capillary wedge pressure and cardiac output. As these 
parameters are a11 required for several calculations, it was hence impossible 
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to calculate left and right ventricular work, and pulmonary and systemic 
peripheral resistance indices for a11 patients over a pro1 onged period of time. 
It was, of course, quite possible to record those parameters that could be 
easily measured by non-invasive means such as heart rate and systemic blood 
pressure. Temperature was measured rectally if the Swan Ganz themistor was not 
available. 
Discussion 
Few authors have commented in much detail on the cardiovascular state of 
patients following WBHT. Hermann et al. (1982) reported 30 WBHT treatments-
16 using waming blankets and 14 using extracorporeal circulation. In 7 
instances they noted mean blood pressure decreases to 60-70 mm Hg for up to 2.5 
hours after treatment. They also noted that decreases of pressure occuring at 
elevated temperatures~ were accentuated at the end of therapy when patients 
were actively cooled. 
Pettigrew et al. (1974b) observed that a persistent tachycardia with low 
blood pressure could develop in patients with 'sensitive 1 tumors. Barlogie et 
al. (1979) commenting on the diastolic pressure (which had decreased during 
treatment), noted a rapid return to normal during the ensuing 12 hours, while 
Bull et al. (1979) noted that 5 out of !4 patients had systolic blood pressures 
bet>~een 70 and 90 mm Hg for 30 minutes to 3 hours post treatment. This 
'postoperative hypotension' was also noted by Smith et a1. (1980). 
It would seem, from the above, that hypotension is a fairly frequently 
occurring phenomenon in the early recovery phase following WBHT. Apart from the 
above mentioned comment by Pettigrew et a1. (!974b) there have been no comments 
on pulse rate changes nor have there been reports of changes we noted in other 
card·lovascualar parameters. The most likely explanation is that these 
determinations were never performed. 
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CHAPTER VI I 
OXYGEN TRANSPORT AND OXYGEN CONSUMPTION 
The cardiovascular and respiratory systems together provide the function of 
transporting oxygen from the 1 ungs to the cell. This may be regarded as their 
most important function (N unn 1977b}. 
The amount of oxygen transferred from the 1 ung to the cells of the body per 
minute has been termed the oxygen 'flux' by Nunn and Freeman (1964}. This is 
determined by 
arterial blood. 
the cardiac output per minute and the oxygen content of the 
The latter is in its turn dependent on the haemoglobin content 
of the blood and the arterial oxygen saturation of the blood. 
In theory, one gram of haemoglobin can combine ~<i th 1.39 ml of oxygen. 
Previously the figure ,;as taken as 1.34 ml, but the former figure was adopted 
following the determination of the molecular weight of haemoglobin (Braunitzer 
1963}. Some studies (Prys-Roberts et al. 1971} have indicated that the factor 
1.34 may give good results at nonnal acid base values and when calculating 
arterial/mixed venous oxygen content differences over a wide range of 
differences. On the other hand, Gregory (1974) studied oxygen capacities of 
foetal and adult blood by determination of their oxygen and carbon monoxide 
combining power. In the adult he came to a mean value for oxygen combining 
power of 1.306 (+ 0.006 s.E.r~.) ml of oxygen combining with 1 gram of 
haemoglobin. This mean value was used in all calculations used in this thesis. 
It is perhaps important to realise that it is largely unimportant, in the 
present study, 
and hence any 
which factor is used. Content differences are being estimated 
inaccuracy in the absolute values obtained will automatically 
cancel each other out. 
In addition to the oxygen that is carried, reversably bound to haemoglobin 
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a very sr:1all amount of gas is carried in physical solution in the blood. At 
normal arterial p02 of the blood approximately 0.25 ml of oxygen is carried in 
this V~ay in 100 ml of blood. This solubility is dependent on the oxygen 
partial pressure (Pa02) of the arterial blood and when breathing 100% oxygen 
the level of dissolved oxygen rises to 1,5 ml per 100 ml of blood. The amount 
of dissolved oxygen also rises with decreasing temperatures {Nunn 1977c} and 
conversely increasing the temperature will decrease the amount of di sso1 ved 
oxygen. As mentioned in tile section on anaesthesia, the patients were main-
tal ned during treatment on 33% oxygen. The mean Pa02 at raised body tempera-
tures at markers 3 (beginning of plateau), 4 (mid plateau) and 7 (after 30 
minutes of cooling) were 117.8(+ 5.8 S.E.M.), 110.7 (+ 3.05 S.E.I~.), and 
110.0 (+ 5.44 S.E.~I.)respectively. 
In vie11r of the smail amounts of oxygen carried in solution at these partial 
pressures at the raised body temperatures obtaining) these have been ignored in 
the calculations presented below. The oxygen saturation ofthe blood was cor-
rected for pH, temperature, and pC02 using the computer routine described by 
Kelman (1966) and this corrected value was used in all ensuing calculations. 
Oxygen flux V>'as calcul ateG as: 
C! X Sa02 X Hb X 1.306 
wher-e CI Cardiac Index in ml per minute 
Sa02 Percentage arterial oxygen saturation 
Hb Haemoglobin concentration in grams per 100 ml blood 
This cal cul ati on results in the oxygen flux in ml per minute per m2 of body 
surface area. 
Oxygen consumption was calculated as: 
CI x (Ca02- Cv02) 
where CI Cardiac Index in ml per minute 
C a02 Arterial Oxygen Content per !00 ml of blood 
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Cv02 = Mixed venous oxygen content per 100 ml of blood 
Ca02 is derived from the equation: 
Ca02 = Hb X Sa02 X 1.306 
and Cv02 is derived from the equation 
Cv02 Hb X Sv02 X 1.306. 
when SV02 Percentage mixed venous oxygen saturation 
Results 
Figure 6 is a graph of the calculated oxygen consumptions of patients 
during Y~hol e body hyperthermia treatment at the points at which it was 
assessed. These points were: before induction of anaesthesia (marker 1}, after 
induction of anaesthesia and at the beginning of wanning {marker 2), at attain-
ment of plateau temperature of 41.8oC (marker 3), after one hour at plateau 
(marker 4), and half an hour after commencement of cooling (marker 7). 
Figure 7 is a graph of the calculated oxygen flux during this treatment 
period. As stated in the figure legends, significance indicated is in 
comparison with the previous data point. There were no significant differences 
in oxygen consumption between marker 1 and marker 7. In other words, after 30 
minutes of cooling there was no longer any significant increase in oxygen 
consumption compared with the consumption when the patients were awake (and 
normotllermic). At 30 minutes of cooling the mean pulmonary. artery temperature 
was 39.4oC (+ 0.31 S.E.M.). The oxygen flux, on the other hand, was still 
significantly raised at this point above the awake values (p<_.Ol). 
It is of great importance to know, not so much the absolute value for 
oxygen flux or oxygen consumption, but the ratio between the two. Figure 8 
is a graphical represer.tati on of this ratio obtai ned by di vi ding the oxygen 
flux by the oxygen consumption. It should be noted that, during warming, there 
is a highly significant rise in this value and that, after 30 minutes 
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of cooling, it is still significantly higher than when the patients were awake 
(p(O.OSI · The figures from which the calculations for the above graphs were 
obtained together with figures used in the graphs are presented in Table III. 
Discussion 
A number of studies of basal oxygen consumption have attempted to link the 
figures obtained with various physical characteristics of the subjects such as 
age) sexs height, weight and body surface area. Most studies find a re1ation-
sh·ip between the surfa-ce area and tr1e oxygen consumption. Altman and Dittmer 
(1971) quote figures from Baldwin (1948) for oxygen consumption. These mean 
figures are: 131 x surface area for males between 35 and 49, 132 x surface area 
for maies between 50 and 69, and 129 x surface area for females between 50 and 
79. Tfle above figures have been quoted as all the patients, in whom oxygen 
consumption was estimated before induction of anaesthesia, fall into these 
groups. 
Using the above figures and surface area values for our patients, we arrive 
at a mean figure for oxygen consumption of 130.8 rnl rnin-1 m-2. The figures 
presented in this study give a mean of 104.8 ml min-1m-2, which is a reduction 
of !9.9% on the estimated figures. Nunn (1977a) has produced figures for 
predicted va.1ues for oxygen consumption during uncomplicated anaesthesia based 
of figures of basal data from Aub and Dubois (1917) and Boothby and Sandiford 
(1924]. Using these figures it was ca1culated that the patients, in whom 
oxygen consumption was measured under anaesthesia and before warming, should 
have had a mean oxygen consumption of 105.1 ml min-1m-2 instead of the 
calculated mean of 99.1 ml min-1m-2 - a decrease of 5.7% on the calculated 
figures. The fact that the percentage mean decreases at the two marker points 
vary, may be accounted for by the fact that the mean body temperature of the 
patients 11ad risen slightly by the time marker two had been reached - in some 
0 
OJ 
Table III: Oxygen Consumption and Flux under Hyperthermia 
Marker 1 Marker 2 l~arker 3 Marker 4 Marker 7 
Before induction Beginning of on reaching After 1 hour After 30 mi ns 
of anaesthesia Warming Plateau of 41.8oC at 41.8 oc of cooling 
(Tpo = 39.45°C _:': 0,12) 
Cardiac Index 4,19 + 0.37 3,33 + 0 ,33** 7,50 + 0,41*** 7,02 + 0,36 6,62 + 0,30 
(L min-1 rn-2) - (20) - (22) - (22 I -_ (22 I - (22) 
Arterial Oxygen 95,43 .:': 0,65 98,29 + 0,36*** 94,10 + 1,58* 93,03 + I ,02 94,50 + 0,89 
Saturation ('n (8) - (15 I - (16 I - (25) - (18) 
H aemogl obi n 9,17 .:': 0,73 9,83 + 0,57 9,44 + 0,52*** 9,70 + 0,36 9,22 + 0,33** 
Concentration (9 I - (14) - (16) - (25) - (29) 
( gm/100 ml I 
(Ca02-Cv02 I 2,77 + 0,15 3,04 + 0,21 1,86 + 0,09*** 2.01 + 0,12 1,81 + 0,08 
ml per 100 ml blood - (8) - (12) - (!4) - (21 I - (20) 
Oxygen Flux 561,1 .:': 72,0 520,8 + 65,5 !078,9 + 58,8*** 980,7 + 44,7 870,17 + 56,7* 
(ml min-I m-2) (8) - (12) - (13 I - (21 I -(18) 
Oxygen Consumption 104,8 .:': 13,2 99,1 + 9,5 133,4 + 10,0*** 136,0 + 8,3 113,2 + 7,1** 
(ml min-1m-2) (8) -(12) - (13 I -(19) -(17) 
Oxygen Flux 5,37 .:': 0,22 5,18 + 0,30 8,32 + 0,42*** 7,67 + 0,34 7,81 + 0,44 
Oxygen Consumption (8 I - ( 12 I - (13 I -(19) Tl6l 
- - ------------- ------ -----------
The effects of Whole Body Hyperthermia (41.8oC for 2 hours) on a number of oxygen flux and consumption parameters. Means+ 1 
S.E.M. The 
*=p(.05, 
sample markers 
** = p(O.l, 
are given in brackets. 
*** = p < .001. 
Significance on paired t-test in comparison with previous marker point. 
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cases warm water was being circulated through the heating blanket and the cabin 
heaters were already switched on. It would therefore appear from the above 
discussion that, either the patients had lower than normal oxygen consumption 
values or that there was a slight systematic error in the method of measure-
ment. 
Prys-Roberts (1974) has produced, based on various data (Brandfonbrener 
et al. 1955; Schroder et al. 1966; Frohlich et al. 1969; Cournand et al. 1944; 
Stead et al. 1944; and Emi rgi 1 et al. 1967) figures to show that there is a 
good correlation between cardiac index and age and has presented the formula: 
Cardiac Index 4.16- 0.02 (age in years). Using this fomula we arrive at a 
theoretical mean figure of 3.04 litres per minute in the patients in whom 
oxygen consumption was measured before anaesthesia was induced. This compares 
with the actual measured mean value of 3.85 litres per minute. This means that 
the patients, as a group 5 were somewhat hyperdynamic. 
As a group in order to achieve an oxygen consumption of 130.8 ml min-1m-2 
(which was calculated above to be their oxygen consumption according to the 
figures of Bald>lin (1948)) the patients should have had a mean arterial-mixed 
venous oxygen content difference of: 
130.8 x 100 = 3.40 ml per 100 ml of blood. 
3.85 
The mean measured difference was 2.77 ml per 100 ml of blood. 
It is unlikely that constant errors of measurement would occur in either 
cardiac index measurement or arteri a1 and mixed venous oxygen saturation 
estimations. It must therefore be concluded that the error was in sampling of 
the mixed venous blood from the Swan Ganz catheter, with consequent withdrawal 
of a mixture of pu1monary artery blood and blood that was being withdrawn from 
pulmonary capi 11 aries and veins, and was hence partially or wholly reoxygen-
ated. This would result in decreased arterial mixed venous oxygen content 
difference and hence lower than mean oxygen consumption. As the position of 
the Swan Ganz catheter was not moved after placement, it is likely that similar 
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errors of a similar magnitude would have occurred each time a sample was taken 
and hence the resultant values obtai ned waul d be 1 ow by the same proportion. 
It may thus be concluded that though the oxygen consumption figures that are 
presented in this thesis are probably too low, it may still be possible to draw 
valid conclusions from them. 
The oxygen flux, as can be seen by reference to Table III and figure 7, is 
greatly increased under conditions of hyperthermia. The oxygen carried by the 
blood, (as previously stated, the minimal amounts of oxygen carried in solution 
have been disregarded), increased from a mean value of 561.1 ml min-! m-2 in 
the sedated awake 
plateau. This was 
of hyperthermia. 
state to a mean value of 1078.9 ml min-! m-2 on reaching 
due to the 1 arge increase of cardiac index under conditions 
The flux decreased slowly but was still 980.7 ml m·in-1 m-2 at 
mid plateau. These rises in oxygen flux of 92.1% and 74.6% respectively, are 
very much greater than the corresponding mean increases of oxygen consumption~ 
which amount to 27.3~; and 29.8% respectively. 
As Nunn and Freeman ( 1964) have pointed out, the oxygen flux is usually 
considerably 
They have 
in excess of oxygen consumption and the nonnal ratio is about 4. 
suggested that a flux of 400 ml min-] would be the lowest tolerable 
for a short period under anaesthesia. This would correspond to an oxygen ratio 
of about 1.6. It can thus be seen that the oxygen ratio can be regarded as a 
sort of safety factor - the higher the ratio the 1 arger the reserve of oxygen 
that can be used at any one moment~ the lower the percentage extraction of 
oxygen from the blood~ and hence the lower the arterial/mixed venous oxygen 
content difference. This we saw in the patients that we studied, who had 
reduced arterial mixed venous oxygen content differences at hyperthenTiic 
temperatures. 
The increases in 
as presented 
oxygen consumption during whole body hyperthemi a 
above, were relatively modest. Lees et al (1979) have treatment, 
presented figures from patients undergoing fiBHT at under 
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thiopentone/fentanyl anaesthesia. Their oxygen consumption figures showed a 
mean rise of 58.5% over nonmorthermic control values. Our own figures indicate 
an increase of 34.6% over the norrnothenni c anaesthetised controls. Our patients 
were paralysed and venti 1 a ted while those of Lees et al. ( 1979) were breathing 
spontaneously indeed they were often grossly hyperventi 1 ati ng with average 
increases of nearly 200% in minute volume (Lees et al. 1980). The muscular work 
of breathing, and hence the oxygen consumption of the respiratory muscles, was 
thus increased. 
Myocardial Oxygen Consumption 
Blain et al. {1956} give a mean figure of oxygen consumption of the myo-
cardium of 9.1 ml of oxygen consumed per 100 grams of myocardium as the normal 
consumption in resting subjects. The nonnal weight of the heart of man varies 
witi1 body length and sex varying from 219 (+ 30 SO) grams for females of 135 em 
of length to 378 (~ 40 SO) grams for males of 200 em length (Ziek, 1942). 
Using the nol1llogram for heart size presented by Bove and Scott (1971), the 
expected cardiac oxygen consumption for our group of patients was calculated to 
be 27.4 ml per minute or 16.2 ml per minute per m2 of body surface area. The 
mean value for those patients 
mar-ket~ 1 (before induction of 
body surface area. 
in whom oxygen consumption was calculated at 
anaesthesia) was 18.0 ml per minute per m2 of 
The.ye (1972} ln a study in dogs under halothane anaesthesia has presented 
the formula: 
voz work x 2.1 + 1.4 
where: 
v02 left ventricu1 ar oxygen consumption in ml per minute per 100 
gm of heart tissue 
and work = left ventricular work in kilogram metres per minute. 
TABLE IV Myocardial oxygen consumption under Whole Body Hyperthermia 
Time Mean calculated Mean calculated Mean total Mean whole % change in total body 
Right Ventricular Left Ventricular cardiac oxygen body oxygen oxygen consumption from 
oxygen consumption oxygen consumption consumption consumption t1arker 1 accounted for by 
myocardial oxygen consumption 
Marker 1 3,4 20,7 24,1 104,8 
Marker 2 3,1 16,9 20,0 99,1 71,9% 
Marker 3 4,3 28,5 32,8 133,4 37,3% 
Marker 4 4,0 24,0 28,0 136,0 21,7% 
Marker 7 3,9 20,9 24,8 113,2 34,0% 
---- --~-~--------·· 
---·-·······-
Calculated mean right and left ventricular oxygen consumption in ml per m2 body surface area in comparison with total body oxygen 
consumption . 
._,. 
"' 
I 
I 
' I 
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Applying this formula to the patients in this study, a mean oxygen consumption 
of the left ventricle at marker 1 of 20.4 ml per minute per m2 of body surface 
area was obtained. 
Vinten-Johansen et al. (1982) studied left ventricular oxygen requirements 
in dogs under pressure loading or volume loading conditions. They determined 
that volume 1 oadi ng conditions had greater oxygen requirements than was 
previ ous1y appreciated; being consistently greater than that obtai ned for 
pressure loading conditions. There was. however, no statistical significance 
between the two regression lines. Using the results presented in this study, 
{assuming equal distribution of volume and pressure loadings), left ventricular 
minute oxygen consumption at marker 1 was calculated to amount to 21.0 ml per 
m2 of body surface area. As can be seen the values for left ventricular work 
calculated by the two different methods correspond quite well with each other. 
The first calculation gave an oxygen consumption figure of 20.4 ml per m2 body 
surface area and the second a value of 21.0 m1 per m2 body surface area - the 
mean value was 20.7 ml per m2 of body surface area. 
Using the data presented in the two publications (Theye, 1972 and 
Vinten-Johansen et al. 1982) of right ventricular work, one can calculate mean 
oxygen consumptions for both right and left ventricles for each marker point at 
k-Ihich total body oxygen consumption under WBHT was estimated. These are 
presented in the accompanying table IV. It can be seen that the estimated 
total myocardium o.rygen consumption increased by about 14% for every 1 °C rise 
of body temperature. The rest of the whole body increased its oxygen consump-
tion by about 6% per loC rise in temperature. As can be seen approximately 37% 
of the increased oxygen consumption occurring at marker 3 can be accounted for 
by increase in myocardial oxygen demand. 
In the case of the cardiovascular system we have a very good indicator of 
organ oxygen consumption which has been shown to have good correlation with 
oxygen uptake - this is the work that is performed by the heart. It is there 
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fore reasonable extrapolaLe cardiac work in terms of oxygen consumption under 
hyperthermic conditions. Without direct measurements of hyperthermic oxygen 
consumption of other organs it may be unwise to further discuss percentage 
contributions of other organ systems to whole body oxygen consumption. As 
Hales et al. (1979) have pointed out there exist basic differences in the 
circulatory responses to different species to heat stress would it would 
therefore be unwise to draw too many conclusions about oxygen consumption in 
man under hyperthenni a based on extrapolation from animal experimentation. 
Factors affecting oxygen transport to the tissues 
The 
pally 
oxygen 
by the 
saturation of the haemoglobin in the blood is affected princi-
the two 
partial 
parameters 
pressure of oxygen. A graph of the relationship between 
forms the foundation of the S-shaped oxyhaemoglobin 
dissociation curve. 
various factors will cause a shift of the curve to the right or the left, 
thus raising or lowering the p50 value (the value at which the haemoglobin is 
50% saturated with oxygen). A shift to the right implies a decreased oxygen 
saturation for the same partial pressure. Hence arterial desaturation may 
occur; but at the same time oxygen wi 11 be released from haemoglobin more 
easily at the p02 levels existing in the tissues. The curve is shifted to the 
right and 
pH), pC02, 
the p50 is raised by increasing hydrogen ion concentration (lowered 
temperature~ i ani c strength or haemoglobin concentration. The 
effect of a rise of temperature is to be seen from the figures in table III for 
arterial oxygen saturation under WBHT, where it can be seen that the maximal 
decreases of Sa02 were observed at midplateau. At this point there had been a 
mean statistically significant decrease in Sa02 of 5.6% from the post anaes-
thetic induction value. We must of course assume that, at the same time, that 
no changes had taken place in intrapulmonary shunt values. This assumption is 
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a reasonable one to make in view of the fact that the alvelor arterial p02 
differences did not increase, as mentioned above. 
In view of the easier release of oxygen to the tissues afforded by the 
shift to the right of the dissociation curve it is unlikely that tissue hypoxia 
lrJOuld be occurring, especially in view of the increased oxygen flux that was 
present. This view is supported by the fact that no significant blood arterial 
or mixed venous pH changes occurred during treatment. 
A further factor causing changes in the position of the dissociation curve 
is the level of 2,3-diphosphoglycerate (2,3-DPG) in the erythrocytes. A decease 
of 2 ,3-DPG will shift the curve to the left and this may hinder tissue 
oxygenation. Kim (1979) has measured 2,3-DPG during hyperthermia and has found 
no changes. 
The final pathway of oxygen into the cell is by diffusion. Diffusion co-
ef"f1 ci ents for oxygen have been measured under nonnothenni c conditions (Erdmann 
and Krell 1976), but work in this field still needs to be done in the case of 
hyperthenni a. 
In conclusion. it may be stated that no excessive rises in oxygen consump-
tion occurred in our patients and that the rise in oxygen f1 ux that took p1 ace 
vuas more than adequate to supply the needs of the body. There was no reason to 
suspect the occurrence of generalised tissue hypoxia. 
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CHAPTER VIII 
SIDE EFFECTS AND COMPLICATIONS FOLLOWING WHOLE BODY HYPERTHERMIA 
A number of complications and side effects of whole body hyperthennia have 
been reported in the literature. Both major and minor complications will be 
briefly discussed. rvlinor complications include the very commonly occurring 
generalised lethargy~ which may last for several days after treatment. Minor 
burns at pressure points have been described by Pettigrew et al. 1974; 
Mackenzie et al. {1975); Barlogie et al. {1979); Lees et al. {1980); Hennann et 
a 1 ( 1982) and many others. 
Gastral ntesti nal disturbances have been seen by many authors i ncl udi ng 
Larkin et al. (1977); Moricca et al. {1979); Smith et al. {1980) and Ostrow et 
al. (1981}. These are presumably due to fluid accumulation as a result of the 
capillary leak syndrome described by Hennan et al. {1982) and previously 
menti a ned in this thesis. Our patients often suffered from the resulting 
di ahroea and vomiting" 
Herpes simplex 
et al. (1974a); 
al. {1980). In 
may occur following treatment and has been seen by Pettigrew 
Mackenzie et al. (1975); Barlogie et al. (1979) and Smith et 
the present study this complication waS also seen and is 
probably due to activation of the latent herpes virus. Post hyperthel1Tiia fevers 
have been commented on by a number of authors including Bull et al. {1979) and 
Barlogie et al. (1979). These did not form a feature of the present series of 
patients~ but further details of temperature patterns in the recovery phase 
will be given and discussed later. 
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H aematol ogi cal Changes 
A number of authors have commented on haematological changes following 
WBHT. Pettigrew et al. (1974b) have noted haemoglogbin decreases averaging 0.8 
gms per 100 ml within 30 hours of each treatment. As can be seen from table 
III, Chapter VII, there were highly significant decreases in haemoglobin during 
waming in our patients (between markers 2 and 3) and also at the onset of 
cooling (between markers 4 and 7). These decreases were almost certainly due to 
haemcdilution consequent upon vasodilatation and net movement of fluid into the 
vascular space aided) during warming, by the osmotic effect of the administra-
tion of Dextran 40 and, during cooling, by the manitol that was given. This 
view is also held by Larkin et al. (1977), who commented that the only signifi-
cant changes in haemoglobin and haematocrit were explainable by volume shifts. 
T!1e haemoglobin values in our patients remained significantly lowered, (in 
comparison with those obtaining at the beginning of treatment), until 8 hours 
after the commencement of cooling. At 24 hours after cooling there were no 
longer any significant differences to be seen. 
Many authors report a leucocytosis following WBHT. Pettigrew et al. (1974b) 
'r"eported a mean rise of 67% in white cell count to a mean of 13,700 per mm3 
after 4 hours treatment~ returning to nonna1 within 24 hours. Both Larkin et 
a1. (1977) and Bull et al. (1979) comment that the leucocytosis was caused by a 
rise in the polymorphonuclear cells accompanied by absolute mean falls of 
lymphocyte counts. This has also been our own experience. Barlogie et al. 
(1979) reported marked neutrophilia in some patients but with no overall 
significant trends in the group as a whole. He1111an et a1. (1982) found neutro-
philic leucocytosis of more than 12,000 per mm3 in 7 of 16 treatments using 
blanket technique but sa~< neutropenia (less than 1,000 per mm3) in 3 out of 14 
treatments in which extracorporeal waming techniques were employed. This 
might indicate differences caused by heating technique per se and Parks et a1. 
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(1979), who also used extracorporeal heating, noted, in contrast to most 
authors, that the leucocyte counts were little affected. 
In the patients reported upon in this thesis the total white cell count was 
significantly raised (in comparison with the day before treatment) for up to 4 
hours after cooling commenced but this significance had disappeared by the 
fallowing morning ( + 18 hours after opening of the hyperthemi a cabin). It is 
probable that the total body white cell count was still significantly raised at 
6 hours of cooling, but the probable haemodilution that was present prevented 
the leucocyte concentration from being significantly raised. The lymphocyte 
count remained significantly depressed for 3 days following WBHT. This may 
possibly be caused by destruction in the reticulo-endothelial system as seen by 
Fletcher et al. (1980) following whole body hyperthermia in rats. 
Leucocytosis induced by WBHT may have considerable significance as Grogan 
et al. (1980) have demonstrated that polymorphonuclear cells, from patients 
that have undergone WBHT, showed an increase in bacteriocidal activity. 
Coagulation Changes 
Reduction in the number of circulating platetlets would appear to be a 
frequent occurance during and following hyperthermia, though some authors (Bull 
et al. 1977), have not reported this effect. Pettigrew et al. (1974a) reported 
four deaths associated with evidence of disseminated intravascular coagulation 
in a series of 51 patients. In three cases recent tumor necrosis was evident. 
Barlogie et al. (1979) noted a decrease in the mean platelet count from 
243,000 to 147,000 per mm3, 24 hours after treatment. The count returned to 
nonnal after about one week. They also observed prolongation of the prothrombin 
and partial thromboplastin times by an average and 4 and 6 seconds at 24 hours 
post treatment. These were accornpani ed by mi 1 d to moderate decrease of fi bri no-
gen 1 evel s (minimum 100 milligrams per 100 ml during treatment) and increases 
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in fibrin split products in 4 out of 13 patients. These changes they attributed 
to a low grade disseminated intravascular coagulation syndrome. 
Larkin et al. ( 1977) noted no appreciable changes in prothrombin or partial 
thromboplastin values but commented on the fact that platelet counts were 
occasionally noted to drop dramatically. This they attributed to prior chemo-
therapy. Parks et al. (1979) noted that platelet counts, which reduced from 
mean 235,000 to 160,000 per mm3, might remain reduced for several months (even 
in the presence of nonnal megakaryocyte activity}. Fibrin split products 
remcined v,;ithin normal limits and they noted that there was a correlation 
bet~ojeen the magnitude of the patient 1 s tumor mass and the 1 evel of thrombo-
cytopenia that was observed. 
Herman et al. (1982) regularly saw platelet counts post treatment depressed 
below the 70,000 per mm3 level with decreases in fibrinogen accompanied by pro-
longation of prothrombin and partial thromboplastin times. The platelet reduc-
tions were more common after heating using extracorporeal circulation than 
after using water circulating blankets. One patient out of 11 died from 
disseminated intravascular coagulation. 
1 n the pr-esent series of patients there were no significant changes in 
t.:hroi"f!bocytes to be observed at mid plateau (after one hour at the treatment 
temperatur-e of 4l.8°C) 5 but l!z hours later, and~ an hour after cooling had 
comrnenc:ed, there had been a highly significant fall {p<..OOl). The mean value 
before treatment of 262)000 per mrn3 had fallen to a mean value of 127,000 at 
this point. The mean value at mid plateau was 222,000. The thrombocyte count 
r·enE~ined 1ov1 and was still high.ly significantly lowered (mean of 88,000 per 
mm3) three c:,ays post treatment. Fibrinogen levels showed highly significant 
falls at marker 7 (.1-z hour after commencement of cooling) but had recovered by 2 
days post treatment. 
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Electrolyte Changes 
Many authors have 
during and fol101·1ing 
magnesium, phosphate 
reported by Larkin 
( 1982), though the 
were not remarkable. 
reported changes in blood electrolyte concentrations 
WBHT. The three electrolytes most commonly changed are 
and calcium. These all tend to fall during treatment as 
et al. ( 1977), Barl ogi e et al. ( 1979) and Herman et al. 
falls ·in calcium concentration seen by the latter autl1ors 
Phosphate levels tended to return to normal levels at 24 
hours and magnesium at 48 hours. Bull et al. (1979) observed similar patterns. 
Ostrow et al. (1981) reported lowered calcium levels for more than 24 hours. 
Potassium levels were seen by Pettigrew et a]. (1974b) to rise during 
warming and treatment and to fall in the post-treatment phase. Low levels of 
potassi urn have been seen following treatment by Larkin et al. ( 1977), Barl ogi e 
et al. (1979), Ostrow et al. (1981) and versteegh et al. (1981). 
In the present series of patients similar results to the above were seen~ 
and highly significant decreases in both phosphate and magnesium were observed, 
but whereas phosphate levels had returned to normal at 48 hours the magnesium 
levels had not returned to nonnal until 72 hours after treatment. Calcium 
concentrations remained low after treatment and there were sti 11 highly 
significant decreases at 72 hours after the begirming of WBHT. Potassium levels 
were also still significantly lowered for up to 72 hours. 
In general no great problems have been reported in maintaining sodium and 
chloride levels during and following treatment. This accords with the present 
findings that tf1ough there were significant falls in these electrolytes, the 
changes ltJere of minimal clinical significance. 
Mi sce11 aneous Changes in Blood Chemistry 
Some authors have commented on changes in glucose leve1s taking place as a 
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result of WBHT and both Larkin et al. {1977) and Ostrow et al. {1981) have 
shown that there may be considerable rises during treatment. Barl ogi e et al. 
(1979) have shown that mean increases may still be considerable (50% rise) 24 
hours after treatment" 
In the pr-esent series mean rises of 100% in glucose 1 evel s were seen during 
the cooling phase of treatment and in the intensive care unit. These returned 
to no'i111al somewhere between 6 and 18 hours after cooling was commenced. These 
rises in glucose levels are almost certainly sympathetically mediated and Kim 
et al. (1979) demonstrated significant rises in both adrenaline and noradrena-
line ·ievels in the plasma of patients undergoing WBHT. 
In the present series of patients urea and creatinine levels in the blood 
were monitored once during cooling {marker 7), and then at 24, 48, 72 hours 
post-treatment. Highly significant rises were seen in both parameters (in 
comparison ¥Jith the pretreatment values) at marker 7, and whereas the 
creatinine levels had returned to normal by 24 hours the increased urea leve1s 
did not return to normal for 72 hours. Increases in blood urea and creatinine 
levels have also been observed by Versteegh et al. (1981} returning to nonnal 
within 5 days. Other investigators (Bull et al. 1979), on the other hand, have 
found no changes in creatinine or creatinine clearance levels. Impainnent of 
renal fuction under hyperthermia is probably quite common and Logawney-Malik et 
a·l, \1979); in a study in dogs~ have observed reversabl e decreases of renal 
plasma. flow and glomeru1ar filtration r·ates under 42°C hyperthermia. 
From the above discussion it may be concluded that, in the present series, 
none of the complications or side effects mentioned caused an insuperable 
problem in the safe clinical treatment of patients under WBHT. The sometimes 
severe hepatic problems that were encountered wi 11 now be discussed in the next 
chapter. 
94 
CHAPTER IX 
THE LIVER AND HYPERTHERMIA 
Reports of raised serum enzyme levels suggesting the presence of impair-
ment of hepatic function are very widespread in literature concerning whole 
body hyperthenni a treatment. 
It would appear that 41.8oC should, at the moment, be taken as the upper 
safe limit for whole body hyperthennia treatment. Many authors have commented 
on the carrel ation between the temperature at which the patients ~o>Jere treated 
and the incidence and severity of raised serum enzyme levels. Pettigrew et a1. 
(1974b) reported that there were no significant changes in SGOT, SGPT and LDH, 
following 47 treatments at or below 41.8oC whereas after 17 treatments at 
temperatures between 41.8° and 42°C, even though the temperatures were only 
held for between 10-40 minutes, dramatic rises in SGOT {25 fold), and SGPT {8 
fold) occurred. The bilirubin levels increased following the higher treatment 
temperatures to leveis of 1.56 mg per 100 ml of blood and were almost 3 times 
as high as those following treatment at 41.8oC or below. Similar findings have 
beer reported by Blair and Levin (1977) and by Pettigrew and Ludgate il977). 
Morrica et al. (1979) commented that signficant increases in SGOT, SGPT, LDH 
and gamma-GT only occurred when the treatment temperature was held between 42o 
and 42.3oC though again the high temperture was only held for short periods 
(15-20 minutes). 
Larkin et a1. { 1977) held patients' temperatures at 42 oC for 2 hours and 
observed an eight-fold increase in mean SGOT levels at 24 hours after treatment 
together with twelve-fold increases in CPI< and almost three-fold increases in 
LDH. These values had returned to normal 96 hours post-treatment. The alkaline 
phosphatase values were not affected. 
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3arolgie et al. {1979), treated patients at 42oC and noted that all 
patients had some elevation of CPK levels peaking at 24 hours after thenTio-
therapy. They showed figw'es to indicate mean eight-fold increases at 24 hours. 
They made the observation that greatest rises were seen following the first 
treatment and patients did not necessarily have increased CPK levels following 
subsequent treatments} even if the first treatment had resulted in substantial 
rises of the enzyme. One patient developed myoglobinuria. r~yocardial CPK 
fraction v1as normal. An LDH rise, not associated with haemolysis, was attibuted 
to change in liver function, though changes in SGOT and alkaline phosphatase 
were not consistently noted in the patients with marked LDH elevations. 
Lees et a1. { 1980), while agreeing that the level of the treatment tempera-
ture is important, have suggested that mechanical ventilation of the lungs 
migl1t also play a role in the occurrence of hepatic damage by reducing hepatic 
blood flow. However, Libonati et al. {1973) have demonstrated that there were 
no changes in total splancnic blood flow or oxygen consumption as between 
patients spontaneously breathing or those whose ventilation was controlled. To 
the best of our knowledge no comparative studies have been performed under 
hyperthermic conditions. 
Rises in the 1 eve1 s of serum enzymes fo11wi ng WBHT are not confined to 
those patients in vJhom the temperature was raised above 41.8°C, though the 
severity of the changes may be very much reduced by not exceeding this level. 
Blair and Levin {1977) found a mean ten-fold increase in SGOT following 10 WBH 
treatments where the temperature was held above 41.8°C but a1so a 2.6-fold 
increase 'fn the 25 treatments in which the temperature was maintained at 41.8oC 
or below. The corresponding mean values in bilirubin were seven-fold and 
1.5-fold respect·ively. One of the patients from the first group, who was on 
pher.oba.rbi tone treatment for epilepsy, died on the fourth postoperative treat-
ment day in liver fai"lure. A relationship was found between the incidence of 
1ivet~ failure and the ingestion of alcohol or enzyme inducing drugs. 
TABLE V Serum Enzyme changes following Hyperthenni a 
I 1 Day before During Cooling 1 day after 2 days after 
Treatment (Marl<er 7) Treatment Treatment 
SGOT 12,9 15 '1 48,4 210,1 
u/1 ~ 2,4 
-= 3,8 ~ 7 ,8*** -= 68,4** 
(up to 19) (28) (24) (27) (30) 
SGPT 13,6 9,8 27 ,9 141 ,1 
u/1 .:': 2,7 
-= 2,1 -= 4,6 * ~ 39,5** 
(up to 10) (28) (24) (27) (28) 
CPK 21,7 20,0 156,1 99,1 
u/1 
-= 3,3 _.! 6,2 ~ 41,1** ..:_ 20 ,8*** 
(25) (27) (23) (22) 
LDH (total) 157,2 151,3 242,9 437,1 
u/1 .:': 11 ,8 .:': 14,8 _:_ 22,9** .:': 166,8 
(up to 240) (27) (27) (25) (21) 
' 
LDH1 24,3 25,3 25,6 24,2 
Percent ..!. 1,4 .! 1 ,4 .:': 1,6 .! 1 ,8 
( 18-38) (26) (26) (24) (18) 
LDH2 43,4 42,7 40,8 44,1 
Percent ~ 1,4 _!_ 1,5 .! 1 ,4 .! 2,9 
( 28-48) (26) (26) (24) (18) 
---------··--··-------------·-~ ·------------------------
3 days afte 
Treatment 
235,7 
.:': 125,7 
(28) 
322,3 
.:': 172,5 
(15) 
53,5 
.:': 10 ,5** 
(12) 
632,6 
.:': 277,2 
(7) 
15,5 
.:': 5, 7 
(4) 
36,0 
.:': 8,6 
(4) 
i 
<O 
"' 
LDH3 20,8 19,8 18,5 14,2 14,8 
Percent ~ 1,2 :: 1,1 :: 1,0 .! 1 ,3** _!4,7 
(!2-32) (26) (26) (24) (18) (4) 
LDH4 7,6 7,2 5,8 6,5 11,5 
Percent ! 0,5 :: 0,6 ~. 0,8 .:+_ 1 ,0 .! 4,9 
(2-10) (26) (26) (24) (18) (4) 
LDH5 3,9 5,0 9,0 11,6 22,3 
Percent .! 0,4 .! 0,8* ..::. 1 ,6** ..::. 4,4 .:+_ 11,8 
(0-6) (26) (26) (24) ( 18) (4) 
Alkaline 29,7 22,6 31,6 34,3 38,0 
Phosphatase ..::. 2,3 ..::. 2,7*** :: 4,3 .:+_ 3,4 .::. 6,5 
u/1 (26) (19) ( 16) ( 18) (4) 
gamma-GT 25,6 22,4 + 25,7 28,7 34,3 
.! 3,2 ..::. 4,0- .! 4,4 .::. 4,6 .:+_7,7 
u/1 (26) (16) (13) ( 14) ( 4) 
Serum enzymes before, during, and following Whole Body Hyperthermia Treatment (2 hours at 41.8°(). 
Means+ 1 SEM. Significance in comparison with 1 day before treatment usin'g paired t-test. 
x = P'~05, xx = p~O.l, xxx = pL.QOl. Normal values of the estimating laboratory are given 
in brackets under the name of the enzyme in question. 
"' 
___, 
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Bull et al. ( 1979) noted in five of fourteen patients treated for the first 
time for one hour at 41.8oC 'transient elevations occurring at 24 hours' in 
SGOT (median 2.4-fold increase) and SGPT (median 3.7-fold). Six days later the 
values were the nonnal range. CPK values were elevated but the isoenzymes did 
not shift from the fraction associated with skeletal muscle. Ostrow et al. 
( 1981) , noted 
following four 
'SGOT, CPK and 
significant elevations of LDH (pL.OS) and SGOT (p.<;OOl) 24 hours 
hours treaunent at 41.8'C. Herr,an et al. (1982) noted tt1at 
LDH generally increased during the first 48 hours following 
therapy and then decreased to normal in the next two days'. Of their 30 
treatments, 28 were at 42'C or above for periods of 2.5 to 3 hours. 
The serum enzyme results that were obtained in tt1e present series of treat-
ments carried out at 41.8oC show similar trends to those mentioned above. 
Results for SGOT, SGPT, CPK, LDH and i soenzymes, alkaline phosphatase and 
g amma-GT are shown in the accompanying Table Y. 
The only changes taking place in the patients as a group at marker 7 (half 
an hour into the cooling period}, in comparison to the day before treaUnent, 
occurred in the LOH5 isoenzyme fraction- this was then significantly increased 
and in the serum alkaline phosphatase value, which had decreased to a highly 
significant extent. 
One day after treatment significant rises in the follovving enzyme levels 
were seen: SGOT (mean 4-fold increase), SGPT (mean 2-fo1d increase), CPK (mean 
7-fold increase), LDH (mean ).5 fold increase), and LDH5 fraction (mean 2-fold 
increase). 
At two days after treaunent further mean rises have taken p1ace in SGOT 
(now a 16-fold increase), SGPT (now a 10-fold increase), LDH (now a mean 2.7 
-fold increase - this was no longer statistically significant) and LDH5 
fraction (now a mean 3-fold increase- again no longer significant). 
One should be wary of drawing too many conclusions from the figures 
presented for values obtained three days following treatment. By this time 
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most patients witf1 an uneventful recovery following the hypertilermia t1ad been 
discharged from hospital. If not, they wete considered sufficiently 1 nonnal 1 
not to warrant per-formance of further i nvesti gati ons. The figures presented in 
the table thus consist of results from patients already having abnonnalities in 
their serum enzyme levels. The results presented are thus biased towards 
abnorma·r ·1 evel s, 
Description of the enzyme cha.nges occurring fonowing WBHT is easy 
interpreting them is considerably more difficult. From the results presented 
and after reviewing the work of others in this fi e1 d it is tempting to suggest 
that a mixed syndf~ome might exist. 
The fl rst pan: of the syndrome may be composed of non-specific effects of 
heat on the body with particular reference to the skel eta1 muscular system. 
This tends to be ref1ected in changes in CPK, levels of which have been 
observed to rise by many authors including ourselves. From results of Bull et 
al. (1979) and Barlog~e et al. (1979) it may be concluded ti'Bt there is little 
CPK 1 eaka.ge from damaged myocardi urn and that the bulk of the enzyme originates 
in tile sk.eleta.·! musculature. CPK isoenzyme leve·ls were not estimated in the 
present ser·les of patients. Hov1ever~ the LDH isoenzyme fraction originating 
from ca!'·diac muscle (LDN4} showed no r-ise. This would indirect1y support the 
prE:v·ious suggestions made concerning the origin of the higll levels of CPK that 
\,Je cannot confirm the observations of Barlogie et al. (1979) that CPK 
leve1s were 91~ea.test fol-lot,1ing a patient's first hyperthemria treatment. There 
was, hoh'ever, a tendency for the first treatment to pr·oduce higher 1 evel s of 
SGOT, SGPT, and LDH, The LDHS fraction {which originates from the liver) aiso 
shov,·ed tili s trend. It should be stressed that the above remarks are only 
'·impr-essions~ and., aue to the low numbers of patients involved~ cannot be 
supported. ana·ysis of statistical significance. 
In or·der to separate somewhat the supposed ·1 iver damage, (as reflected by 
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SGOT and SGPT 1 evel s), from hyperthermic muscular damage reflected by CPK 
changes, the results were divided into two groups. Tr1e 1 nonnal liver! group 
consisted of those cases in which the maximum SGOT levels never exceeded a 
value of twice the laboratory normal values {up to 19 units per iitre). Twice 
nonnal va1 ues were chosen as opposed to nonnal values due to the small numbers 
of patients that showed no rise in SGOT- in only five cases did the SGOT never 
rise above 1 norma1 values 1 • The 'normal liver 1 group was made up of patients 
from ten treatments. The rest made up the 'abnormal liver' group. The CPK 
values following treatment in the two groups were analysed using a Students 
t-test. At no time were statistically significant differences seen between the 
groups. This v.Jould indicate that the CPK changes were largely independent of 
SGOT changes, 
The pattern of changes observed in CPK~ SGOT, and SGPT folloHing static 
hyperthermia is probably species dependent in view of the findings of Hubbard 
et al. (1979). They observed that CPK activity in rats fol-lowing hyperthernia 
was a less sensitive index of thermal stress than transaminaseso They suggested 
that the release patterns of the three enzymes could be useful in differential 
diagnosis between heat and work induced damage. This differential pattern does 
not appear to exist in man. 
A number of studies into hepatic integt~·jty under hypertr1errnic conditions 
have been carried out in perfused liver models in rats. Barrows et al. (1978) 
observed significant decreases in bile secretion after 30 minutes at 43oC and 
dramatic increases in SGOT and SGPT leakage from tile iso1ated ·liver after 45 
minutes at the same temperature. They demonstrated rel ativeiy linear increases 
from 60 to 90 minutes at temperatures ranging from 39 to 42°C, 
Collins et al. (1980) in an isolated perfused rat liver model using the 
ratio of 3 hydroxybutyrate to acetoacetate concentration in tile biood draining 
from the liver as an indication of hepatic function (Krebs 1968) ~'~·ere abie to 
demonstrate progressive decreases i n function 
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Administration of palmitate significantly increased the ratio at all 
tetnperatures indicating a protective effect of fatty acids in the thermally 
stressed perfused liver. Collins and Skibba (1980) demonstrated that 
hyperthermia {43°C) largely inhibited macromolecular synthesis in the perfused 
rat fiver by suppressing precursor incorporation into hepatic DNA~ RNA and 
proteirL Decreased gluconeogenesis, decreased urea synthesis and a decrease in 
lactate consumption have been demonstrated in similar mode1s by Skibba and 
Collins (1978}. 
In summary it may be concluded that CPK changes fell owing WBH are a 
reflection of thermal damage to skeletal muscu-lature and that) in our 
experience, rises ·in SGOT ~ fo1lowed at a 1ater stage by SGPT, are a reflection 
of hepatic damage \tllhich tends to be most severe following a patient's first WBH 
treatrnent. 
CASE REPORT OF .A CASE OF FATAL HEPATIC NECROSIS 
One patient in the present series died of hepatic necrosis and a case 
report will be presented. 
The patient~ Mrs D, was a 51 year o1d house\ollife~ V~ihO was admitted to the 
hjiperthemia unit for combineo radiotherapy and whole body hyperthermia treat-
rPent. Four years previously she had attended tl1e outpatients clinic complaining 
of pain in the left upper ,javv, the severity of which had increased over the 
1ast year" Examination revealed a swelling in the a1veo1ar process of the 
ma:d1la~ extending into the soft palate" Biopsy revealed a cystic adeno-
carcfniflla and a resection of the left upper jaw was carried out under general 
anaest!iesia" rJo halothane had been administrered on this~ or any other 
occasion. One month before the operation she had undergone a course of local 
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radiotherapy of 20 x 200 Rads and 3 months after the maxillary resection she 
had also received a course of radiotherapy- this time she received 20 x 150 
Rads. 
When presenting 
routine follow-up 
for hyperthenni a the patient was symptom free~ but on a 
chest x-ray scatterd metastatic deposits had been observed. 
Old tuberculous scarring was also visible- the patient had undergone drainage 
of a tuberculous empyema forty four years previous1y. Before the hyperthermia 
treatment, she received a prophylactic course of isoniazid. Further medical 
history was uneventful. 
The patient presented with a palato-maxillary prosthesis in the 1eft upper 
jaw. Obvious trismus was present and the mouth could not be further opened than 
about 2 centimeters 
Blood pressure was 
(as 
140/90 
measured between the upper and 10\·ver incisor teeth). 
and auscultation of heart and lungs revealed no 
obvious abnonnality. She was well nourished and she we·ighed 69 kg. 
No contrai ndi cti ons to whole body hyperthermia treatrnent ~1ere noted on 
preliminary 
and 
rate 
examination. Heart function, as assessed by bicycle ·ergometry, was 
the patient performed well at 120 watts. Tflis resulted in a maximum 
of 150 beats per minute and resulted in n-o changes in heart rhythm 
good, 
pulse 
on the electrocardiogram. ~Jo repol arisation disturbances were seen. Puimonary 
function testing revealed that the patient had a vita! capacity of 3,5 liters 
with a 1 second forced expiratory volume of 72 percent of the vital capacity. 
The maximum breathing capacity was 150 liters per minute. All three values may 
be considered as normal. The arterial blood gas and acid/base va1ues were 
normal. 
Isotrophic cerebral scanning revealed no abnormality, but on liver scanning 
a zone of hyperactivity was seen at the hylum, indicating the presence of a 
space occupying lesion. Further investigation with cholescintography revealed 
good hepatocyte function, but there was some~r1hat delayed excretion into an 
enlarged gall bladder. 
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Routine laboratory values revealed no gross abnormality : Alkaline phos-
phatase ~;as 28 U/1; ga"'ma-GT 11 U/1; SGOT 9 U/1; SGPT 5 U/1; LDH 172 U/1 and 
Bilirubin .:10 micromo1 . F1. fractions were: LDHl - 15%; LOH2 - 56%; LDH3 -
157;; LDH4 - lO~In; LDHS - 4~::;. The haemog·l obi n concentration was 7,8 mmo·! /1. 
Hyperthermia Treatment 
On the day of treatment t1-1e patient was premedicated in the usual way with 
15 mg of papavaratum and 0.25 mg of hyoci ne given intramuscularly one hour 
before sile was brought to ti1e hypertherrrda treatment room. She was placed in 
tr,e hyoertherrni a cabin - the perspex cover was first removed - and an infusion 
of Ringer lacatate solution was started after insertion of a cannula into a 
vein on t!~1e dorsum of tr1e 1eft hand" 
An i ntraarteri a1 catlleter- was inserted percutanous1y into the radial artery 
of the left wrist, after first establishing that good collateral circulation 
v1as pl"esent from the ulnar arteryo This catheter was advanced into the 
brachi a1 artery and connected in the usua1 '>'!O.Y to the pressure transducer. A 
Swan Ganz cathete\~ was inserted into the 1eft subclavian vein and advanced, 
unaer protection of a intravenous bolus of 100 mg of lignocaine, into the 
pulmonary artery., 
Anaestnesia wc.s induced W'ith 100 mg of methohexitone intravenously, pre-
ceeded by 5 mg of d-tubocurar·lne to prevent fasicu'lations following the suxa-
met~lonium, 100 mg of vihi-ch was admirristeted after the patient ~1as asleep. 
In viev,: of tf;e lrism~s that was present, the patient was intubated using 
U'le retrograde intubation technique (Faithful1, 1982). An epidural catheter 
was passed througl1 3 Tuoey need1e, inserted through the cricothyroid membrane. 
After passage ti~-rough the larynyx, trds car.heter was retrieved from the naso-
pi1aryx and attacr1ed to a suction cat;1eter, wrli ch was then drawn dortn through 
th,2 voca"i chordso ,'iJJ 8.5 mrn diameter armoured latex cuffed endotracheal tube 
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was passed over the suction catheter and into the larynyx. The epidural 
catheter and suction catheter were then removed through the endotrachea-l tube. 
This intubation was accomplished rapidly and without ct·ifficulty. 
The patient was further relaxed with 25 mg of d-tubocurarine after the 
action of the suxamethonium 101as seen to be over. A further 10 mg was 
administered 10 minutes later ~vhen ·it became clear that paralysis was not 
complete. The patient was ventilated with a Siemens Eler:1a Ser-vo ventilator 900A 
with a mixture of 33% oxygen and 66% nitrous oxide. Tidal volume was 900 ml and 
the frequency was 10 res pi rations per minute. 
Waming was commenced after covering the patient with plastic foil and this 
was accomplished using hot air in the cabin and circu·tation of wann water 
through the wanni ng mattress on which the patient 1ay. Tr1e body temperature was 
raised from 37.8oC to 41.8°C in 90 minutes. 
During the initial warming period the ieft ventricular work index rose 
sharpl,y from 4 kg m min-1 at 3l.8oC to 7.7 kg m min-1 at 39.5°C. This ~~~as more 
than usual for the group of patients as a whole. Small (5 mg) incremental 
doses of dehydrobenzperi dol \II ere administered and this resulted in decreases in 
systemic vascular resistance and 1eft ventricular work. 
At 4lo6°C body temperature, the left ventricular t>JOIAk again Sf"lmved a ten-
dency to rise and 0.5% ha·iothane was added to tile inspired mixture. Ten 
minutes later this was increased to l~s and the patient was maintained or: this 
concentration until an hour and a quarter of plateau had elapsed. (~'irs D. began 
to 1 fighti the ventilator at this stage and 1.5% ha1otr,ane was g·Jven for a 
further 15 minutes by wl1ich time the mean systemic blood pressure had slo\<lly 
decreased to 50 mm Hg. Tl1is was considered to be rather lo'0J and the vaporiser 
was turned off. The systemic pressure rapidly recovered to a mean value of 64 
mm Hg. 
It should be noted that the cardiac index was considered to be quite 
adequate at all times and never fell bela'# 5 l min-l m-2. It should further be 
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noted that mean arterial pressures between 50 and 60 mm Hg were not at a11 
unconm10n ir: the present series of treatments. These 1evels were seen at one of 
the fixed marker points (3, 4 or- 5) in 15 of the 30 treatments. 
After switching off the halothane 10 mg of d-tubocLwarine was given. 
Further movernent during the 1 ast minutes of the plateau phase was controlled 
with 1 ~0 halothane. This 1vas switched off as the mean systemic pressure again 
started to fal1 - this time the 1 owest 1 eve1 reached was 55 mm Hg. 
Cooling vJas uneventful 
-
a dip in mean arterial pressure from 60 to 57 mm Hg 
was noted . .-1\t this stage the arterial line became blocked but further measure-
ments revealed S.,Ystolic blood pressures (measured with a von Reck1inghausen 
asci ll otonometer) remained above 90 mm Hg for the rest of the treatment. 
Arterial oxygen saturation at plateau was 94.9%. This was we11 within one 
standard deviation for the group~ as was the oxygen consumption~ oxygen flux 
and the rario of the two. It might be suggested that changes in liver function 
might result. in part from hypotensive episodes occurring during the plateau 
phase of treat.'llent. Hmlever, statistical analysis (Student t-test) of SGOT 
values 48 hours following treatment revealed no differences between the 9 
treatments in which mean artE:ri al va.l ues were between 55 and 50 mm Hg and the 7 
in whi cf1 pressures were between 60 and 55 mm Hg. There were also no differences 
ten,ueen this group and the 14 treatments where the pressures \!Jere always above 
60 mm Hg" In short there Has no indication that the changes in cardio-
respiratory parameters was abnormal fr-om the group of patients as a whole. 
Post- treatment Period 
Immedi ate1y after treatment slight electrolyte disturbances were found such 
as are found after every treatment. Levels of calcium} potassium and phosphate 
~vere l mv but caused r.o anxiety. 
Five hours aft.er opening tf1e cabin the potassium level in the blood had 
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fallen to 3.1 mmol/1 -this ~;as corrected to 4.6 mmol/1 by 9 l1ours of cooling 
by administration of 2 gm of potassium chloride in tt1e intravenous infusion. 
By the following morning the calcium level had fallen to 1.76 mmol/1 and 1 gm 
of calcium chloride was given intravenously. The phosphate levels had fallen 
from 1.14 mrnol/l pretreatment to 0.66 mmol/1 at this time (this is just within 
the 'normal' 1 evel for the estirnati ng laboratory). 
Haematological investigations the folloi>Jing morning gave indications of a 
mild intravascular coagulation syndrome. This nonnally recovers by 2 days post 
treatment without further therapy, but, in this case~ on the second post 
treatment day, abnormalities were still present. Fibrinogen levels had 
decreased to 0.4 gm/1 (pretreatment level 2.6 gm/1 I and thrombocytes were at a 
1 evel of 29,000 per mm3 (pretreatment 1 evel was 230,000 per mm3). Fibrin 
breakdown products were detected in the plasma at levels between 40 and 80 
mg/1. Treatment was instituted with low dosage of heparin and fresh plasma. 
Following this regime the clotting parameters gradually improved. At this time 
(2 days) prothrombin time was 3.9 x normal, thrombin time was t11vice norma1 and 
parital tl1romboplastin time was 1.3 x normal. 
It should be noted that, in the recovery period, the cooling !"ate of the 
patient in the intensive care unit was very much slower than in the group as a 
whole. Between t~''o to five hours after cooling had been commenced, ail ter•.pera-
ture measurements revealed values that 1ay more than one standard deviation 
higher than the mean of the group. In the series of patients r1ere described, it 
was noted that slower cooling tended to be associated with evidence of liver 
function changes following treatment" 
In order to further investigate this phenomenon. two groups of patients 
were retrospectively studied" One group consisted of four patients in whom the 
highest levels of SGOT were obtained two days after treatment. The other group 
was composed of patients in Y.Jhorn the lowest levels of the enzyme were found. 
The difference between the two groups with respect to the SGOT 1 evel s was very 
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significant {p(.Ol). The boGy temperature differences betvveen these two groups 
of patients was analysed using a Student 1 s t-test. It was found that the body 
ternperature of the high SGOT group 1-11as o.lwa':/S significantly higl1er than in the 
low SGOT group bet'>"feen 12 and 18 hours after cooling had started. The 
differences at earlier stases in the cooling period were also largely 
significant. f},t all times between tvw hours of cooling and eieven hours of 
cooling signif·icant differences in body temperature was found between the two 
gr·oups (p<.OS} 1 titn ~:ne exception of two hours of cooling (p-<:.2),, seven hours 
of coo1ing (pL:ol), and ten hours of cooling (p£..1). 
It is interesting 5 at this point~ to remember the work of Hubbard et al. 
( 1977), \•ihi ch has already been r-eferred to in chapter I~ in i•Jhi ch they were 
ab1e to find a telationsllip between cooling speed and survival in hyper-
thermically stressed rats. It may be tf·1at the severity of liver damage in 
patients caul d be r'educed by more attention to rapt d cooling" 
lt is, of course) al'!most impossible to de-cennine if the slower cooling was 
as a result of tile production o·f pyrogenic substances by an a1 ready compromised 
·1 iver or the caused by prolongation of the 1 hyperthermia 1 -
though this 'das very 1 ON grade in the post treatrnent phase. In view of the 
fact that Pet"t:igre\1>:· and Luclgate (1977) held patientsr temperatures at, or just 
belm-,'~ 4l-8"'C for 'about 4- hours' witl1out obsN\Iing significant toxicity \F~ou1d 
point to the fanner possi b·i 11 i t.v as bel ng more or-obabl e. 
At Two hours of cooling {on env·y into tf1e intensive care unit} ~1,rs D1s 
pulse rcrte 'iiCS more tf1an one standard deviation l 0\"'er tha.n tr1e mean of the 
group as a ~;;hole, and ner mean systolic pulse pressure was more than two 
standard deviations lower than tfle :nean of al1 pat.i ents. Cardiac index was, 
howeve1~, normal and, on c1 i nical grounds, there was no reason to suspect that 
her oxyg-en "flux v-.ras diminished" ft,s the arterial line had unfortunately become 
irretrievably b"locked at the end of treatment~ no blood gas data are available 
for the intensive care recovel"y phase of this patient. The heart rate remained 
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low, (more than one SO), for a further hour and the mean arterial pressure was 
low, (more than one SD), for a further three hours. Otherwise there were no 
marked differences, from the group of patients as a whole, in the measured or 
calculated cardiovascular parameters during the recovery phase of this patient. 
Measurements of the serum enzyme levels the day following treatment were as 
follows: SGOT 47, SGPT 16, CPK 191, and LDH 266 U/1. LDH isoenzymes were as 
follows: LDHI 22%, LDH2 48%, LDH3 13%, LDH4 7%, and LDH5 10%. All these values 
were within one SO of the mean of all treatments with the exception of LDH2 
which was more than one SD raised, and LDH3 more than one SO lower. The total 
bilirubin level was 20.7 micromol/1 (13,2 micromol/1 was in the conjugated 
form). 
Two days after treatment the following values were seen: SGOT 1540, SGPT 
805, CPK 149, and LDH 3586 U/1. LDHl was 3%, LDH2 7%, LDH3 2%, LDH4 12%, and 
LDH5 had risen to the huge value of 76%. All these values were outside two 
standard deviations of the mean of the group and it was obvious the patient was 
severely ill. The bilirubin level had risen to a total of 62.4 micromol/l (46.5 
micromol/1 was in the congugated form). 
The patient 1 S condition continued to deteriorate and at three days post 
treatment the SGOT had risen further to 1738 U/1 and the SGPT to 2002 U/1 - the 
LDH was 2185 U/1. The total bilirubin had risen to 118 micromoles per litre. 
The patient died on the eighth post treatment day in hepatic coma. Renal 
function had remained good throughout the course of the hepatic problems. 
Autopsy revealed massive hepatic necrosis and a few small metatstatic 
seconday deposits were seen at the hylum of the liver. No indications of 
thrombotic processes or bleeding were observed. 
Discussion 
The cause of the fatal hepatic necrosis in this patient was not 
109 
immediately obvious, but as soon as it was rea"lized that the patient had 
received halothane auri ng treatments ·suggestions were made that this was the 
cause of the disaster. 
k nmvl edgab·i e physicians 
1 hepatotoxic' agent.. 
A number 
are under 
of 
the 
very highly placed, and otherwise very 
impression that halothane is a highly 
Early findings by little et alo (1958} indicated that i1epatic functions 
were not more affected fc11ovdng anaesthesia by halothane than following 
anaestr1esia by cyclopropane and etfler. Bunker and B1umeflifeld (1963) reported 
two cases of fatai hepatic necrosis following halothane but they concluded that 
it was not possible to implicate the anaesthetic ·in either case. They pointed 
out that in the U.S.A. 15-20 patients per year. might, on epidemiological 
grounds, be expected to contract infectious hepatitis within 5-10 days of 
sur9ery, t"lushin et a.l, (1964) after a retrospective study of l5s774 halothane, 
and 6 ~ 123 non-hal otnane anaesthetics concluded that there was no evi de nee to 
show vd;eti'ler halothane Nas producing a specific toxic or allergic affect. They 
wel~e also unable to detect any important differences witn respect to the 1iver 
p a the i ogy betv1eer. the halothane a:r1d the non-halothane group. Tr1ey also 
co~cluded tnat there was 'unlikely tG be a graduated response on the liver 
l~el a te-d to dose 1 , 
In 1966 tl1e subcommittee of the national halothane study presented its 
find·ings in tr•e L:.S.A. They perfomea a compa.rative study of ha.lothane and 
other anaestnes;;.ics as to tf1e ·rnc:dence of fatal massive hepatic necrosis 
htithin six weeks of anaesti1esla" They examined 82 cases of necrosis. Of the 9 
'unexplained' cases, 7 1'10-d received halothane for- tile final operation, and 4 
had received 2 halothane anaesthetics within 6 weeks of the final operation. 
T !1ey studied more -chan one mi 11 ion anaesthetics and the committee commented 
that 'the study failed to establish a causal reiat·ionship between halothane and 
hepatic nec\~osisj. i<lion et aL (1969) concluded that there v-;as no evidence-
that preexisting liver disease increased the risk of adverse hepatic reactions 
110 
to halothane. 
Mus hi n et al. ( 1971) examined the pattern of incidence of previous 
anaesthetics and found that there was a significant association between post-
anaesthetic jaundice and a previous administration of halothane when the 
interval between the two halothane administrations was 4 weeks or less. 
Simpson et a1. (1971) however, considered that it was still not possible to 
conclusively rule out viral infection as a cause of liver damage in an 
individual case. Later Inman 
following multiple exposures 
reported as 1 postha1 ethane 
anaesthetic within 4 weeks. 
and Mus hi n 
to hal a thane 
jaundice 1 had 
(1978) further reviewed jaundice 
and found that 75% of patients 
received a previous halothane 
In a recent review Cousins (1980) has discussed possible precipitating 
factors in the production of 1 halothane hepatitis 1 and pointed out that under 
conditions of decreased hepatic oxygen delivery, binding of reactive halothane 
intermediates (~<hi ch may be capable of direct hepatic damage) might be 
increased. 
From tr1e evidence available it was not considered that Mrs D. had suffered 
from hepatic hypoxia during i1BHT. At plateau temperature she had a high 
cardiac index (6.2 min-1 m-2) and normal mixed venous oxygen saturation 
( 72.1%) in the presence of an adequate haemoglobin 1 evel (10. 0 gm per 100 ml of 
blood). She had not received halothane within 4 weeks of WBHT - indeed she had 
never received the drug. It was therefore not considered that the use of 
halothane had contributed to her tragic demise. 
A further factor that might possibly have had an influence on the hepatic 
function of this patient was the pretreatment by i soni azi d. Hepatoxci ty 
following administration of this drug has been reported and these effects are 
often more severe if isoniazid administration is repeated after a period of 
abstinence (Repertori urn Verpakte Geneessmi del en, 1976). The incidence is 1 ow 
(0.1% Elis, 1980) and tends to occur during the early months of therapy. The 
111 
prognosis is almost always good and, if treatment is interrupted, elevated 
chemical values return to normal (1·1eyer and Hoigne 1980). 
The question arose as to the likehood of isoniazid producing enzyme induc-
tion. This is especially important in view of the reports of Cousins et al. 
(1979) of hepatoxcity produced in rats by hypoxic administration of halothane 
in the presence of phenobarbitone. Blair and Levin (1977) reported 3 cases of 
hepatic failure following WBHT. Two patients had been regular consumers of 
alcohol and the third had received longterm treaunent of epilepsy with pheno-
barbitone. Tl1e authors 
increase the i nci de nee 
suggested that alcohol and enzyme inducing drugs could 
of liver damage above 42'C. No details of anaesthetic 
techniques or cardiorespiratory parameters were given for these patients. 
It is not clear whether isoniazide can, in fact, produce enzyme induction 
and it is not included in the list of more than 200 enzyme inducing drugs given 
by Conney (1967). 
It was concluded after lengthy discussion that neither halothane nor 
isoniazid had a significant influence on the course of the hepatic necrosis in 
this case. It was clear that further work was necessary to elucidate the cause 
of hepatic necrosis after WBHT. 
HEPATIC BLOOD FLOW ESTIMATIONS IN PATIENTS UNDER HYPERTHERMIA 
As a result of the above conclusions, it was decided to estimate the total 
splanchnic D"food flow during subsequent WBH treatments. Monitoring of sodium) 
potassiums lactate~ ammonium~ SGOT and SGPT levels in hepatic venous blood was 
carried out after sampling through a catheter introduced via the femoral vein 
into one of the hepatic veins. 
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The continuous infusion technique for estimation of hepatic blood flow was 
introduced by Bradley et al. (1945). This technique is based on the Fick 
principle and was introduced using bromsulphthalein (BSP). The use of this 
substance has largely been superceded by the use on indocyanine green (ICG) 
which has been shown to have no extrahepatic extraction routes (Caesar et al. 
1961). Estimated hepatic blood flow (EHBF) is calculated from the formula: 
EHBF= ICG infusion rate (mg mins-1) 
!CGa (mg ml-1) - !CGhv (mg ml 1) 
where: 
ICGa Systemic arterial concentration of ICG 
X 1 
1=-Ht 
ICGhv hepatic venous concentration of ICG 
and Ht the percentage haematocrit of the patients blood. 
Dye determinations were performed photometrically using a Carl Ziess P~1Qll 
spectrophotometer. Determinations of !CG contents were performed in undiluted 
plasma. As the blank densities of the plasma appear to change during treat-
ment, a blank correction was used as applied by l<inlcler and Tygstrup (1960). 
Dye concentration \tlas calculated as: 
where: 
D805 - f X D600 
E805 - f xtoOO 
D = optical density at 805 or 600 namometres 
E extraction coefficient of ICG in plasma at the same wavelengths, 
and f = plasma blank factor ie plasma blank at 805 
plasma blank at 600 
A 15 mg loading dose of !CG was given intravenously before anaesthesia was 
induced and continuous infusion was carried using a Hospal KlO infusion pump at 
a dose of 0.333 or 0.167 mg per minute. At least 20 minutes were allowed for 
equi1ibriation before estimations were made. Samples of arterial and hepatic 
venous blood were measured for estimation of total 1 i ver blood flow at the 
following times: before induction of anaesthesia (marker 1), at the start of 
warming (marker 2), beginning of plateau (marker 3), mid-plateau (marker 4), 
TABLE VI Hepatic blood flow studies during hyperthermia 
~1arker 1 Marker 2 Marker 3 l'<larker 4 t~arker 7 
Before induction At beginning on reaching after one hour After half an hour 
of anesthesia of warming 41.8 °C at 41.8 oc of cooling 
Treatment number and 
maximum SGOT 
post treatment 
Extraction Extraction Extraction Extraction Extraction 
EHBF of ICG EHBF of ICG EHBF of ICG EHBF of ICG EHBF of ICG 
Treatment 20 2300 24,4% 1350 32.2% 1960 20,3% 2580 20,5% 2470 16,46% 
I 39,6%1 (39,5%) (20,2%) 124,7% I (29,8%) 
t~aximum SGOT - 18 
Treatment 21 2250 44.7% 7640 13.4% 
(35.9%) (50.9%) 
f1aximum SGOT - 336 
Treatment 22 2180 38,4% !380 47,1% 4020 !9,0% 6890 10.7% 5220 13,1% 
(35.3%) (33,0%) (30,2%) (51 ,7%) (36,4%) 
Maximum SGOT - 72 
Treatment 25 1880 64.8% 3410 57,6% 5900 45,7% 3050 42,7% (49.8%) (34.4%) (52.9%) (29. 7%) 
! l~aximum SGOT - 29 
---·- ----
Estimated hepatic blood flow (EHBF) using indocyanine green {ICG) clearance techniques. EHBF is expressed as ml per minute. The figures 
in brackets respresent EHBF as a percentage of the cardiac output. Hepatic ICG extraction is expressed as percentage. 
~ 
~ 
w 
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and half an hour after opening the hyperthermia cabin (marker 7). In addition 
to total splanchnic blood flow the hepatic extraction ratios for !CG were cal-
cul a ted from the fallowing formula: 
Results 
Extraction = ICGa - ICGhv 
ICGa 
Results of !CG estimations of total splanchnic blood flow from 4 WBH treat-
ments are shown in Table VI. The flows are also expressed as a percentage of 
the cardiac output. Details are also given of the calculated extraction of 
ICG, and of the maximum SGOT levels measured following treatment. As can be 
seen, estimated flows increased dramatically under conditions of hyperthermia, 
while at the same time ICG extraction decreased. The greatest changes occurred 
in patients having the greatest rises in SGOT following treatment. 
0 i scussi on 
Values for liver blood flow in the awake state have been estimated by 
Cooperman et al. (1968) using ICG clearance methods. They measured the flow in 
six subjects and they range between 1.38 and 2. 93 l i tres per minute, with a 
mean of 2.06 liters per minute. The two measurements obtained in the this study 
in the awake patients fall into that range. In four patients Cooperman et al. 
(1968) measured cardiac output. The splanchnic blood flows ranged from 27.9 to 
50% of the cardiac output again our figures fall into that range, though 
figures of 25% of cardiac output are often quoted (Strumin 1980). Cooperman et 
al. (1968) studied the effect of anaesthesia with nitrous oxide/oXYgen and 
hyperventilation under d-tubocarine. This is the same sequence as was used .in 
the patients reported .here. Splanchnic blood flow in their subjects fell to a 
mean of 1.4 1/min (range 0.73 to o.41) and this represented a mean of 25% of 
cardiac output (range 12.4 to 29.5%). Our estimated flows did not fall to this 
extent. Mean flows of the patients in this series were 1. 7 1 i tres per minute 
and this represents a mean of 35.5% of the cardiac output. 
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Wl1en looking at the estimated flows presented in Table VI the most obvious 
change to be seen, under hyperthen'1ia, is a very large increase in splanchnic 
blood flows in three cases to sm~ or 1110re of the cardiac output. It is :nost 
unlikely that splanchnic blood flOIIJ would rise to these levels under conditions 
of hyperthemia in view of the large increase in skin blood flow that is known 
to occur (Wyss et al. 1974). This increase in skin blood flow, which is 
partially mediated by a decrease in venomotor reflex tone. (Zitnik et al. 
1971), may reach large- proportions and the flow IJlay be such that there is 
virtually no difference in blood gas concentrations between blood in the radial 
artery and that in the forearm vein once body temperature has reached 38oC 
(Lees et al. 1980). 
Further discussion of splancf1nic blood flow will be given in a later 
section~ but it shoutd be noted that in a11 cases ICG extraction had decreased 
by the tin1e midplateau {marker 4) had been reached, indicating decreased 
ability of the liver to excrete the drug. 
There were no significant differences in the blood concentrations of 
sodium, potassium, SGOT, SGPT, ammonium ot' lactate between blood drawn from the 
general systemic ci rcul ati on and hepatic venous blood i n the nine patients in 
whom the values were estimated. 
Oxygen saturation of hepatic venous blood was followed during WBHT in seven 
treatments. There was a significant {PL.OS) fan at marker 3 {beginning of 
plateau). This fan becarne nonsignificant when the one patient in the group 
who had a marked rise of SGOT at 48 hours, was excluded. He had a 48 hours 
SGOT value of 336 units as against the other six with a mean value of 35.8 
units (SE~I + 3.2). His values for both SGOT at 48 hours and oxygen saturation 
of the hepatic blood at rnarl<ers 3 and 4 ( beginning and r1id plateau) were all 
more than 2 standard deviations outside the mean of the group. 
In view of the unreliability of ti1e estimated tota1 splanchnic blood flow 
in these patients, it is almost impossible to dra'.-J any finn conclusions from 
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the arterial and hepatic venous saturation values. It can only be stated that 
in the one patient referred to hepatic venous oxygen content ~~as very 1 ow and 
amounted to 5.6 ml /100 ml of blood. 
It became clear that, in man, estif'lation of total hepatic blood flow under 
hyperthennia using ICG clearance methods was unreliable and it was decided that 
animal experiments should be performed. 
EXPERII~EIHAL STUDIES OF HEPATIC BLOOD FL011 
Dye Clearance Methods 
Immature female Yorkshire pigs weighing between 24 and 26 kg were used in 
the study. Anaesthesia was induced with an intraperitoneal injection of sodium 
thiopentone ( 30 mg per kg body weight). After intubation with a cuffed endo-
tracheal tube the animals were ventilated using a Bennett anaesthesia venti-
lator with a gas mixture of 33% oxygen and 67% nitrous oxide. The expired 
carbon dioxide was measured with a Goddard type 146 capnograph and the ventila-
tion was adjusted to maintain an expired concentration of carbon dioxide 
between 4 and 5~b. Pancuronium bromide was used to maintain muscular relaxation 
and this was administered intravenously using a Braun ~1e1sungen Perfuser 
adjusted to administer the drug at a rate of approximately 0.5 mg per kg per 
hour. 
A 5 mg loading dose of indocyanine green was injected intravenously and it 
was then administered using a continuous infusion with another Braun r~elsungen 
Perfusor appartus at a rate of 4.75 mg/hr. Through a skin incision in the 
groin a 7 French 80 em cordis femora- renal A2 catheter was introduced into the 
femoral vein and advanced under x-ray control till its tip lay in one of the 
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main hepatic veins this position 1-1as checked by injection of radio-opaque 
dye (Urografin-Schering AG). This catf1eter was used to sarnp1e hepatic venous 
blood. Arterial blood was samp1ed through a 1.85 mrn bore catheter introduced 
into the femoral artery through the sav.te incision. 
After a minimum of 30 minutes of indocyanine green infusion, heparinized 
hepatic venous and arterial blood samples were withdra~tJan and centrifuged. The 
concentration of indocyanine green in tr1e supernatant plasr:1a was estimated by 
absorption spectometry at 796 nanometers wave1 ength using a Vi tat ron UC 200S 
photomometer and comparing the extinction so obtained with a calibration curve 
previously constructed using freshly prepared indocyanine green solution. 
The estimated hepatic blood flow (EHBP) was calculated from the formula: 
Hhere: 
and 
EHBF (ml mi n-1} ICG infusion rate (mgmin-1) 
II:Ga\mg ml-1)- !CGhv (mg ml 1) 
!CGa = Arterial concentration of ICG 
!CGhv = Hepatic venous concentration of ICG 
Hepatic extraction percentage (E) was calculated using the fomu1a: 
E ICGa - ICGhv 
ICGa 
In two of the six pigs a further estimation was performed after at least 
one hour 1 S pause to check the reproducability of the measuring r.Jethods. 
Using a i'later circulating blanket and a Chut·chill thermo-circulator LTCM 
thermostatically cantrall ed heater ci rcu1 a tor four of the pigs were heated to 
the temperature range of 39c to 40oC and the EHBF estimations repeated. The 
blood temperature in the pulmonary artery was taken as core temperature and 
this was measured using the themi star tip of a 7 Frenc11 gauge KMA thermo-
dilution Swan Ganz catheter. Two of the four pigs were further heated till 
their temperatures \Here above 40oC and again EHBF estimations were repeated. 
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TABLE VII Indocyanine green clearance studies in pigs 
Pig number Before Warming 39° - 40°C ~·lore than 40°C 
I CG ICG ICG 
EHBF Extraction EHBF Extraction EHBF Extraction 
1 48,1 16,6 
2 61,1 25,57 
55,1 26,3 
3 52,4 11,3 137,5 3,5 
4 57,9 16,1 550,0 2,1 
5 40,7 18,0 112,0 2,6 infinite zero 
40,7 22,4 
6 47,0 19,9 39,2 22,7 infinite zero 
Estimated hepatic blood flow (EHBF) in six yorkshire pigs (24-26 kg body weight) 
at various temperatures measured by indocyanine green {ICG) clearance 
techniques. Blood flow is expressed in mil per kg body weight per minute and 
I CG extraction as percent. 
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The tesults of the hepatic blood flow estimations and ICG extraction rates 
are presented in Table VII. As can be seen, at nonnotherr:ria, there is little 
difference between the various animals in tems of estimated flow, but in the 
range of 39o to 40o an enonnous range of calculated flmo,~s INere obtained. Some 
of the flows are clearly incorrect. In both animals above 40oC body temperature 
there was no rneasureable difference between ICG concentrations in the hepatic 
venous blood and the arterial blood. Calculations thus yielded 'infinite' blood 
flow and zero extraction. 
Discussion 
EH8F in pigs has been measured by various authors using ICG clearance 
techniques. Lucke and Hall (1978) using Pietrain pigs with a mean body weight 
of 67,3 kg obtained average flo>~s of 16.3 ml l<g-1 rnin-1 -whereas Imamura and 
Clowes (1975) employed pigs with a mean body weight of 25,8 kg and estimated 
mean f1 ows of 44,2 ml kg-1 mi n-1. The weights of their pigs compare well with 
those used in the present study (mean body weight 25,2 kg), as do flows 
obtained. The pigs in this study had mean flows of 50,7 ml kg-1 min-1. 
Imamura and Clowes (1975) obtained good correlation (correlation coefficient 
of 0,8) between their flo'>I/S measured by indocyanine green clearance and direct 
measurements obtained by a method employing two Swan Ganz thermodilution 
catheters positioned in the inferior vena cava above and below the openings of 
the hepatic veins. ~~lean flows of 43,6 ml kg-1 min-1 were obtained using this 
method. 
In view of the clearly incorrect estimations made by ICG clearance methods 
under hyperthermic conditions it was decided to further pursue the study using 
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other methods. 
Thermodilution Techniques 
It was decided to employ the dual Swan Ganz catheter method of measuring 
total hepatic blood flow as used by Imamura and Clowes(1975). Pigs of similar 
body weight to those used in the ICG clearance studies were anaesthetized as 
described above. 
Via an incision in the upper right side of the throat of the animal, a 
seven french gauge swan ganz thermodilution catheter was inserted as high as 
possible into the right internal jugular vein. This was advanced under pressure 
monitoring through the right atrium and right ventricle until its tip lay in 
the pulmonary artery. It was connected to a KMA thermodilution cardiac output 
computer model 3500. Cardiac output could then be measured by injection of 5% 
dextrose solution through the proximal line of the Swan Ganz catheter. 
A seven french femororenal catheter was inserted into the left femoral vein 
in the groin and advanced under fluoroscopy until its tip lay in one of the 
hepatic veins as described earlier. Into the other femoral vein two further 
seven french Swan Ganz thermodilution catheters were inserted. One was 
advanced until its thermister tip lay in the thoracic part of the inferior vena 
cava half way between the openings of hepatic veins and the exitus of the vena 
cava into the right atrium. The other Swan Ganz was positioned with its tip 
just distal to the exit of the hepatic veins into the inferior vena cava. The 
position of these catheters was checked under fluoroscopy by injection of a 
radiopaque dye (U rografi n-Scheri ng AG). 
Using 
dilution 
tips of 
this experimental 
cardiac output 
both catheters. 
arrangement in conjunction with the KNA thermo-
computer, it was possible to measure the flow at the 
Hence, by subtraction, total blood flow from the 
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hepatic veins, and hence total splanchnic blood flow could be estimated. 
It was found that this technique was only applicable to pigs of 24 kg or 
more bodyweight. Otherwise it was not possible to insert sufficient length of 
the 1 ower catheter to enable measurements to be made. This was due to the 30 
em distance between the proximal injection opening of the Swan Ganz catheter 
and the thermistor measuring tip. A standard catheter was used to ensure a 
good mixing of the i njectate. 
Two flov1 measurements were taken at two phases of the respiratory cycle 
fifty per cent apart and the Bennett ventilator was set to deliver a 1:1 
inspiratory/expiratory ratio. Recent work by Janssen et al. (1981) waul d 
indicate that the mean of the two results so obtai ned should have a good 
correlation with the mean flow during the respiratory cycle. In total, for 
each measurement 3 paired r'.1easurements were made and the results averaged. 
In order to determine the reproducibility of the method, paired estimates 
of liver blood flow (separated by 15-45 minutes) were perfonned on six pigs. 
The pigs were then heated as described in the previous section on dye 
dilutional methods. Measurements were perfomed at the fol1owing points: 
normothermia (between 3r and 38oC); between 39° and 40oC body temperature; 
between 40o and 41 oC; and above 41 °C. Body temperature was again taken as the 
temperature measured by the thermistor tip of the Swan Ganz catheter positioned 
in the pulmonary artery. 
At"terial and mixed venous blood samples were taken at the time of estima-
tions of liver blood flows, and blood gas and acid/base values were estimated 
using a Radiometer ABU acid base laboratory. The oxygen saturations of the 
blood and haemoglobin concentrations were measured using a Radiometer OS~12 
f1emoxirneter. 
From the above measurements the total sp1anchnic oxygen consumptions were 
calculated using the formula: 
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TABLE VIII Splancnic blood flow in pigs 
Paired thermodilution estimations Indocyanine green clearance 
of total splancnic blood flow estimations of total splancnic 
blood flow 
64.2 41.8 
63.8 
61.1 
52.5 55.1 
44.6 
52.4 
50.4 57.9 
48.8 
40.7 
52.4 47.0 
52.4 
40.7 
60.7 
53.5 
46.2 
48.5 
si gni fi cance using 
Student 1 s T test 
Mean 53.2 50.4 
SE +6.5 NS +7 .6 
n (6) (8) 
Paired thermodilution estimations of total splancnic blood flow and 
estimations of total splancnic blood flow using ICG clearance techniques. 
Pigs at normal body temperatures. 
48 
40 
32 
SBF 
-1 -1 (ml min kg ) 
24 
16 
-
8 -
0 
Pre-
Significance versus Pre-warming 
values using paired t-test. 
p < • 05 = * 
p < . 01 = ** 
p < .001= *** 
** 
*** T *** 
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----,-
39°- 40°- >41 ° 
warming40° 41°-
Fig. 9. The effect of Hyperthermia on splancnic 
blood flow (SBF) in pigs. Means± SEM. 
36 
30 
24 
18 -
SBF % 
12 
6 -
Fig. 10. 
Signi fica nee versus Pre-warming 
values using paired t-test. 
p <.OS = * 
p <.01 ** 
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* 
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T 
1 
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warming 40°-
40°- >41° 
41° 
The effect of Hyperthermia on 
splancnic blood flow as percent of 
cardiac output (SBF%) in the pig. 
Means ± SEM. 
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Splanchnic oxygen consumption ( C a02 - Chv02) x CO 
where: 
Ca02 =oxygen content of systemic arterial blood in ml/100 ml blood 
Chv02 =oxygen content of hepatic venous blood in ml/100 ml blood 
and CO= cardiac output in litres per minute 
Ca02 was derived from the formula: 
Ca02 = Hb x Sa02 X 1.306, 
and Chv02 was determined from the equation: 
Chv02 = Hb x Shv02 x 1,306 
where: 
Sa02 = percentage oxygen saturation of systemic arterial blood 
and Shv02 = percentage oxygen saturation of hepatic venous blood. 
Results 
In Table VIII results are presented of the paired thermodilution 
estimations of liver blood flow. Also presented from comparison are the 
(largely unpaired) estimations of liver flow using the ICG clearance tech-
niques. It should be noted that these <~ere performed in a different group of 
animals, and hence no comparison can be made between the individual figures in 
the two columns. 
There was no statistically significant difference (using the Student's 
t-test) between the results obtained by the two methods. The correlation co-
efficient between the two measurements making up the pairs of the thermodilu-
tion measurements was 0.81 (P<..OS). 
Figure 9 is a histogram representation of the changes of total splancnic 
blood flow against temperature. As can be seen, statistically significant 
reductions in flow occurred at all temperatures above 39°C. 
In figure 10 these changes are plotted as a proportion of the cardiac output 
- again, all falls are significant. 
In figure 11 sp 1 ancni c oxygen consumption per kilogram bodywei ght is p 1 otted 
3,0 
2,0 -
502 con 
-1 (m! min kg -1) 
1 '0 -
-
-
-
** 
L 
' ' 
Significance versus Pre-warming 
values using paired t-test. 
p<.OS::* 
p<.01 :: ** 
p<.OOl:: *** 
** * 
r I 
Pre- 39°- 40°- >41 ° 
warming 40°- 41° 
Fig. 11. The effect of Hyperthermia on splancnic 
oxygen consumption (502 con) in the pig. 
Means ± SEM. 
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Fig. 12. The effect of Hyperthermia on arterial 
oxygen saturation (Sa02) and hepatic 
venous oxygen saturation (Shv02) in 
the pig. Means ± SEM. 
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against temperature. Significant decreases occurred when the animals 1 body 
temperatures were raised above 39°C. 
In figure 12 changes with temperature of both systemic arterial oxygen 
saturation and hepatic venous oxygen saturation are presented. \~hereas the 
arterial saturation fell significantly on raising body temperature, there were 
no significant changes in the hepatic venous oxygen saturations. 
Discussion 
Investigations of hepatic blood flo;, under hyperthennic conditions have been 
carried out in a number of animal models and also in man. In the latter case 
the rise in body temperature was not nearly as much as is induced during I<BHT. 
Trai<S and Sancetta (1959) have studied the effects of raised body 
temperature in nomal human subjects using bromsulphalein (BSP) clearance and 
found no change in estimated hepatic blood flow. It should be noted that the 
average body temperature was only raised by 0.8°C. Using the same techniques 
under conditions of induced pyrexia, Bradley and Conan (1947) found that EHBF 
increased si gni fi cantly with concomitant reduction in BSP extraction. 
Using ICG clearance methods, Rowell et al. (1970) have recorded decreases 
in EHBF in spontaneously ventilating human volunteers. The blood temperature 
in the right atrium was between 39.05'C and 39.44'C and the mean decreases in 
flow amounted to 34%. This compares quite well ;,ith the percentage fall that 
was observed in the pig (29,2%) between nonnothermia and 39'- 40'C. Rowell et 
al. (1970) noted that the splancnic blood flow began to decrease near the time 
that the blood temperature began to rise. They stated that the hepatic 
extraction remained constant at 85% and they postulated that splancnic vascular 
resistance might have been increased vi a central baroreceptor reflexes in the 
presence of a decreasing mean arterial pressure. However, in a further study, 
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Rowell et al. (1971) demonstrated that falling mean arterial pressure or aortic 
pulse pressure were not major causes of the splancnic vasoconstriction in 
response to heating in the human subject. 
Using radioactive microspheres to study the splancnic blood flow in 
unanaesthetised baboons Hales et al. (1978) have demonstrated a 35% reduction 
in flow when the body temperature was raised by a mean of 1.7'C. The study 
further revealed 
tions. This is 
output are found 
that there is no rise in cardiac output under these condi-
in contrast to man~ in whom very large increases in cardiac 
(Rowell et al. 1970). The baboon would appear to differ from 
man in a number of its thennoregul a tory mechanisms as a 1 ack of human 1 ike 
active skin vasodilation under conditions of hyperthermia was demonstrated in 
heat stressed baboons by Wyss and Rowell (1976). 
In a study using radioactive microspheres, Hales (1973) has studied blood 
flow changes in the splancnic area of hyperthermic sheep. Hyperthermia at mean 
temperatures 
flow of 20%, 
of 40.2', 40.7' and 42.3'C resulted in mean decreases in splancnic 
42% and 53% respectively. In this study there were no marked 
changes in cardiac output. 
In experiments in anaesthetised cats and rabbits, Walther et al. (1970) 
have demonstratEd that local heating of the spinal cord causes decrease in 
activity in cutaneous sympathetic effects with corresponding increase in 
vi seral sympathetic outflow. Similar effects were 1 ater demonstrated in 
decereberat.ed rabbits by I riki and Kozawa (1976a). These results waul d indicate 
that thermoregulatory responses of the sympathetic nervous system are capable 
of functioning after loss of hypothalamic integration. In addition it has been 
shown that vagal activity is decreased during spinal chord warming (lriki and 
Kozawa 1976b). 
Local heating of the spinal cord has also been shown to decrease blood 
f,low the in superior mesenteric and splenic arteries of anaesthetised dogs, 
with concomitant increase in flow in the dorsalis pedis artery (Hales and 
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Dampney 1975). 
From the above discussion, it may be concluded that the thennoregulation 
responses of the splancnic circulation in response to hypertl1ennia is basically 
similar in all manmal ian species. Cardia-cutaneous responses to heating may 
vary but it would appear that splancnic bloorJ flow is almost always reduced 
under these conditiones. It is tempting to suggest that similar reductions in 
total splancnic hepatic 
the present study, may 
physi ol ogi cal responses 
flow and oxygen consumption to those found in pigs in 
be occuri ng in man undergoing ~JBHT and that these 
might be,in part, responsible for the hepatic toxicity 
that was observed fallowing treatr.1ent. 
It would appear that estimated hepatic blood flows obtained under 
hyperthennic conditions employing dye clearance methods are unreliable and 
there is a need for the development of alternative clinical methods directed 
towards this end. 
Future Possibilities 
If the assumption is accepted that changes in liver function follo>ling WBHT 
are, at least partially, caused by decreases in total splanchnic blood flow 
during treatment, it would see,n logical to attempt to block the increase of 
sympathetic discharge that is taking place. This has been demonstrated in 
experimental models (as mentioned above) by \Jalther et al. (1970) and Iriki and 
Kasa<~a (1976a). 
If spinal epidural 
sympathetic discharge from 
Epidural anaesthesia has 
blockade with loca1 anaesthetics is perfonned 
the thoraco-lumbar outflow wi11 be decreased. 
been employed by both Pettigrew and Ludgate (1977), 
and Blair and Levin (1977) in order to increase cutaneous vasodilation and 
hence by, increasing heat flux from the s!<i n surface, to speed the vJanni ng of 
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the patient. The latter have demonstrated a mean rise of body temperature 
during the first hour of heating of 1.7'C (in three treatments) without 
epidural blockade, as opposed to a rise of 3.1'C per hour (in 32 treatments) 
after blockade. Unfortunately the temperatures at which the patients were held 
at plateau and also the duration of treatments vary between the two groups and 
no conclusions can be drawn as to the prevention of rises of serum enzymes or 
bilirubin levels following treatment. 
Alpha-adrenergic blockade of the sympathetic nervous system might also be 
expected to decrease sympathetic tone in the splanchnic vascular bed. Hence 
less decrease of blood flow to the liver should occur during WBHT. This treat-
ment might, indeed, have other advantages than the increase of splanchnic blood 
flow. 
It has been shown that platelets can take up circulating catecholamines 
from plasma and that this effect is both time and temperature dependent (Born 
and Smith 1970) and it has recently been confirmed by Zweifler and Julius 
(1982) that patients with pheochromocytoma have greatly increased platelet 
levels of catecholamines. Zwiefler and Romero (1975) have shown that platelets 
from patients with pheochromoacytoma exhibit greater sensitivity to adenosine 
diphosphate (ADP) aggregation than do those of normal controls. They have 
further demonstrated that this effect can be prevented by the alpha-adrenergic 
blocking agent phentolamine. 
As already mentioned, Kim et al. (1979) have confirmed the presence of 
increased concentrations of circulating catecholamines in patients undergoing 
WBHT. In some cases the concentrations, that they measured~ were comparable 
with those found in patients suffering from phaeochrornocytoma. It might there-
fore be postulated that alpha-adrenergic blockade during WBHT might prevent 
catecholamine release. Uptake of these substances by the platelets, which may 
take place at an faster than norroal rate at raised temperatures, would then not 
occur. In this way the occurance of disseminated intravascular coagulation 
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following WBHT might be diminished or prevented. 
SUNMARY OF THE EFFECTS OF HYPERTHERei!A ON THE Ll VER 
Rises in serum enzymes, indicating both rnuscle damage and hepatic 
impairment have been seen following whole body hyperthermia treatment. The most 
useful enzymes to follow as indicators of liver damage ·would appear to be SGOT 
and SGPT, which tend to reach their highest 1 evel s at 48 hours fol owing 
treatment. 
Evidence 
temperature 
of treatment 
from published work is available to indicate that a body 
of 41.8oC should, at the moment, be considered an upper safe limit 
temperature. 
hepatic necrosis, 
would appear that 
a case 
Hm11ever 
report 
total splancnic 
and that 
one patient in the present series died of 
of which is reported in this thesis. It 
blood flow is significantly reduced under 
hyperthermic conditions 
u nsui table for estimating 
i ndocy ani ne 
this reduction. 
green clearance techniques are 
Diminution of flow is almost 
certainly mainly mediated through sympathetic vasoconstriction of the splancnic 
bed. It would seem logical to try to block this effect by alpha blockade of the 
autonom·ic nervous system. 
Total splancnic oxygen consumption is reduced at hyperthermia. This is not 
as a result of decreased blood flow, with consequent desaturation of hepatic 
venous blood but as a result of altered hepatic cellular metabolism at high 
temperatures. 
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SUI'it~ARY AND CONCLUSIONS 
In Chapter I, the thennal sensitivity of nonnal tissues in the intact 
animal were discussed and it was pointed out the intact animal was more 
sensitive to temperature rise than some of its individual organ systems. 
The concept of critical thennal maximum was introduced and a discussion was 
presented on the relationship between hyperthermia and the duration of 
mai ntai nence of the raised temperatures. 
In Chapter I I a short review of ce 11 ul ar thermobi o logy was presented. 
It was concluded that malignant cells are probably no more sensitive than 
normal cells from the same tissue of origin. Themosensitivity of cells at 
various stages of the cell cycle under different nutritional conditions was 
discussed. It was concluded that though hypoxia per se had little effect on 
thermosensitivity, the pH of the incubation medium was of great importance. 
Low pH conditions, both during and following hyperthermia, can greatly 
increase cellular thennosensitivity and can markedly increase cell 
mortality. A snort discussion of thermal resistance and therrnotol era nee was 
presented together with 
active cellular 'defence' 
evidence that thennotolerance development is an 
mechanism. Mention was made of the effects of 
'step-dm>~n heating' and of studies of substances that may protect or 
sensitise cells to hyperthermia. 
The discussion of cellular tllermobi ol ogy VJas further expanded in Chapter 
II to include combined cellular effects of hyperthermia and radiation. Again 
the effect of low pH is of importance in cell mortality. A short discussion 
of the tirni ng of hyperthemli a and radiation was presented and the chapter 
was concluded with a few remarks on combined treatment with hyperthennia and 
cytotoxic agents. 
In chapter I I I the thennobi ol ogy of tumors was considered. Studies have 
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revealed that microcirculatory blood flow of rnalignant tumors is essentially 
i nhomogeni ous. Evi de nee is presented that flow can be greatly decreased or 
even completely obstructed under conditions of hyperthen11ia. Tumors have 
been found to be generally hypoxic and at a lower pH than surrounding nomal 
tissues. Under conditions of hyperthennia, the pH is further reduced and 
oxygenation is impaired to a greater extent than under nonnothermia. Glucose 
uptake and metabolism was discussed, as were tfle possible mechanisms whereby 
tumor circulation is comprornised under hyperthermia. 
In Chapter IV a discussion of the various heating techniques in use for 
11ho1 e Body Hypertl1enni a treatment of patients was presented. These encompass 
skin heating 11ith hot wax, water and hot air. The use of extracorporeal heat 
exchangers was mentioned. A detailed description of the apparatus in use in 
Rotterdam for \~BHT was presented together with an outline of the development 
and modification of the heating methods snployed. 
A detailed description of anaesthetic techniques in use in the present 
study was presented in Chapter v. Also included was a description of the 
pretreatment fitness criteria for inclusion of patients in the study, and a 
description of monitoring procedures during treatment. Fluid balance under 
WBHT was considered. The most important conc1usions were that a very light 
general anaesthetic shou1d be administered and that care should be taken not 
to attanpt to alter haemodynamic parameters by administering 1arge 
quantities of colloidal solutions as this may lead to oedema fomation. It 
was further noted that urine output may be greatly diminished under WBHT. 
In Chapter VI~ results were presented of studies of the reaction of the 
cardiovascular systern to lt!BH. This treat'llent is associated wittl large 
decreases in both systemic and pulmonary vascular resistance. Whereas the 
systemic pressure is reduced at the plateau temperature of 4l.8°C, pressure 
in the puln1onary artery is increased.. A considerable tachycardia occured, 
but did not cause undue problems. Though cardiac output was greatly 
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increased, left ventricular work was not raised to levels markedly more than 
those obtaining in the awake sedated patients. On the other hand, right 
ventricular work was greatly increased. The mechanisms responsible for this 
paradox were discussed. The pattern of 'normalization' of cardiovascular 
variables in the post treatment period was a1so presented and discussed. 
In Chapter VI I detai 1 s were presented of whole body oxygen consumption 
and of the oxygen flux to the tissues under conditions of hyperthermia. 
Factors affecting the oxygen supply were discussed and it was concluded that 
there was no evidence of the occurrence of tissue hypoxia. Increases of 
oxygen consumption were modest, {34.6% increase over normothennic anaesthe-
tized controls) and it was shown that 37% of these increases could be 
accounted for by increases in cardiac work. 
In Chapter VIII, a number of side effects and complications that 
occurred following WBHT were described and discussed. These included haemoto-
logical and electrolyte changes. The occurrence of a mild intravascular 
coagulation syndrome in a number of patients was discussed. The 
complications occurring did not cause undue anxiety. 
In Chapter IX the~ sometimes severe, changes in serum enzyme levels were 
discussed and it was postulated that these were caused by a mixed post 
hyperthermic syndrome. Skeletal muscular damage was reflected by raised CPK 
1 evel s, whereas rises of SGOT and SGPT 1 evel s (which tend to be most severe 
following a patient's first hypethermic exposure) weYe indications of liver 
damage. A case report was presented of a patient who died in hepatic 
failure following hyperthennia treatment. The etiology of this tragedy and 
the possible hepatoxicity of the halothane anaesthesia used in this case 
were extensively discussed. lJo finn conclusions could be drawn as to the 
cause of this fatality. 
Results of estimations of total splanchnic blood flow under hypertherrnia 
in patients and in experimental animals (pigs) were presented. It was 
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concluded that the technique of indocyanine green clearance gave unreliable 
results under these conditions. Further studies in pigs of splanchnic blood 
flow and oxygen consumption were presented and it was seen that both values 
were significantly decreased above a body temperature of 39°C. The cause 
and possib1e prevention of these changes was discussed. 
On the basis of the data obtained froo1 patients and experimental animals 
it was concluded that the liver was the limiting organ with respect to the 
safety of Whole Body Hyperthenni a Treatment. Further methods to closely 
monitor liver function during any hyperthennia treatment involving either 
WBHT or large volume local heating must be refined. 
As a final conclusion, it may be stated that this thesis has 
demonstrated that Whole Body Hyperthenni a Treatment under general 
anaesthesia is entirely feasible. Provided that certain precautions and 
adequate monitoring regimes are observed, morbidity can be kept to an 
acceptable minimun. Once the problems of liver toxicity can be overcome~ it 
may be possible to raise treatment temperatures and provide vastly improved 
c1 i nica1 results from this fonn of treatment. 
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GLOSSARY OF ABBREVIATIONS 
Mean Systemic Arterial Pressure 
A radioisotope of Carbon 
Content of oxygen in hepatic venous blood 
Cardiac Index 
Cardiac Output 
Creatine Phosphokinase 
A radioisotope of Chronium 
Critical Thermal Maximum 
Content of oxygen in the mixed venous blood 
Optical Density 
Deuterated water 
Desoxyribo Nucleic Acid 
2,3, Diphosphoglycerate 
Optical Extinction 
Estimated Hepatic Blood Flow 
Haemoglobin concentration in the blood 
Haematocrit 
A radioisotope of Iodine 
I ndocyani ne Green 
Arterial Concentration of lndocyanine Green 
Hepatic Venous Concentration of Indocyanine Green 
Kilowatt 
Lactic Dehydrogenase 
Left Ventricular Work Index 
Megahertz 
A radioisotope of Sodium 
Whole body oxygen consumption per m2 of body surface area 
Oxygen Enhancement Ratio 
Statistical probability of chance occurence 
Partial pressure of oxygen at which haemoglobin is 50% saturated 
Partial pressure of oxygen in the arterial blood 
l~ean Pulmonary Artery Pressure 
Partial pressure of carbon dioxide 
Concentration of hydrogen ions in a solution 
Partial pressure of oxygen 
PVRI 
Rb86 
R02 
RVWI 
Sa02 
SBF 
SBF% 
SD 
SEM 
SGOT 
SGPT 
Shv02 
S02con 
Sv02 
SVRI 
V02 
WBHT 
Xel31 
Pulmonary Vascular Resistance Index 
A radioisotope of Rubidiu~ 
Ratio of whole body oxygen consumption and oxygen flux 
Right Ventricular Work Index 
Saturation of oxygen in the arterial blood 
Splanchnic Blood Flo>~ 
SBF expressed as a percentage of the cardiac output 
Standard Deviation 
Standard Error of the i-~ean 
Serum Glutamate Oxol oacetate Transaminase 
Serum G 1 utarnate Pyruvate Transaminase 
Saturation of oxygen in hepatic venous blood 
Splanchnic Oxygen Consumption 
Saturation of oxygen in mixed venous blood 
Systemic Vascular Resistance Index 
Oxygen consumption 
Whole Body Hyperthermia Treatment 
A radioisotope of Xenon 
137 
138 
REFERENCES 
A 1 gi re GH. I 1943) An adapti on of the transparant chamber technique to the mouse 
J. natn. cancer I nst., 4, 1-11. 
Allen N, Goldman H, Gordon WA and Clendenen NR. (1975) Topographic blood flow 
in experimental nervous system tumors and surrounding tissues. 
Trans. Am. Neural. Assoc., 100, 157-159. 
Altman PL and Dittmer DS. (1971) In: Respiration and circulation. Federation of 
American Societies for Experimental Biology. Betesda, r'iaryland. 
Aub JC and DuBois EF. (1917) Clinical Calorimetry. Ninteenth paper. The basal 
metabolism of old men. Arch. Int. f1ed., 19(5), 823-831. 
Appelgren LK. (1979) ~lethods of recording tumor blood flow. In: Tumor blood 
circulation: Angiogenesis, vascular morphology and blood flow of 
experimental and human tumors. Ed: Hans-Inge Peterson CRC Press, 1979, 
p 87-101 
Auersperg N. (1966) Differential heat sensitivity in cells in tissue culture. 
Nature, 209, 415-416. 
Azzam EI, George I and Raaphorst GP. (1982) Alteration of thermal sensitivity 
of chinese hamster cells by 020 treatment. Radiat. Res., 90, 644-648. 
Back JF, Oakenfull D and Smith fiB. (1979) Increased thermal stability of 
proteins in the presence of sugars and polyols. Biochem., 18(23), 5191-
5196. 
Baldwin E deF. (1948) Medicine, (Baltimore), 27, 243. 
Barlogie B, Corry PM, Yip E, Lippman L, Johnson DA, Khalil K, Tenczynski TF, 
Reilly E, Lawson R, Dosik G, Rigor B, Hankenson Rand Freireich EJ. (1979) 
Total body hyperthermia witt1 and without chemotherapy for advanced human 
neoplasms. Cancer Res., 39, 1481-1489. 
Bender E and Schramm T. (1966) Untersuchungen zur thennosensibilitat von tumor-
und normalzellen in vitro. Acta Biol. ~1ed. Ger., 17, 527-543. 
139 
Ben-Hur E, Elkind ~~~·i and Bronk BV. (1974) Thermally enhanced radioresponse of 
cultured chinese hamster cells: Inhibition of repair of sublethal damage 
and enhancement of 1 ethal damage. Radi at. Res., 58, 38-51. 
Berg van den AP, Wike-Hooley JL, van den Berg-Blok AE, van der Zee J and 
Reinhold HS. (1982) Tumor pH in human mammary carcinoma. 
Europ. J. Cancer Clin. Oneal., 18(5), 457-462 
Sichel P and Overgaard J. (1977) Hyperthermic effect on exponential and plateau 
ascites tumor cells in vitro dependent on enviromental pH. Radiat. Res., 
70, 449-454. 
Bicher HI and Mitagvaria N. (1981) Circulatory responses of malignant tumors 
during hyperthermia. l~icrovasc. Res., 21,17-26. 
Bicher HI, Hetzel FW, Sandhu TS, Frinak S, Vaupel E, 0 1 Hara MD and 0 1 Brien T. 
(1980) Effects of hyperthermia on normal and tumor micro-enviroment. 
Radiology, 137, 523-530. 
Birch J. (1980) personal communication. 
Blain JM Schafer H Siegel AL and Bing RJ. (1956) Studies on myocardial 
metabolism IV. ~1yocardia1 metabolism in congestive failure. Am. J. Med., 
20, 820-833. 
Blair RM and Levin W. (1977) In: Proceedings the 2nd Int. Sym. on Cancer Ther. 
by hyperthermia and Radiation, June 2-7, Essen. Streffer C. (ed.) Urban 
and Schwarzsberg, Baltimore and Munich pp 318-321. 
Blanchard RJW, Grotenhuis !, LaFave JW and Perry JF. (1965) Blood supply to 
hepatic V2 carcinoma implants as measured by radioactive microspheres. 
Proc. Soc. Exp. Biol. Med., 118, 465-468. 
B 1 i gh J. (1979) Aspects of tl1ermoregul a tory physiology pertinent to hyper-
thermic treatment of cancer. Cancer Res., 39, 2307-2312. 
Boothby wr·l and Sandiford I. (1924) Basal metabolism. Physiol. Rev., 18. 1085. 
Born GVR and Smith JB. (1970) Uptake, metabolism a.nd release of (3H)-adrena-
line by human platelets. Br. J. Phannacol., 39, 765-778. 
140 
Bove KE and Scott RC. (1971) Heart weight and body size: man. In: Respiration 
and circulation. Altman PL and Dittmer OS (Eds.) Federation of American 
Societies for Experimental Biology. Betesda, Maryland. p 233. 
Bowers W, Hubbard R, elagner 0, Chisholm P, ~lurphy M, Leav I, Hamlet M and 
Mather J. (1978) Effects of heat on the structure and function of perfused 
rat liver. Fed. Proc., 37, 930. 
Bradley SE, Inglefinger FJ and Bradley GP. (1945) Estimation of hepatic blood 
flow in man. J. Clin. Invest., 24, 890. 
Bradley SE, and Conan NJ. (1947) Estimated hepatic blood flow and Bromsulfalein 
extraction in normal man during the pyrogenic reaction. J. Clin. Invest., 
26, 1175. 
Brandfonbrener M, Landowne M and Shock I~W. (1955) Changes in cardiac output 
with age. Circulation, 12, 557-566. 
Braun J and Hahn Gl1. (1975) Enhanced cell killing by bleomycin and 43' hyper-
thermia and the inhibition of recovery from potentially lethal damage. 
Cancer Res., 35, 2921-2927. 
Braunitzer G. (1963) ~lolekulare struktur der hamoglobine. 
Nova Acta Acad. Caesar. Leop. Carol., 26, 471. 
Bull JM, Lees D, Schuette W, Whang-Peng J, Smith R, Bynu~ G, Atkinson ER, 
Gottdiener JS, Gralnick HR, Shawker TH and DeVita VT. (1979) Whole body 
hyperthermia: A phase I trial of a potent adjuvent to chemotherapy. 
Ann. Intern. Med., 90, 317-323 
Bull J. (1982) Whole body hyperthermia as an anticancer agent. 
Ca- A Cancer Journal for Clinicians, 32(2), 123-128. 
Bull J, Bryan-Brown C, Dubose RK, Tonnesen AS and Quinn J. (1982) Whole body 
hyperthermia (WBH) with controlled respiratory acidosis. Radiat. Res., 
91, 421-422. 
Bunker JP and Blumenfeld CM. (1963) Liver necrosis after halothane anaesthesia. 
Cause or coincidence? New. Eng. J. J,1ed., 268(10), 531-534. 
141 
Burch GE and Giles TD. (1971) A critique of the cardiac index. Am. Heart J., 
82 (3), 424-425. 
Bynum G, Patton J, Bowers W, Leav I, Wolfe 0, Hamlet 1'1 and Harsili 1'.. (1977) 
An anaesthetised dog heat stroke model. J. Appl. Physiol: Respirat. 
Environ. Exercise Physiol., 43(2), 292-296. 
Bynum GO, P andolf KB, Schuette WH, Goldman RF, Lees DE, Whang-Peng J, 
Atkinson ER and Bull JM. (1978) Induced hyperthermia in sedated humans and 
the concept of critical thermal maximum. Am. J. Physiol: Regulatory 
Integrative Camp. Physiol., 4(3), R228-R236. 
Caesar J, Shaldon Sand Chiandussi L. (1961) The use of indocyanine green in 
the measurement of hepatic blood flow as test of hepatic function. 
Clin. Sci., 21, 43-47. 
Caro CG and McDonald. (1961) The relation of pulsatile pressure and flow in the 
pulmonary vascular bed. J Physiol., 157, 426-453. 
Cavaliere R, Ciocatto EC, Giovanella BC, Heidelberger C, Johnson RO, 
Margottini M, Mondovi B, Moricca G and Rossi-Fanelli A. (1967) Selective 
heat sensitivity of cancer cells. Cancer, 20, 1351-1381. 
Chen TT and Heidelberger C. (1969) Quantitative studies on the malignant trans-
formation of mouse prostate cells by carcinogenic hydrocarbons in vitro. 
Int. J. Cancer, 4, 166-178. 
Collins FG, ~litros FA and Skibba JL. (1980) Effect of palmitate on biosynthetic 
functions at hyperthermic temperatures. Metabolism, 29(6), 524-531. 
Collins FG and Skibba JL. (1980) Inhibition of macromolecular processes in 
normal and regenerating liver by hyperthermia. Cancer Biochem. Byophys., 4, 
227-232. 
Coley I<B. (1893) The treatment of malignant tumors by repeated i nnocul ati ons 
of erysipelas: with a report of ten orignial cases. Am. J. Med. Sci., 
105(5}, 487-511. 
142 
Canney AH. (1967) Pharmacological implications of microsomal enzyme induction. 
Pharmacological Rev., 19(3), 317-366. 
Cooperman LH, Warden JC and Price HL. (1968) Splanchnic circulation during 
nitrous oxide anesthesia and hypocarbia in normal man. Anesthesiology, 
29(2), 254-258. 
Cournand A, Riley RL, Breed ES, Baldwin EdeF and Richards OW. (1944) 
Measurement of cardiac output in man using the technique of catheterisation 
of the right auricle or ventricle. J. Clin. Invest., 24, 106-116. 
Cousins MJ, Sharp JH, Gourlay GK, Adams JF, Haynes WD and Whitehead R. (1979) 
Hepatotoxicity and halothane metabolism in an animal model with application 
for human toxicity. Anaesth. Intens. Care, 7{1), 9-24. 
Cousins MJ. (1980) Halothane Hepatitis: What's new? Guest Editorial. Drugs, 19, 
1-6. 
Cowles RB, and Bogert CM. (1944) A preliminary study of the thermal 
requirements of desert reptiles. Bull. Am. Mus. Nat. Hist., 83, 265-296. 
Crile G. (1963) The effects of heat and radiation on cancers implanted on the 
feet of mice. Cancer Res., 23, 372-380. 
Dewey WC, Hopwood LE, Saparreto SA and Gerweck LE. (1977) Cellular responses 
to combinations of hyperthermia and Radiation. Radiology, 123, 463-474. 
Dickson JA and Shah OM. (1972) The effects of hypertheYTTlia (42'C) on the 
biochemistry and growth of a malignant cell line. Europ. J. Cancer, 8, 
561-571. 
Dickson JA and Oswald BE. (1976) The sensitivity of a malignant cell line to 
hyperthermia (42'C) at low intracellular pH. Br. J. Cancer, 34, 262-271 
Dickson JA, MacKenzie A, and l~cl eod K. (1979) Temperature gradients in pigs 
during whole body hyperthermia at 42'C. J. Appl. Physiol: Respirat. 
Environ. Excercise Physiol., 47(4), 712-717. 
143 
Donaldson SS, Gordon LF and Hahn Gfl. (1978) Protective effect of hyperthennia 
against the cytotoxicity of actinomycin 0 on chinese hamster cells. 
Cancer Treatment Reports, 62 (10) 1489-1495. 
Dubois r~, Sato S, lees DE, Bull Jf,1) Smith R~ White BG, Moore H and 
Nacnamara TE. (1980). Electro-encephalographic changes during whole body 
hyperthermia in humans. Electroenceph. and Clin. Neurophys., 50,486-495. 
Eddy HA. (1980) Alterations in tumor microvasculature during hyperthennia. 
Radiology, 137,515-521. 
Eden M, Haines B and Kahler H. (1955) The pH of rat tumors measured in vivo. 
J. natn Cancer lnst., 16, 541-556. 
Eisler A, Pheiffer H-G, Landauer 8, Lange J and KolbE. (1982) Anesthetic 
problems in therapeutic whole body hyperthennia. Sixth European Congress 
of Anaesthesiology, Volume of Summaries. Anaesthesia, p 265. 
Elis J, (1980) Drugs used in tuberculosis and leprosy. In: Side effects of 
drugs annual 4. Dukes I~NG (ed. I Excerpta Medica, Amsterdam- Oxford-
Princeton. p 213. 
Emirgil C, Sobol BJ, Campodonico SHerbert WH and Mechkati R. (1967) 
Pulmonary circulation in the aged. J. Appl. Physiol., 23(5), 631-640. 
Endrich B, Reinhold HS, Gross JF, and lntaglietta M. (1979) Tissue Perfusion 
Inhomogeneity during early tumor growth in rats. J. natn Cancer Inst., 
62 (.2)' 387-393 0 
Erdmann W and Krell W. (1976) Measurement of diffusion parameters with noble 
metal electrodes. In: Oxygen Transport to Tissue II. Grote J, Reneau D 
and Thews G. (Eds.). Plenum Publishing Company, New York. pp 225-228. 
Euler-Rolle J, Priesching A, Vormittag E, Tschakaloff C and Polterauer P. 
(1977). Prevention of cardiac complications during whole body hyperthermia 
by beta receptor blockage. Proceedings of the Second International 
Symposium on Cancer Therapy by Hyperthenni a and Radiation. June 2-7 Essen, 
Streffer C. et al. (Eds.), Urban and Swarzberg, Baltimore-Munich, 1977, pp 
302-305. 
144 
Faithfull NS. (1969) Awareness during anaesthesia. Brit. Med. J., (1969), 2, 
117. 
Faithfull NS, van den Berg, AP, Wike-Hooley J, van der Zee J. and 
Reinhold HS. (1980) Tissue pH measurements in human tumors. Abstracts 
3rd Int. Symp. Cancer Ther. by Hyperthermia, Drugs and Radiation. Fort 
Collins, Colarado, June 22-26, p88. 
Faithfull NS. (1982) Liver blood flow and splancnic oxygen consumption under 
whole body hyperthermia. Strah1entherapie, 158(6), 381. 
Faithful] NS. (1982) Retrograde intubation. Sixth European Congress of 
Anaesthesiology 1982. Volume of Summaries. Anaesthesia, p458. 
Faithfull NS. (1982) Cardiovascular and oxygenation changes during whole 
body hyperthermia. Proceedings of the 1st annual meeting of the North 
American Hyperthermia Group. In: Hyperthermia. Bicher HI and Bruley OF. 
(eds). Plenum Publishing Corporation, pp 57-70. 
Ferris EB, Blankenhorn MA, Robinson HW and Cullen GE. (1938) Heat stroke: 
Clinical and chemical observations on 44 cases. J. Clin. Invest., 17, 
249-262. 
Field SB and Bleehen NM. (1979) Hyperthermia in the treatment of cancer. 
Cancer Treatment Rev., 6, 63-94 
F 1 etcher AM, Seats TC, and Wilson SO. ( 1980) Liver temperatures in rats 
subjected to whole body hyperthermia. Evidence for Congestion and 
lymphocyte damage. Abs. Third Int. Symp. Cancer Ther. by Hyperthermia, 
Drugs, and Radiation. p89. 
Foex P. (1980) In: The Circulation in Anaesthesia. Prys-Roberts C. (Ed.) 
Blackwell Scientific Publications, Oxford, Edunburgh, Melbourne. p 258. 
Frankel HM, Ellis JP and Cain SM. (1963) Development of tissue hypoxia 
during progressive hyperthermia in dogs. Am. J. Physio1 ., 205(4), 
733-737. 
Frohlich ED, T arazi RC and D us tan HP. ( 1969) Re-examination of the hemo-
dynamics of hypertension. Am. J. Med. Sci., 257, 9-23. 
145 
Freeman ML, Raaphorst GP, Hopwood LE and Dewey we. (1980) Effect of pH on cell 
lethality induced by hyperthemic treatPlent. Cancer, 45, 2291-2300. 
Freeman ML, Holahan EV, Highfield DP, Raaphorst GP, Spiro IJ and Dewey WC. 
(1981a) The effect of pH on the hyperthermic and x ray induced cell 
killing. Int. J. Radiat. Oncol~iol. Phys., 7, 211-216. 
Freeman ML, Boone ~1U~, Ensley BA and Gillette EL. (1981b) The influence of 
envi romental pH on the interaction and repair of heat and radiation damage. 
Int. J. Radiat. Oncology, Biol. Phys., 7, 761-764. 
Gerner EW, Boone R, Connor WG, Hicks JA and Boone MLM. (1976) A transient 
thermotolerant survival response produced by single thermal doses in Hela 
cells. Cancer Res., 36, 1035-1040. 
Gerweck LE. (1977) l~odification of cell lethality at elevated temperatures. The 
pH effect. Radiat. Res., 70, 224-235. 
Ger•eck LE and Bascomb F. (1982) Influence of hypoxia on the development of 
thermotalerance. Radiat. Res., 90, 356-361. 
Gerweck LE, Gillette EL and Dewey WC. (1974}. Killing of chinese hamster cells 
in vitro by heating under hypoxic or aerobic conditions. Furop. J. Cancer, 
10, 691-693. 
Gerweck L and Rettinger E. (1976) Enhancement of mammalian cell sensitivity to 
hyperthermia by pH alteration. Radiat. Res., 67, 508-511. 
Giovanella BC, Stehlin JS and Morgan AC. (1976) Selective lethal effect of 
supranormal temperatures on human neoplastic cells. ~ancer Res., 36, 
3944-3850. 
Grantham FH, Hill Dt'i and Gulli no PM. (1973) Brief communication: Primary 
mammary tumors connected to the host by a single artery and vein. 
J. natn. Cancer Inst., 50, 1381-1383. 
Greenla>l RH, Loshek DD and Swamy PG. (1980) Clinical trial of whole body hyper-
thermia by the Pettigrew method. Abstracts 3rd Int. Sym. Cancer Ther. by 
Hyper. Drugs and Radiat. Fort Collins, June 22-26, p125. 
146 
Gregory !C. (1974) The oxygen and carbon monoxide capacities of foetal and 
adult blood. J. Physiol ., 236, 625-634. 
Grogan JB, Parks LC and ~linaberry D. (1980) Polymorphonuclear leucocyte 
function in cancer patients treated with whole body hyperthermia. Cancer, 
45(10), 2611-2615. 
Gulli no PM and Granthan FH. (1961) Studies on exchange of fluids between host 
and tumor. II The blood flow of hepatomas and other tumors in rat and mice. 
J. natn. Cancer I nst., 27, 1465-1491 
Gulli no PM, Yi P-N, and Grantham FH. (1978) Relationship between temperature and 
blood supply or consumption of oxygen and glucose by rat mammary carci-
nomas. J. natn Cancer Inst., 60. 835-847. 
Hahn GM. (1974) ~~etabolic aspects of the role of hyperthennia in mammalian cell 
inactivation and their possible relevance to cancer treatment. Cancer Res., 
34, 3117-3123. 
Hahn G~l and Strande DP. (1976) Cytotoxic effects of hyperthermia and adriamycin 
on chinese hamster cells. J. natn. Cancer Inst., 57(5), 1063-1067. 
Hahn GM, Li GC and ShiuE. (1977) Interaction of Amphotericin Band 43' hyper-
thermia. Cancer Res., 37, 761-764 
Hahn GM. (1979) Potential for therapy of drugs and hyperthermia. Cancer Res., 
39, 2264-2268. 
Hales JRS, Ro;,ell LB and King RB. (1979) Regional distribution of blood flow in 
awake heat-stressed baboons. Am. J. Physiol., 237(6), H705-H712. 
Hales JRS and Dampney RAL. (1977). Redistribution of cardiac output in the dog 
during heat stress. J. Thermobiol., 1, 29-34. 
Harisiadis L, Hall EJ, Kraljevic U and Borek C. (1975) Hyperthermia: Biological 
studies at the cellular level. Radiology, 117, 447-452. 
Haveman J. (1979) The pH of the cytoplasm as an important factor in the survival 
of in vitro cultured malignant cells after hyperthermia. Effects of 
carbonyl cyanide 3-chlorophenylhydrazone. Europ. J. Cancer, 15, 1281-1288. 
147 
Haveman J. (1980) The influence of pH on the survival after X-irradiation of 
cultured malignant cells. Effects of carbonylcyanide-3-chlorophenyl-
hydrazone. Int. J. Radiat. Biol., 37(2), 201-205. 
Haveman J. (1983) Influence of pH and thermotol erance on the enhancement of 
x-ray induced inactivation of cultured mammalian cells by hyperthermia. 
Int. J. Radiat. Biol., (in press). 
Heckel M. (1975) Whole body hyperthermia using infra-red lamps. In: Proceedings 
I nternati anal Symposi urn on Cancer Therapy by Hyperthermia and Radiation. 
Washington DC, April 28-30, 1975. 
Hellmann K and Weiner JS. (1953) Antidiureyic substance in urine following 
exposure to high temperature. J. Appl. Physiol., 6, 194-198. 
Henderson MA, and Petti grew RT. (1971) Induction of contra 11 ed hyperthermia in 
treatment of cancer. Lancet, 1275-1277. 
Henle KJ and Leeper D8. (1976) Combinations of hyperthermia (40", 45"C) with 
radiation. Radiology, 121, 451-454. 
Henle KJ, Karamuz JE and Leeper 08. (1978) Induction of thermotolerance in 
chinese hamster ovary cells by high (45"C) or low (40oC) hyperthermia. 
Cancer Res., 38, 570-574. 
Henle KJ and Leeper DB. ( 1982) Modi fi cation of the heat response and thermo-
tolerance by cycloheximide, hydroxyurea, and lucanthone in CHO cells. 
Radiat. Res., 90. 339-347. 
Henle KJ and Warters RL. (1982) Heat protection by glycerol in vitro. 
Cancer Res. 42, 2171-2176. 
Herman TS, Zul<oski CF, Anderson Rl~, Hutter JJ, Blitt CD, Malone JM, Larson DF, 
Dean JC and Roth HB (1982) Whole body hyperthermia and chemotherapy for 
treatment of patients with advanced, refractory malignancies. 
Cancer Treatment Reports, 66 ( 2), 259-265. 
148 
Hubbard RW, Bowers WD, Mathew WT, Curtis FC, Criss REL, Sheldon G~~ and 
Ratteree JW. (1977) Rat model of acute heatstroke mortality. 
J. Appl. Physiol: Respirat. Environ. Excercise Physiol., 42(6), 809-816. 
Hubbard RW, Criss REL, Elliot LP, Kelly C, Matthew WT, Bowers WD, Leav I 
and ~1ager H. ( 1979) 0 i agnostic significance of selected serum enzymes in 
a rat heatstroke model. J. Appl. Physi ol: Res pi rat. Environ. Exercise 
Physiol., 46(2), 334-339. 
Hutchinson VH. (1961) Critical thermal maxima in salamanders. Physiol. Zool., 
34, 92-125. 
Imamura M and Clowes GHA. (1975) Hepatic blood flow and oxygen consumption in 
starvation, sepsis and septic shock. Surg. Gyn. Obstet., 141, 27-34. 
I mnan WHW and Mushin WW. (1978) Jaundice after repeated exposure to halothane: 
a further analysis of reports to the Committee on Safety of Medicines. 
Br. Med. J., 2, 1455-1456. 
I riki M and Kozawa EM!. (1976a) The change of vagal activity evoked by spinal 
cord thermal stimulation in anesthetized rabbits. Experientia, 32(10), 
1293-1294. 
I riki M and Kozawa EM!. (1976b) Patterns of differentiation in various 
sympathetic efferents induced by hypoxic and by central thermal stimulation 
in decerebrated rabbits. Pflugers Arch., 362, 101-108. 
Jansen JRC, Schreuder JJ, Bogaard JM, van Rooyen W, and Versprille A. (1981) 
Thermodilution technique for measurement of cardiac output during 
artificial ventilation. J. Appl. Physiol: Respirat. Environ. Exercise 
Physiol., 50(3), 584-591. 
Johnson HA and Pavelec M. (1973) Thermal Enhancement of Thio-TEPA cytotoxicity. 
J. Natl. Cancer Inst., 50, 903-908. 
Kase K and Hahn GM. (1975) Differential heat response of normal and transformed 
human cells in tissue culture. Nature, 255, 228-230. 
Kelman GR. (1966) Digital computer subroutine for the conversion of oxygen 
tension into saturation. J. Appl. Physiol., 21(4), 1375-1376. 
Kim JH, Kim SHand Hahn E. (1974) Themal enhancement of the radiosensitivity 
using cultured normal and neoplastic cells. Radiology, 121(4), 860-864. 
149 
Kim JH, Hahn EW, Tokita Nand Nische LZ. (1977) Local tumor hyperthermia in 
combination with radiation therapy. l. Malignant cutaneous 1 esi ons. Cancer, 
40, 161-169. 
Kim SH, Kim JH and Hahn EW. (1976) The enhanced killing of irradiated Hela 
cells in synchronous culture by hyperthermia. Radiat. Res., 66, 337-345. 
Kim YD, Lake CR, Lees DL, Schuette WH, Bull Jl~, Weise V, and Kopin J. (1979) 
Hemodynamic and plasma catecholamine responses to hyperthennic cancer 
therapy in humans. Am. J. Physiol., 237(5), H570-H574. 
Kim YD. (1979) The effect of themally-induced respiratory alkalosis on 
erythrocyte 2,3 DPG levels and hemoglobin p50 determinations. Abstract, 
53rd congress, International Anesthesia Research Society. 11-15 March, 
Hollywood, Florida. 
Kjartansson IE, Appelgren LK, Ivarsson L, Peterson H-I and Sivertsson R. (1976) 
Total blood flow in a 20-methylcholanthrene induced rat sarcoma determined 
by plethysmography. Effect of aging and of a single dose of x-ray 
irradiation. Acta chirugica scandanavica, Suppl. 471~ 45-57. 
Klion Fl~, Schaffner F and Popper H. (1969) Hepatitis after exposure to halo-
thane. Ann. intern. Med., 71(3) 467-477. 
Larkin JH, Edwards WS, Smith DE and Clarke PJ. (1977) Systemic thennotherapy: 
description of a method and physiologic tolerance in clinical subjects. 
Cancer, 40, 3155-3159. 
Larkin Ji1. (1982) Results of total body hyperthermia in cancer treatment. 
Radiat. Res., 91, 421. 
Lees DE, Kim YD, Schuette W, Bull J and Wang-Peng J. (1979) Causes of induced 
hyperthermia. Anesthesiology, 50(1), 69-70. 
150 
Lees DE, Kim YD, Bull JM, Whang-Peng J, Schuette W, Smith Rand ~lacnamara TE. 
{1980) Anesthetic management of whole body hyperthermia for the treatment 
of cancer. Anesthesiology, 52, 418-428 
Leith JT, Heyr1an P, DeWyngaert JK, Dexter DL, Calabresi P and Glicksman AS. 
{1982) Responses of oxic and hypoxic human colon tumor cells to hyper-
thermia. Radiat. Res., 90, 638-643. 
L eVe en HH, Wapni ck S, Piccone V, Fal k G and Ahmed N { 1976) Tumor eradication 
by radi ofrequency therapy. JA~IA, 235 { 20), 2198-2200. 
L i GC, Hahn GM and Shiu EC. {1977) Cytotoxicity of commonly used solvents at 
elevated temperautes. J. Cell. Physiol ., 93, 331-334. 
Li GC, Fischer GA and Hahn GM. {1982) Induction of thermotolerance and evidence 
for a well-defined thermotropic cooperative process. Radiat.Res., 89, 
361-368. 
Libonati 11, Malsch E, Price HL, Cooperman LH, Baum Sand Harp JR. {1973) 
Sp1ancnic Circulation in Man during methoxyflurane anesthesia. 
Anesthesiology, 38{5), 466-472. 
Little DM, Barbour U1 and Given JB. {1958) The effects of fluothane, cyclopro-
pane, and ether anesthesias on liver function. Surgery. Gynec. Obstet., 
107' 712-718. 
Logawney-Malik S, Shalla S and Thomas S. {1979) Effects of hyperthermia on 
renal functions. Indian J. Med. Res., 69, 321-318. 
Loshek DD, Greenla>~ RH and Doyle LA. (1981) Whole body hyperthermia using a 
water circulator. Strahlentherepie, 157, 620-621. 
Lucke JN and Hall GM. (1978) A technique for measuring hepatic blood flow and 
oxygen consumption in the anaesthetised pig. Res. Vet. Sci., 25, 393-394. 
Lunec J and Parker R. {1980) The influence of pH on the enhancement of 
radiation damage by hyperthermia. Int. J. Radiat. Biol. 38{5), 567-574. 
151 
Mackenzie A, Mcloed K, Cassels-Smith AJ and Dickson JA. (1975) Total body 
hyperthermia: techniques and patient management. Proceedings of the 
International Symposi urn on Cancer Therapy by Hyperthermia and Radiation. 
Washington DC April 28-30. 
Magazanik A, Shapiro Y, and Shibolet S. (1980) Dynamic changes in acid base 
balance during heat stroke in dogs. Europ. J. Physiol ., 388, 129-135. 
Meyer KA, Kammerl i ng Efl. Amtman, L, Ko 11 er ~I and Hoffman SJ. ( 1948) pH studies 
on malignant tissues in human beings. Cancer Res. 8., 513-518 
Meyer M and Hoigne R. (1980) Drugs used in tuberculosis and leprosy. In: 
Meyler's Side Effects of Drugs. An enclyclopaedia of Adverse Reactions and 
Interactions. Ninth Edition. MIJG Dukes (ed). Excerpta fledica, Amsterdam-
Oxford-Princeton. p527. 
Milnor WR, Bergel DH, Bargainer JD. (1966) Hydraulic Power associated with 
pulmonary blood flow and its relation to heart rate. Circulation Res., 
19(3), 467-480. 
Mondovi B, Strom R, Rotilio G, Agro AF, Cavaliere Rand Rossi-Fanelli A. (1969) 
The biochemical mechanism of selective heat sensitivity of cancer cells. I. 
Studies on cellular respiration. Europ. J. Cancer, 5, 129-136. 
Moritz AR and Henriques FC. (1947) Studies of thermal injury. II. The relative 
importance of time and surface temperature in the causation of cutaneous 
burns. Am. J. Path., 23, 695-720. 
~ioricca G, Cavaliere R, Lopez t~ and Caputo A. (1979) Combined whole body hyper-
thermia and chemotherapy in the treatment of advanced cancer with diffuse 
pain. In: Advances in pain research and therapy Vol. 2. Bonica JJ and 
Ventafridda V. (eds). Raven Press, New York. pp 195-210. 
Morris CC, Myers R and Field SB. (1977) The response of the rat tail to hyper-
thermia. Br. J. Radial., 50,576-580. 
152 
MUller-Klieser W, Lierke EG and Vaupel P. (1982) A feedback control system 
for localised ultrasonic hyperthermia in tumors. II Application and first 
experiments in DS-carcinoma. Strahlentherapie, 158, 387. 
Muckle DS and Dickson JA. (1971) The selective inhibitory effect of hyper-
thennia on the metabolism and growth of malignant cells. Br. J. Cancer, 
25, 771-778. 
Mushin WW, Rosen 11, Bowen DJ and Campbell H. (1964) Halothane and liver 
dysfunction: a retrospective study. Brit. Med. J., 2, 329-341. 
Mushin WW, Rosen I~ and Jones EV. (1971) Post-Halothane Jaundice in relation 
to previous administration of halothane. Brit. Med. J., 1, 18-22. 
Naeslund J and Swenson KE (1953) Investigations on the pH of malignant tumors 
in mice and humans after the administration of glucose. 
Acta. Obstet. Gynec. Scand., 32, 359-367. 
National Academy of Sci ences-Nati anal Research Council - Subcommittee on the 
National Halothane Study of the Committee on Anesthesia. (1966) Summary of 
the National Halothane Study. Possible Association between Halothane 
Anesthesia and Postoperative Hepatic Necrosis. JAMA, 197(10) 775-788. 
Nauts HC. (1975) Pyrogen therapy of cancer. An historical overview and current 
activities. Proceedings The International Symposium on Cancer Therapy by 
Hyperthermia and Radiation. Washington DC, April 28-30, 1975. 
Nielsen OS and Overgaard J. (1979) Effect of extracellular pH on thermo-
tolerance and recovery of hyperthermic damage in vitro. Cancer Res., 39, 
2772-2778. 
Nielsen OS (1981) Recovery from hyperthermic damage and development of thermo-
tolerance in unfed plateau phase cells in vitro. J~ natn. Cancer Inst •• 66, 
61-66. 
Neumann H, Englehardt R, Fabricius H-A, Stahn R and Ltihr GW. (1979) Klinisch-
chemisch untersuchungen an tumorpatienten unter zytostica- und ganzkOrper-
hyperthermiebehandlung. Klin. Wehr., 57, 131!-1315. 
Nunn JF and Freeman J. {1964) Problems of oxygenation and oxygen transport 
during hae~orrhage. Anaesthesia, 19 (2), 206-216. 
Nunn JF (1977a) In: Applied Respiratory Physiology. Butterworths, London, 
Boston. p 181. 
Nunn JF (1977b) In: Applied Respiratory Physiology. Butterworths, London, 
Boston. p 397. 
Nunn JF (1977c) In: Applied Respiratory Physiology. Butten;orths, London, 
Boston. p 409. 
O'Brien flO and Veall N. (1974) Partition coefficients between various brain 
tumors and blood for Xe133. Physics. ~1ed. Biol., 19, 472-475. 
Okumura Y and Reinhold HS. (1978) Heat sensitivity of rat skin. 
Europ. J. Cancer., 14, 1161-1166. 
153 
Ostrow S, van Echo D, 11hitacre M, Aisner J, Simon R, and 11iernik PH. (1981) 
Physiologic response and toxicity in patients undergoing whole body hyper-
thermia for the treatment of cancer. Cancer Treatment Reports, 65, 323-325. 
Overgaard J. (1977) Effect of hyperthermia on malignant cells in vivo. Cancer, 
39' 2637-2646. 
Overgaard J and Bi chel P. (1977) The influence of hypoxia and acidity on the 
hyperthermic response of malignant cells in vitro. Radiology, 123, 511-514. 
Overgaard J and Poulsen HS (1977). Brief communication: Effect of hyperthermia 
and enviromental acidity on the proteolitic activity in murine ascitis 
tumor cells. J. natn. Cancer Inst. 58(4), 1159-1161. 
Overgaard J and rlielsen OS. (1980) The role of tissue enviromental factors on 
the kinetics and morphology of tumor cells exposed to hyperthermia. 
Ann. N. Y. Acad. Sci., 335, 254-278. 
Owen LN. (1960) A rapid method of studying tumor blood supply using lissamine 
green. Nature, 187, 795-796 
Palzer RJ and Heildelberger C. (1973) Studies on the quantitive biology of 
hyperthermic killing of Hela cells. Cancer Res., 33, 415-421. 
154 
Pampus F. (1963} Die wasserstoffionenkonzentration des hirngewebes bei 
raumfordernden intracraniellen prozessen. Acta Neurochirg., 11, 305-318. 
Parks LC, Minaberry D, Smith DP and Neely WA. (1979} Treatment of far advanced 
bronchogenic carcinoma by extracorporea11y induced systemic hyperthermia. 
J. Thorac. Cardiovasc. Surg., 78, 883-892. 
Peterson H-I, Appelgren KL, Rudenstam C-M and Lewis DH. (1969} Studies on the 
circulation of experimental tumors. I. Effect of induced fibrinolysis and 
antifibrinolysis on capillary blood flow and the capillary transport 
function of two experimental tumors in the mouse. Europ. J. Cancer, 5~ 
91-97. 
Peterson H-I. (1979} Tumor blood flow compared with normal tissue blood flow. 
In: Tumor Blood Circulation: Angiogenesis, vascular morphology and blood 
flow of experimental and human tumors. H-1. Peterson (ed). CRC Press, 1979, 
103-114. 
Pettigrew RT, Galt JM, Ludgate 0~, Horne DB and Smith AN. (1974a) Circulatory 
and biochemical effects of Whole Body Hyperthermia. Br. J. Surgery, 61, 
727-730. 
Pettigrew RT, Galt JM, Ludgate CM, and Smith AN. (1974b} Clinical effects of 
whole body hyperthermia in advanced malignancy. Br. Med. J., 4, 679-682. 
Pettigrew RT, and Ludgate CM. (1977). Whole body hyperthermia. A systemic 
treatment for disseminated cancer. In: Recent Results in Cancer Research 
Vol 59. Rossi-Fanelli A, Cavaliere R, Mondovi Band l'loricca E. (eds). 
Springer Verlag, Berlin, Heidelberg, New York. pp 153-170. 
Pomp H. (1978) Clinical application of hyperthermia in gynecological malignant 
tumors. In: Cancer Therapy by Hyperthermia and Radiation. Streffer C, 
van Beuningen 0, Ditzel F, ROttinger E, Robinson JE, Scherer E, Seeber S, 
Trott KR {eds). Proceedings 2nd Int. Sym. on Cancer Therapy by Hyper-
thermia and Radiation. June 2-7, Essen. Urban and Schwarz berg, Baltimore 
and Munich. pp 326-327. 
155 
Power JA and Harris JW. (1977) Response of extremely hypoxic cells to hyper-
thermia: survival and oxygen enhancement ratios. Radiology, 123, 767-770. 
Prys-Roberts C.(1974) In: Scientific foundations of anaesthesia. Schurr C and 
Feldmann S.(Eds:) Heinemann :1edical Books Ltd., London. p 127. 
Prys-Roberts C, Foex P and Hahn CEW. (1971). Calculation of blood 02. 
Anesthesiology, 34(6), 581-582. 
Randall JE and Stacy RW. (1956) Mechanical impedance of the dog's hind leg to 
pulsatile blood flow. Am. J. Piwsiol., 187, 94-98. 
Rankin JHG and Phernetton T. (1976) Effect of prostaglandin E2 on blood flow 
to the V2 carcinoma. Fed. Proc., 35, 297. 
Reed WA. (1965) Tolerance of dog lung to hyperthermic perfusion. 
Am. J. Physiol ., 208(3), 451-454. 
Reed WA, Manning RT, and Hopkins LT. (1964) Effects of hypoxia and hyperthermia 
on hepatic tissue of the dog. Am. J. Physiol., 206(6), 1304-1308. 
Reinhold HS. (1971) Improved microcirculation In irradiated tumours. 
Europ. J. Cancer 7, 273-280. 
Reinhold HS and van den Berg-Blok A. (1981) Enhancement of thermal damage to 
the microcircu1ation of 1 Sandwich 1 tumors by additional treatment. 
Eur. J. Cancer Clin. Oneal., 17(7), 781-795. 
Reinhold HS and van den Berg-Blok A.(1982) The influence of a heat pulse on 
the thennally induced damage to tumor microcirculation. Europ. J. Cane., 
(in press) 
Reinhold HS, van der Zee J, Faithfull NS, van Rhoon G and Wlke-Hooley J. (1982) 
Utilisation of the Pomp-Siemens hyperthermia cabin. J. natn Cancer Inst. 
In: Proceedings of the Third International Symposium on Cancer Therapy by 
Hyperthertnia, Drugs and Radiation. National Cancer Institute r•lonograph, 
Vol 61, p361. 
Repertorium Verpakte Geneesmiddelen (1976) de Torts, Haarlem. p 306. 
156 
Robert J, Martin J and Burg c. (1967) Evolution de la vascularisation d'une 
tumeur isologue solide de la souris au cours de sa croissance. 
Strahlentherapie, 133, 621-630 
Robertson JD and Reid DO. (1952) Standards for the basal metabolism of normal 
people in Britain. Lancet, 940-943. 
Robinson JE, Wizenburg I<IJ, McCready I,A. (1974) Combined hyperthermia and 
radiation suggest an alternative to heavy particle therapy for reduced 
oxygen enhancement ratios. Nature, 251, 521-522. 
Roizin-Towle L and Hall EJ. (1978) Studies with bleomycin and misonidazole 
on aerated and hypoxic cells. Sr. J. Cancer, 37, 254-260. 
Ross-Riveros P and Leith JT. (1979) Response of 9L tumor cells to hyperthermia 
and X irradiation. Radiat. Res., 78, 296-311. 
Rettinger Et~, Mendonca t~. (1982) Radioresistance secondary to low pH in human 
glial cells and chinese hamster ovary cells. Int. J. Radiat.Oncol. Biol. 
Phys., 8, 1309-1314. 
Rowell LB, Blackmon JR, Martin RH, Mazzarella JA and Bruce RA. (1965) Hepatic 
clearance of indocyanine green in man under therma1 and exercise stresses. 
J. Appl. Physiol., 20(3), 384-394. 
Rowell LB, Brengelmann GL and ~1urray JA. (1969) Cardiovascular responses to 
sustained high skin temperature in resting man. J. Appl. Physiol., 27(5), 
673-680. 
Rowell LB, Brengelmann GL, Blackmon JR and Murray JA. (1970) Redistribution of 
of blood flow during sustained high skin temperature in resting man. 
J. Appl. Physiol., 28(4), 415-420. 
Rowell LB, Detry J-MR, Profant GR and Wyss C. (1971) Splanchnic vaso-
constriction in hyperthermic man - role of falling blood pressure. 
J. Appl. Physiol., 31(6), 864-869. 
Schmid-Schonbein H, Weiss J, Ludwig H (1973) A simple method for measuring red 
cell deformability in models of the microcirculation. Slut, 24, 369-379. 
Schroder R, Dissman W, Kauder HG and Schiiren (1966). Alterabhiigigkeit und 
kOrperbezugsmasse des herzzietvolumens mit einern beitrag zur methodik 
der farbstoffverdunnungskurven. Klin .. Wschr., 44, 753-764. 
157 
Sapareto SA, Hopwood LE and Dewey WC. (1978) Combined effects of X irradiation 
and hyperthermia on CHO cells for various temperatures and orders of 
application. Radiat. Res., 73, 221-233. 
Sapirstein LA. (1958) Regional blood flow by fractional distribution of 
indicators. Am. J. Physiol., 193(1), 161-168. 
Scott JW. (1966) In: The physiological basis of medical practice. Best CH and 
Taylor N. (eds.). The Williams and Wilkins Co., Baltimore. p 1419. 
Shapiro Y, Rosenthal T and Sohar E. (1973) Experimental heatstroke: A model in 
dogs. Arch. intern. ~led., 131, 688-692. 
Shibolet S, Lancaster I~C. and Danon Y. (1976) Heat stroke: A review. 
Aviat. Space Environ. 11ed. 47(3), 280-301. 
Shoulders HS and Turner EL. (1942) Observations on the results of combined 
fever and x-ray therapy in the treabnent of malignancy. Southern Med. J., 
35, 966-970. 
Simpson BR, Strunin L and Walton B. (1971) The halothane dilemma: A case for 
the defence. Brit. Med. J., 4, 96-100. 
Sinclair I<K and ~lorton RA. (1965) X-ray and ultraviolet sensitivity of 
synchronized chinese hamster cells at various stages of the cell cycle. 
Biophys. J., 5, 1-25. 
Skibba JL and Collins FG. (1978) Effect of temperature on biochemical functions 
in the isolated perfused rat liver. J. Surg. Res., 24, 435-441. 
Smith R, Bull J .M., Lees DE and Schuette WH. (1980) Whole Body Hyperthermia: 
Nursing management and intervention. Cancer Nursing, June 1980, 185-189. 
Song CW. (1978) Effect of hyperthermia on vascular functions of nonnal tissues 
and experimental tumors: Brief communication. J. natn. Cancer Inst. 60, 
711-713. 
158 
Song CW, Kang ~1S, Rhee JG and Levitt SH. (1980) The effect of hyperthennia 
on vascular function, pH and cell survival. Radiology, 137, 795-803. 
Stead EA, Warren JV, Merrill AJ and Brannon ES. (1945) The cardiac output in 
male subjects as measured by the technique of right heart catheterisation. 
Normal values with observations on the effect of anxiety and tilting. 
J. Clin. Invest., 24, 326-331. 
Stickney DG, Hem1an TS and Gerner EW. (1980) Inhibitors of polyamine biosynthe-
sis can modulate the development of thennotolerance. Abstract. Third 
I nternati anal Symposi urn on Cancer Therapy by Hyperthermia Drugs and 
Radiation. Fort Collins, June 22-26. 
Stone HB. (1978) Enhancement of local tumor control by misoidazole and hyper-
thermia. Br. J. Cancer, 37 3, 178-183. 
Stratford IJ and Adams GE. (1977) The effect of hyperthermia on differential 
cytotoxicity of a hypoxic cell radiosensitizer Ro-07-0582 on mammalian 
cells in vitro. Br. J. Cancer, 35, 307-313, 
Strunin L. (1980) In: The circulation in anaesthesia. Prys-Roberts C. (ed.) 
Blackwell Scientific Publications, Oxford, London, Edinburgh, Melbourne. 
p 242. 
Suit HD. (1977) Hyperthennic effects on animal tissues. Radiology, 123, 
483-487. 
Suit HD and Gerweck LE. (1979) Potential for hyperthenni a and radiation 
therapy. Cancer Res., 39, 2290-2298. 
Sutherland K. (1980) personal communication. 
Symonds RP. (1982) Differential heat sensitivity of normal hemopoietic stem 
cells L1210 leukaemic cells in mouse bone marow. Strahlentherapie, 158(6), 
390. 
Takacs L, Debreczeni LA and Farsang C. (1975) Circulation in rats with Guerin 
carcinoma. J. Appl. Physiol., 38(4), 696-701. 
159 
Theye RA. (1972) The contributions of individual organ systems to the decrease 
of whole body V02 with halothane. Anesthesiology, 37(4), 367-372. 
Traks E and Sancetta SM. (1959) The effects of 'dry heat' on the circulation of 
man. II Splancnic haemodynamics. Ar1. Heart J., 57(3), 438-448. 
van der lee J, van Rhoon GC, Bonke-Spit L, Faithfull NS and Reinhold HS. 
(1979) Some problems encountered in the application of hyperthermia to 
patients. In: Proceedings of First Heeting of European Group of Hyper-
thermia in Radiation Oncology. Arcangeli G and Mauro F. (eds.) Masson 
Press. pp 283-288. 
van Rhoon GC and van der Zee J. (1981) Temperature distribution during whole 
body hyperthermia. Strahlentherapie, 157, 621-622. 
van Rhoon GC (1982) Personal communication. 
Vaupel P. (1974) Atemgaswechsel und glusosestoffwechsel von implantations-
tumoren (DS-carcinosarkom) in vivo, In: Funktionsanalyse biologischer 
systeme, Vol 1. Thews G. (ed.) Steiner Wiesbaden. 
Vaupel P. (1975) Interelationship between mean arterial blood pressure, blood 
flow and vascular resistance in solid tumor tissue of DS-carcinosarcoma. 
Experientia, 31(5), 587-589 
Vaupel P, Thews G, and Wendling P. (1976) Kritische sauerstoff- und glucose-
versorgung mal igner tumoren. Dtsch. r1ed. Wschr., 101, 1810-1816 
Vaupel P. (1977) Hypoxia in neoplastic tissue. Microvasc. Res., 13, 399. 
Vaupel P, Ostheimer K and Thome H. (1977) Blood flow, vascular resistance, and 
oxygen consumption of malignant tumors during normothermia and hyper-
thennia. Microvasc. Res., 13, 272. 
Vaupel P, Groenewold I,A, Manz R. and Sowa W. (1973) Intracapillary Hb02 
saturation in turnor tissue of DS-carcinoma during nonnoxia. In: Oxygen 
Transport to Tissue III. Eds: Silver lA, Erecinska M and Bicher HI. Plenum 
Press, New York 1978~ p367. 
160 
Vaupel P. (1979) Oxygen supply to malignant tissues. In: Tumor blood 
circulation: Angiogenesis, vascular morphology and blood flow of 
experimental and human tumors. Peterson H-1 (ed.), CRC Press, 1979, 
pl43-l68. 
Vaupel P, Ostheimer K and Miiller-Klieser W. (1980) Circulatory and metabolic 
responses of malignant tumors during 1 ocal i sed hyperthermia. 
J Cancer Res. Clin. Oneal., 98, 15-29. 
Versteegh PMR, van den Hoogen RHWM and Zwaveling A. (1981) Systemic hyper-
thermia by the immersion bath method. Neth. J. Surg., 33(4), 195-199. 
Vi nten-Johansen J, Barnard RJ, Buck berg GD, Becker H, Duncan HW and 
Robertson JM. (1982) Left ventricular 02 requirements of pressure and 
volume loading in the normal canine heart and innacuracy of pressure-
derived indices of 02 demand. Cardiovasc. Res., 16, 439-447. 
Voegtlin C, Kahler H and Fitch RH. {1935) The estimation of hydrogen ion 
concentration of tissues in living animals by means of the capillary glass 
electrode. Natn. lnst. Health Bull., 164, 15-27. 
Vollmar H. (1941) Uber den ei nfl uss der temperatur auf normal es gewebe und auf 
tumorgewebe. z. Krebsforsch., 51, 71-99. 
Von Ardenne M and Reitnauer PG. (1980) Selective occlusion of cancer tissue 
capillaries as the central mechanism of the cancer multistep therapy. 
Jap. J. Clin. Oncol., 10(1), 31-48. 
von Ardenne I~ and Kruger W (l980a) The use of hyperthermia within the frame 
of cancer multistep therapy. Anns. N.Y. Acad. Sci. 335, 356-361. 
von Ardenne M and Reitnauer PG (!980b). Selective inhibition of microcircula-
tion in tumor tissue. Naturwissenschaften, 67, 154. 
Walther 0-E, lriki M and Simon E. (1970) Antagonis<ic changes of blood flow 
and sympathetic activity in different vascular beds following central 
thermal stimulation. II Cutaneous and visceral sympathetic activity during 
spinal cord heating and cooling in anesthetized rabbits and cats. 
Pflugers Arch., 319, 162-18. 
161 
Warren SL. (1935) Preliminary study of the effect of artifical fever upon hope-
less tumor cases. Am. J. Roentg., 33(1), 75-87. 
Westra A and Dewey WC. (1971) Variation in sensitivity to heat shock during the 
cell-cycle of chinese hamster cells in vitro. Int. J. Radiat. Biol., 19(5), 
467-477. 
Winkler K and Tygstrup N. (1960) Determination of hepatic blood flow in man by 
cardia-green. Scand. J. Clin. Lab. Invest., 12,353-356. 
Wright GL. (1976) Critical thermal maximum in mice. J. Appl. Physiol., 40(5), 
683-687. 
Wiist G. (1975) HGH, corticosteroids, insulin, and glucose in serum during 
hyperthermia and effects of somatostatin in male volunteers. Proceedings 
of the International Symposium on Cancer Therapy by Hyperthermia and 
Radiation. Washington, D.C. April 28-30. pp 303-305. 
Wyss CR, Brengelmann GL, Johnson JM, Rowell LB and Niederberger M. (1974) 
Control of skin blood flow, sweating~ and heart rate: role of skin vs. core 
temperature. J. Appl. Physiol., 36(6), 726-733. 
Yatvin ~lB. (1977) The influence of membrane lipid composition and procaine on 
hyperthemic death of cells. Int. J. Radiat. Biol., 32(6), 513-521. 
Yaw TM. (1979) Procaine-mediated modification of membranes and of the response 
to X-irradiation and hyperthermia in mammalian cells. Radiat. Res., 80, 
523-541. 
Zeek P~l. (19421 Heart weight 1. The weight of the normal human heart. 
Arcll. Path., 34, 820-832 
Zitnik RS, Ambrosioni E and Shepherd JT. (1971) Effect of temperature on 
cutaneous venomotor reflexes in man. J. Appl. Physiol ., 31(4), 507-512. 
Zweifler A,J and Romero S. (1975) Effect of phentolamine on platelet aggregation 
in patients >Jith pheochromocytoma. Thromb. Res., 7, 505-513. 
Zweifler AJ and Julius S. (1982) Increased platelet catecholamine content in 
pheochromocytoma. A diagnostic test in patients with eleva ted plasma 
catecholamines. l'ew Eng. J. ~led., 306(15), 890-894. 

ACKNOWLEDGEMENTS 
am indebted to my promotors for their enthusiastic help and support 
during the performance of the work necessary for this thesis. My thanks are 
also due to my co-referents, in particular to Prof. Dr. C. Prys-Roberts for his 
helpful guidance and advice during my visits to Bristol. 
am also grateful to Prof. Dr. J .F. Koster for his interest and helpful 
comments on the changes in serum enzyme levels following hyperthermia. 
The clinical work in Hyperthermia was conducted together with members of 
the Department of Experimental Radiotherapy in the Rotterdam Radiotherapeutic 
Institute Dr J. van der Zee, Ing. G. van Rhoon, Mrs J. Wike-Hooley and my 
co-promotor Prof. Dr. H. Reinhold and I am grateful for their support. 
In particular must give credit and thanks tor the many hours of hard work 
and enthusiastic involvement supplied by Drs A. van den Berg, without whom none 
of the data analysis would have been possible. 
The cheerful and long suffering personality of my secretary Miss J. Theuerzeit 
was indispensible during the writing of this thesis. She will be sadly missed 
following her imminent return to t~ew Zealand. 
Finally must thank all those, to many to mention by name, including the 
technicians of the Experimental Anaesthesia 
Audiovisual Department of Erasr.ws University, 
University Hospital Dijkzigt. Their help and 
this thesis possible. 
Department, members of the 
and my co 11 eagues in the 
support in many ways has made 

CURRICULUM VITAE 
The writer of this thesis was born in 1940 in Whitchurch, England and was 
educated in Ruyton XI towns and Oxford. In 1958 he began his medical studies 
at Guys Hospital Medical School of the University of London. In 1963 he 
obtained his MRCS (Eng}, LRCP (Land}, and the MB, BS (Land}. 
After spending a year in preregistration house officer posts in Shrewsbury 
he served a 5 year commission in the British Royal Army Medical Corps. 
Anaesthesic training was undergone in various military hospitals in Germany and 
England. In 1977 he obtained his primary FFARCS. After leaving the forces the 
writer worked in the University Hospital of Birmingham where he obtained his 
final FFARCS (Eng} in 1970. 
After serving a year as a senior registrar in the United Birmingham 
Hospitals he moved to the Netherlands in 1971. He worked for one year in St. 
Nicolaas Ziekenhuis in Waalwijk and St Joseph Ziekenhuis in Dosterhout and then 
took up a post as anaesthetic specialist in the Academic Ziekenhuis Dijkzigt in 
1973. Since 1981 the author has been Director of Experimental Anaesthesia of 
the Erasmus University Rotterdam. 
The work for this thesis was performed in the Department of Experimental 
Radiotherapy at the Rotterdam Radiotherapeutic Institute and in the Department 
of Experimental Anaesthesia of the Erasumus University Rotterdam. 

